Towards an understanding of the role of Connexin26 in breathing by van de Wiel, Joseph
warwick.ac.uk/lib-publications   
 
 
 
 
 
A Thesis Submitted for the Degree of PhD at the University of Warwick 
 
Permanent WRAP URL: 
http://wrap.warwick.ac.uk/130001 
 
 
 
Copyright and reuse:                     
This thesis is made available online and is protected by original copyright.  
Please scroll down to view the document itself.  
Please refer to the repository record for this item for information to help you to cite it. 
Our policy information is available from the repository home page.  
 
For more information, please contact the WRAP Team at: wrap@warwick.ac.uk  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 TOWARDS AN UNDERSTANDING 
OF THE ROLE OF CONNEXIN26 IN 
BREATHING 
 
 
JOSEPH VAN DE WIEL 
 
DOCTOR OF PHILOSOPHY IN  
INTERDISCIPLINARY BIOMEDICAL SCIENCE 
 
THE UNIVERSITY OF WARWICK,  
WARWICK MEDICAL SCHOOL 
 
 
FEBRUARY 2019  
	 1	
TABLE OF CONTENTS 
FIGURES AND TABLES ............................................................................................................. 5	
ACKNOWLEDGEMENTS ........................................................................................................... 7	
DECLARATION ...................................................................................................................... 8	
SUMMARY........................................................................................................................... 9	
ABBREVIATIONS.................................................................................................................. 10	
1	 INTRODUCTION ........................................................................................................... 16	
1.1	 Taking a breath ............................................................................................... 16	
1.1.1	 How do we breathe? ............................................................................... 16	
1.1.2	 Why do we bother breathing? ................................................................. 17	
1.1.3	 What keeps us breathing? ....................................................................... 17	
1.1.4	 Why should we study central breathing networks? ................................. 21	
1.2	 Central respiratory chemoreception ............................................................... 22	
1.2.1	 Locus Coeruleus (LC) ............................................................................... 24	
1.2.2	 Nucleus tractus solitarious (NTS) ............................................................. 24	
1.2.3	 preBötzinger complex (preBötC).............................................................. 25	
1.2.4	 Retrotrapezoid nucleus (RTN) .................................................................. 26	
1.2.5	 Caudal chemosensitive site/caudal ventrolateral medullar (cVLM) .......... 27	
1.2.6	 Serotonergic neurons .............................................................................. 27	
1.2.7	 Glia and ATP release ................................................................................ 29	
1.3	 Central respiratory chemosensory transducers for pCO2 ................................. 31	
1.3.1	 ASIC1 and ASIC2 ...................................................................................... 32	
1.3.2	 TASK channels ......................................................................................... 33	
1.3.3	 GPR4 ....................................................................................................... 34	
1.3.4	 Inwardly rectifying potassium (Kir) channels ........................................... 35	
1.3.5	 Electrogenic sodium bicarbonate cotransporter (NBCe1) ........................ 36	
1.3.6	 Connexin26 ............................................................................................. 37	
1.4	 Connexin26 ..................................................................................................... 39	
1.4.1	 Connexin26 trafficking and assembly ...................................................... 39	
1.4.2	 Connexin26 structure .............................................................................. 40	
1.4.3	 Connexin26 gating ................................................................................... 42	
1.4.4	 Connexin26 CO2-sensitivity ...................................................................... 44	
1.4.5	 Connexin26 in disease ............................................................................. 46	
1.4.6	 Connexin26 as a conduit for evolutionary adaptions of air breathing 
 animals .................................................................................................... 48	
1.5	 Experimental aims .......................................................................................... 49	
2	 GATING DETERMINANTS OF CONNEXIN26 HEMICHANNELS: INTRACELLULAR CALCIUM AND CO2 
SENSITIVITY OF A PATHOLOGICAL MUTATION ............................................................................. 50	
2.1	 Introduction .................................................................................................... 50	
2.2	 Materials and methods ................................................................................... 52	
2.2.1	 HeLa cell culture and sample preparation................................................ 52	
2.2.2	 Photoactivation of intracellular Ca2+ ........................................................ 53	
	 2	
2.2.3	 Ca2+ imaging data capture and analysis .................................................... 53	
2.2.4	 Patch clamping data capture and analysis................................................ 54	
2.2.5	 Construction of connexin gene constructs ............................................... 54	
2.2.6	 Experimental aCSF solutions .................................................................... 56	
2.2.7	 Dye loading assay .................................................................................... 57	
2.2.8	 Dye loading data capture and analysis ..................................................... 59	
2.3	 Results ............................................................................................................ 59	
2.3.1	 Increased intracellular Ca2+ can be evoked through photolysis of NP-EGTA.. 
  ................................................................................................................ 59	
2.3.2	 CO2-dependent opening of Connexin26 hemichannels causes an influx of 
Ca2+ ......................................................................................................... 60	
2.3.3	 Connexin26 gap junctions, but not hemichannels, exhibit a whole cell 
conductance change in response to [Ca2+]i .............................................. 62	
2.3.4	 Whole cell conductance change evoked by [Ca2+]i  does not occur after 
exposure to hypercapnia ......................................................................... 63	
2.3.5	 Connexin26 N14K hemichannels do not open in response to CO2 ............ 65	
2.3.6	 The Connexin26 N14K mutant acts to drastically reduce CO2 sensitivity 
from cells expressing wild-type Connexin26 ............................................ 67	
2.4	 Discussion ....................................................................................................... 69	
2.4.1	 Differential opening of Connexin26 hemichannels and gap junction ........ 69	
2.4.2	 Blocking of [Ca2+]i-mediated Connexin26 gap junction gating by CO2: 
possible stimuli interactions .................................................................... 71	
2.4.3	 A hemichannel is not half of a gap junction ............................................. 72	
2.4.4	 Possible mechanisms by which the N14K loss of function mutant prevents 
Connexin26 hemichannel gating by CO2 .................................................. 73	
2.4.5	 Implications for KID syndrome ................................................................. 75	
2.4.6	 A gateway to studying Connexin26 CO2 sensitivity in vivo ........................ 77	
3	 CHARACTERISATION OF CO-ASSEMBLY AND CO2-INSENSITIVITY OF A CONNEXIN26 DOMINANT 
NEGATIVE MUTANT .............................................................................................................. 78	
3.1	 Introduction .................................................................................................... 78	
3.2	 Materials and Methods ................................................................................... 81	
3.2.1	 HeLa cell culture and sample preparation ................................................ 81	
3.2.2	 Construction of connexin gene constructs ............................................... 81	
3.2.3	 Acceptor depletion FRET assay ................................................................ 82	
3.2.4	 FRET data capture and analysis ................................................................ 85	
3.2.5	 Experimental aCSF solutions .................................................................... 88	
3.2.6	 Dye loading assay .................................................................................... 88	
3.2.7	 Dye loading data capture and analysis ..................................................... 88	
3.3	 Results ............................................................................................................ 88	
3.3.1	 Connexin26 WT colocalises with Connexin26 DN and Connexin43 WT 
when expressed in vitro ........................................................................... 88	
3.3.2	 Connexin26 WT and Connexin26 DN subunits more closely interact than 
Connexin26 WT and Connexin 43 WT ...................................................... 89	
	 3	
3.3.3	 Connexin26 WT and Connexin26 DN constructs show a negative 
correlation between FRET efficiency and donor-acceptor ratio ............... 94	
3.3.4	 Connexin26 DN hemichannels do not open in response to CO2 ............... 96	
3.3.5	 Expression of Connexin26 DN removes CO2-sensitive dye loading in cells 
stably expressing Connexin 26 WT........................................................... 99	
3.4	 Discussion ..................................................................................................... 101	
3.4.1	 Connexin26 DN is capable of trafficking to the membrane in the presence 
of wild-type Connexin26 ........................................................................ 101	
3.4.2	 Connexin26 WT and Connexin26 DN subunits coassemble into 
heteromeric connexon hemichannels.................................................... 102	
3.4.3	 Connexin26 connexons can be found within 10nm of each other .......... 104	
3.4.4	 Connexin26 and Connexin43 connexons can be found within 10nm of each 
other ..................................................................................................... 105	
3.4.5	 Refinement of a previously published quantitative adFRET approach .... 106	
3.4.6	 Connexin 26 DN acts in a dominant negative fashion to eliminate CO2-
Sensitivity from connexon hemichannels............................................... 109	
3.4.7	 Dominant Negative Connexin 26 could be used for in vivo experiments to 
investigate the CO2 sensitivity of connexin 26 expressing cells .............. 111	
4	 PROGRESS TOWARDS TESTING THE ROLE OF CO2-SENSING VIA CONNEXIN26 IN GLIAL CELLS AS A 
CHEMOSENSORY REGULATOR OF BREATHING ........................................................................... 112	
4.1	 Introduction .................................................................................................. 112	
4.2	 Materials and Methods ................................................................................. 114	
4.2.1	 Lentivirus design and handling .............................................................. 114	
4.2.2	 Animals and brain surgery ..................................................................... 117	
4.2.3	 Immunohistochemistry ......................................................................... 118	
4.2.4	 Immunohistochemistry imaging and virus expression scoring ............... 121	
4.2.5	 Whole-body plethysmography .............................................................. 121	
4.2.6	 Plethysmography data capture and analysis .......................................... 123	
4.2.7	 Power calculation .................................................................................. 126	
4.3	 Results .......................................................................................................... 126	
4.3.1	 Design and expression of lentivirus constructs ...................................... 127	
4.3.2	 Initial analysis of batch 1 animals showed no breathing phenotype....... 128	
4.3.3	 Batch 1 immunohistochemistry revealed two sub-groups of animals .... 130	
4.3.4	 Batch 1 animals with expression at the caudal chemosensitive region show 
a blunted tidal volume response to 6% hypercapnia ............................. 132	
4.3.5	 Batch 2 animals showed no breathing phenotype and accurate injection 
sites ....................................................................................................... 136	
4.3.6	 Different GFAP+ cell morphologies at the ventral medullary surface ...... 137	
4.4	 Discussion ..................................................................................................... 144	
4.4.1	 The role that Connexin26 CO2 sensitivity plays in adaptive changes in 
breathing frequency at the rostral chemosensitive site ......................... 144	
4.4.2	 The role that Connexin26 CO2 sensitivity plays in adaptive changes in tidal 
volume at the rostral chemosensitive site ............................................. 147	
	 4	
4.4.3	 Connexin26-mediated ATP release in the RTN ....................................... 149	
4.4.4	 The role that Connexin26 CO2 sensitivity plays in adaptive changes in 
breathing frequency at the caudal chemosensitive site ......................... 151	
4.4.5	 The role that Connexin26 CO2 sensitivity plays in adaptive changes in tidal 
volume at the caudal chemosensitive site ............................................. 151	
4.4.6	 Summary of the role Connexin26 CO2 sensitivity plays in chemoreception 
at the ventral medullary surface ............................................................ 153	
4.4.7	 Glia morphologies could prove important for function .......................... 154	
4.4.8	 Future work: design of a full study to investigate the role of Connexin26 
CO2 sensitivity in glia within the caudal chemosensitive site .................. 156	
5	 DISCUSSION ............................................................................................................. 158	
5.1	 Caveats of the LV-GFAP:Cx26 experiments .................................................... 158	
5.1.1	 Experimental controls ............................................................................ 159	
5.1.2	 Undetermined roles of Cx26 .................................................................. 160	
5.2	 Connexin26 mediated ATP release in RTN - what does it do if it does not 
regulate breathing? ....................................................................................... 161	
5.2.1	 Control of airway resistance .................................................................. 162	
5.2.2	 Species-specific role .............................................................................. 163	
5.2.3	 Hypercapnia-induced auditory hypervigilance ....................................... 163	
5.3	 Better understanding central respiratory chemoreception: experimental 
considerations ............................................................................................... 164	
5.3.1	 Age dependent hypercapnic respiratory response ................................. 165	
5.3.2	 Relevant experimental techniques......................................................... 166	
6	 CONCLUSION ............................................................................................................ 168	
REFERENCES ..................................................................................................................... 169	
 
 	  
	 5	
FIGURES AND TABLES 	
Figure 1.1  Neuroanatomy of central respiratory chemoreceptors in the medulla 
oblongata ..................................................................................................... 18 
Figure 1.2  Equation of the reaction driven by carbonic anhydrase ................................. 32	
Figure 1.3  Connexin26 structure .................................................................................... 41	
Figure 1.4  Amino acid residues vital for Connexin26 CO2-sensitivity .............................. 45 	
Figure 2.1  Hypothesis for enhanced CO2-mediated ATP release via [Ca2+]i ..................... 51 
Figure 2.2  Measurements and calculation for conductance change ............................... 55	
Figure 2.3  Dye loading protocol ..................................................................................... 58	
Figure 2.4  Experimental rationale: Increased [Ca2+]i can be evoked through photolysis of 
NP-EGTA....................................................................................................... 60	
Figure 2.5  Connexin26 gap junctions but not hemichannels open in response to [Ca2+]i 61 
Figure 2.6  Connexin26 gap junction opening via [Ca2+]i may be blocked by CO2-
dependent closing of Connexin26 ................................................................ 64	
Figure 2.7  Connexin26 N14K hemichannels do not open in response to CO2 ................. 66	
Figure 2.8  The Connexin26 N14K mutant acts in a dominant negative manner to remove 
CO2 sensitivity from cells expressing wild type Connexin26 .......................... 68	
Figure 2.9  Location of the N14K Keratitis, Ichthyosis, and Deafness (KID) syndrome 
mutation ...................................................................................................... 74 	
Figure 3.1  Hypothesis for Removal of Hemichannel Opening by the Dominant Negative 
Connexin26 mutant ...................................................................................... 79	
Figure 3.2  Acceptor depletion Förster Resonance Energy Transfer rational ................... 84	
Figure 3.3  FRET signals between connexin variants ....................................................... 90	
Figure 3.4  Dominant Negative Connexin 26 localises to gap junction plaques ............... 92 
Figure 3.5  FRET efficiency of coexpressed Connexin variants ......................................... 94	
Figure 3.6  Connexin26 variants coassemble into heteromeric connexons ..................... 95	
Figure 3.7  Gap junction ROIs vs. non-gap junction ROIs ................................................. 97	
Figure 3.8  The Dominant Negative Connexin26 mutant (Cx26DN) does not open in 
response to CO2 ........................................................................................... 98	
Figure 3.9  The Dominant Negative Connexin26 mutant (Cx26DN) removes CO2-sensitivity 
in HeLa cells stably expressing Cx26WT (Cx26-HeLa cells) ............................ 100 	
Figure 4.1  Hypothetical contribution of Connexin26 to the hypercapnic respiratory 
response initiated in the rostral ventral medullary surface ......................... 115	
Figure 4.2  Lentivirus design and in vivo expression ...................................................... 116	
Figure 4.3  Virus injection target location ..................................................................... 119	
Figure 4.4  Plethysmography apparatus and setup ....................................................... 124	
Figure 4.5  Representative whole-body plethysmography trace from conscious wild-type 
mice showing typical breathing changes in response to hypercapnia ......... 125	
	 6	
Figure 4.6  Batch 1: Connexin26-mediated hypercapnic breathing response in conscious 
mice ........................................................................................................... 131	
Figure 4.7  Batch 1: Immunohistochemistry showing locations of virus expression ....... 133	
Figure 4.8  Batch 1 caudal virus expression only: Connexin26-mediated hypercapnic 
breathing response in conscious mice ........................................................ 135	
Figure 4.9  Batch 1: possible tidal volume phenotype in response to 6% CO2 at 3 weeks 
post-transduction ....................................................................................... 138	
Figure 4.10  Batch 2: Connexin26-mediated hypercapnic breathing response in conscious 
mice ......................................................................................................... 139	
Figure 4.11  Batch 2: Immunohistochemistry showing location of virus expression ...... 140	
Figure 4.12  Batch 2: expression of Cx26 variants in the RTN shows no suggestion of a 
phenotype in response to 6% CO2 at 3 weeks post-transduction .............. 141	
Figure 4.13  Glia morphologies in the RTN region of the ventral medullary surface ...... 143	
Figure 4.14  Glia morphologies in the caudal chemosensitive region of the ventral 
medullary surface..................................................................................... 146	
Supplement figure 4.1  Connexin26 expression in GFAP+ cells contributes to respiratory 
chemoreception ..................................................................... 148	
Supplement figure 4.2  Connexin26 expression in neural crest cells of the caudal medulla 
contributes to respiratory chemoreception ............................ 154 		
Table 3.1  Summary statistics for connexin co-expressions ............................................. 93 	
Table 4.1  Summary of the role that Cx26 hemichannels play in chemoreception at 
different chemosensitive sites at the ventral medullary surface ................. 154 
 
	 7	
ACKNOWLEDGEMENTS 
 
Thank you to my supervisor, Professor Nicholas Dale, for proving me with the fantastic 
opportunity to take on this PhD project, and for his continual support, guidance, and 
encouragement in all aspects of my work and professional development these past 3 
years. I would also like to thank my secondary supervisor, Dr Mark Wall. 
 
Thank you to my advisory committee – Dr Robert Dallmann and Dr Robert Durafford-
Huckstepp – for their corrections, suggestions, and genuine enthusiasm to see me 
succeed. Additional thanks to Dr Robert Durafford-Huckstepp, for his exceptional 
teaching and continued mentorship concerning the in vivo aspects of my project, and for 
all his advice and explanations concerning research techniques and the respiratory field. 
 
Thank you to all members of C116 and C117, past and present, for the teaching and 
support – with special mention to Greta, JC, Liz, Eric, Louise, and Amol, without whom I 
would have got nowhere. 
 
Thank you to all members of the BSU facility, for their teaching and the diligent work 
they do for the animals in the facility. 
 
Thank you to the MRC for my funding, and to The Univeristy of Warwick and the IBR-DTP 
for providing me with abundant opportunities. Thank you to Nick and Gokhan, who 
traversed the DTP years with me and brought me endless laughter. 
 
To those named above: I did not deserve to be so lucky to have met and worked with 
even one of you and I am very glad that I got to share my PhD with you. 
 
Thank you to my parents and family for their unconditional love, and the blind faith that 
they have always had in me.  
 
Most of all thank you to my fiancée Kathryn, words cannot express my gratitude for all 
you have done for me during my PhD, and I only hope that I can repay you over the rest 
of our life together.   
	 8	
DECLARATION 
 
This thesis is submitted to the University of Warwick in support of my application for the 
degree of Doctor of Philosophy. It has been composed by myself and has not been 
submitted in any previous application for any degree. 
 
The work presented (including data generated and data analysis) was carried out by the 
author except in the cases outlined below:  
• Patching of cells for [Ca2+]i experiments in chapter 2 was done by Nicholas Dale, 
all other parts of the experiments and analysis were performed by Joseph van de 
Wiel 
• A subset of dye loading experiments in chapter 2 were performed in conjunction 
with Elizabeth de Wolf and Jonathan Cook 
• Time course dye loading experiments in chapter 3 (Figure 3.9) were performed by 
Louise Meigh 
• Connexin26-KO data shown in chapter 4 (Supplement figure 4.1 and Supplement 
figure 4.2) was performed by Xintao Zhang 
 
Parts of this thesis have been published by the author: 
• de Wolf, E., van de Wiel, J., Cook, J., & Dale, N. (2016). Altered CO 2 sensitivity of 
connexin26 mutant hemichannels in vitro. Physiological reports, 4(22), e13038. 
 
All figures or images not originally produced by the author were reproduced with 
permission.  
	 9	
SUMMARY 
 
Connexin26 (Cx26) hemichannels expressed in glia at the ventral medullary surface 
(VMS) have been proposed to play a role in respiratory chemoreception, although this is 
disputed. At the VMS Cx26 hemichannels open in response to CO2 directly, causing ATP 
release that is capable of increasing respiratory drive. The main aim of this work was to 
establish a genetic strategy that can be used in vivo to elegantly remove Cx26 CO2-
sensitivity from chemosensitive areas of the VMS, and to thereby investigate the role 
that Cx26 CO2 sensitivity plays in the chemoreception of awake mice. 
Using Förster resonance energy transfer and dye loading studies a Cx26 mutant 
(Cx26DN) was found to coassemble with Cx26WT subunits (forming heteromeric connexon 
hemichannels) and to remove CO2-induced hemichannel opening from cells stably 
expressing Cx26WT.  
In mice aged 12-18 weeks, bilateral lentivirus injections were used to express 
Cx26DN in GFAP+ cells at the VMS, as a means of removing CO2-induced Cx26 
hemichannel opening and subsequent ATP release. As determined by whole-body 
plethysmography, expression of Cx26DN in the retrotrapezoid nucleus (RTN) had no effect 
on the hypercapnic ventilatory response in mice. Accidental Cx26DN expression in the 
caudal chemosensitive area resulted in reduced tidal volume 3 weeks post-transduction, 
however this was not well supported statistically. Such an auspicious result from sub-
optimal caudal expression warrants this to be repeated in order to validate these results.  
The work performed in this thesis outlines the first use of a highly novel genetic 
tool to remove the CO2-sensitivity property of Cx26 from specific cells, without removing 
the protein from the system. The results shed light on our understanding of central 
respiratory chemoreception, suggesting that Cx26 plays no role in chemoreception in the 
RTN but is likely to play a role in caudal areas of the VMS. Such a tool could aid research 
into the virtually unexplored role that Cx26 CO2 gating has in the body.   
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“Our breath… ever renewed it was always forthcoming, destined to be 
the last adjunct that shall leave the body, and the only one to remain 
when all is gone beside; it drew, in fine, its origin from heaven” 
 
- Pliny the Elder (approx. 50 AD) 
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1 INTRODUCTION 
 
1.1 Taking a breath 
	
Breathing is essential for human life – this has been recognised for millennia. In 
approximately 400 BC, Democritus theorised that breathing exists to bring mind and soul 
atoms into the body as a means to counteract pressure from internal soul atoms – thus 
preventing expulsion of the soul that resides in the animal (Aristotle approx. 350 BC). Our 
understanding of how and why we breathe has progressed somewhat since then, 
although certain parts of this process still remain a mystery.  	
1.1.1 How do we breathe? 
A breath consists of the flow of air from the external environment into the lungs 
(inspiration), followed by the flow of air within the lungs out into the external 
environment (expiration). Air flows in through the mouth or nose, down the trachea, 
through the bronchi and bronchioles, and into alveolar sacks. Alveoli are richly supplied 
with capillaries and therefore provide a perfect environment for the exchange of gases 
between the outside air and the blood.  
Inspiration occurs due to contraction of the diaphragm and external intercostal 
muscles, which expands the chest cavity and subsequently the lungs. This deceases the 
pressure within the lungs (Boyle’s law) below the atmospheric pressure in the outside 
environment, resulting in air to flow into the lungs (i.e. from higher to lower pressure). 
Expiration occurs due to compression of the chest cavity and lungs, which increases the 
pressure within the lungs above that of atmospheric pressure and subsequently expels 
air out of the lungs. At rest expiration usually occurs simply through the relaxation of the 
diaphragm and external intercostal muscles and subsequent elastic recoil of the lungs. 
However, when the body is in demand of greater gaseous exchange forced expiration 
can be employed, during which internal intercostal muscles and abdominal muscles 
contract (in addition to diaphragm and external intercostal relaxation) in order to help 
drive a quicker and more forceful breathing (Evans, Hartridge, and Starling 1956, Pocock 
et al. 2013). 
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1.1.2 Why do we bother breathing? 
Every cell in the body undergoes (cellular) respiration in order to produce energy for 
performing various tasks. This requires the use of O2 and yields CO2 as a waste product. 
As cells are rarely dormant, there needs to be both a continuous supply of O2, for 
metabolic processes, and continual removal of CO2, which will otherwise build up and 
disrupt the acid-base balance (potentially leading to respiratory acidosis) (Engelking 
2015). In vertebrates this is achieved via breathing. 
Breathing facilitates the exchange of gas at the alveoli-capillary interface, thereby 
enabling the partial pressure of blood O2 (pO2) and CO2 (pCO2) to be maintained at the 
levels required for cellular processes to continue. In humans pO2 is adjusted from ~40 
mmHg to 100 mmHg, and pCO2 is adjusted from 45 mmHg to 35 mmHg; although pCO2 
levels may range as far as 20 mmHg and 70 mmHg (West 2012).  
 
1.1.3 What keeps us breathing? 
In order to maintain pO2 and pCO2 homeostasis we have to breathe all the time, even at 
rest. The two mechanical respiratory phases (inspiration and expiration) are controlled 
by three neural phases: i) inspiratory, ii) post-inspiratory, and iii) expiratory (when active 
expiration is required) (Richter 1996). Therefore, it is logical for a central pattern 
generator (CPG) to set up rhythmic breathing, which can then be adapted to meet our 
dynamic metabolic needs (Hooper 2000). Accordingly, this is what has been found for 
breathing, although emerging evidence suggests that separate CPGs might exist for the 
three neural phases of respiration.  
The pre-Bötzinger Complex (preBötC) was the first of these CPGs to be proposed. 
It is found close to the ventral medullary surface (VMS) in the ventrolateral respiratory 
column (VLRC) (Figure 1.1c,d). The preBötC has a wealth of evidence (and support from 
the respiratory community) showing that it is the microcircuit responsible for the 
rhythmogenesis of inspiratory neurons (Feldman et al. 1990, Smith et al. 1991, Feldman 
and Kam 2015, Schwarzacher, Rüb, and Deller 2010, Tan et al. 2008, Johnson, Koshiya, 
and Smith 2001, Dobbins and Feldman 1994, Koizumi et al. 2008, Heywood et al. 1996, 
Feldman, Del Negro, and Gray 2013, Moore et al. 2013, Moore, Kleinfeld, and Wang 
2014). It has been proposed that the preBötC consists of pre-inspiratory neurons that 
produce ‘burstlets’, thus providing rhythmogenic properties of the CPG, as well as  
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Figure 1.1  Neuroanatomy of central respiratory chemoreceptors in the medulla oblongata. a) 
Ventral view of the mouse medulla showing the classic chemosensitive sites that were first 
identified - Rostral, Intermediate, and Caudal (blue ovals). b) Top: Confocal image (ventral view) 
showing serotonergic neurons of the rat medulla stained with anti-TpOH antibody (green), and 
blood vessels filled with fluorescein-tagged albumin (red). (image reproduced from Bradley, S. R., 
et al., 2002). Bottom: same image as the top panel but overlaid is the classical chemosensitive 
sites (blue ovals), and sites that exhibit an ATP release in response to CO2 (black circles), along 
with sites that do not exhibit such ATP release (white circles). These serotonergic neurons, and 
the sites of ATP release are chemosensitive. c) Parasagittal view of the mouse medulla, 
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representing the entire mediolateral axis, showing regions with evidence supporting their role in 
central respiratory chemoreception (blue), and landmarks in grey. For the visual purposes of 
distinguishing between the chemosensitive regions two diagrams are shown, with the bottom 
only showing chemosensitive raphé nuclei. Below each diagram show how the classical 
chemosensitive sites correlate to the rostrocaudal axis: unlike the rostral area, the true position 
of the intermediate and caudal areas are poorly characterised, as such they are represented by 
dashed lines. d) Coronal view of the mouse medulla, representing the entire rostrocaudal axis, 
showing regions with evidence supporting their role in central respiratory chemoreception (blue). 
R, rostral; I, Intermediate; C, caudal; LC, locus ceruleus; 7N, facial nerve; NTS, nucleus tractus 
solitarious; cNTS, caudal nucleus tractus solitarious; Amb, ambiguous; VII, facial nucleus; SO, 
superior olive; preBotC, pre-Bötzinger Complex; BotC, Bötzinger Complex; VRG, ventral 
respiratory group; cVLM, caudal ventrolateral medulla; RTN/pFRG, retrotrapezoid 
nucleus/parafacial respiratory group; PB, parabrachial nucleus; K-F, Kölliker-Fuse nucleus; Mo5, 
motor trigeminal nucleus; RM, raphé magnus; ROb, raphé obscurus; RPa, raphé pallidus. Scale 
bars; 1 mm in (a, c, d), 1.5 mm in (b). 
 
inspiratory neurons that pattern the respiratory output (Feldman and Kam 2015, Kam et 
al. 2013, Cui et al. 2016). 
It has been hypothesised that different rhythm generators exist for inspiration 
and active expiration (Janczewski and Feldman 2006), and this notion has since been 
supported with the discovery of silent neurons that, during active expiration, can be 
transformed into rhythmically active cells with a firing pattern correlating with late-phase 
active expiration (Pagliardini et al. 2011, Huckstepp et al. 2015). The location of this 
conditional expiratory oscillator has been defined, by injection site, as the lateral 
parafacial region (pFL) (Huckstepp et al. 2015). The pFL is located within the VLRC (Figure 
1.1c,d) and develops from the embryonic parafacial region (e-pF) (Huckstepp et al. 2016) 
– the region responsible for early rhythmic and patterned respiratory activity in the 
embryo (Oku, Masumiya, and Okada 2007). 
The most recently proposed CPG is the post-inspiratory complex (PiCo). This is a 
region containing neurons with autonomous rhythmogenic properties that are sufficient 
for post-inspiratory activity (Anderson et al. 2016). The PiCo is also found within the 
VLRC, medial to the rostral section of the nucleus ambiguous (NA) (Figure 1.1c,d). The 
status of the PiCo as a CPG has been strongly contested (Poon and Song 2017), and other 
studies would suggest that much of the post-inspiratory drive is derived from pontine 
structures such as the Kollicker Fuse nucleus (K-F) (Mörschel and Dutschmann 2009). 
Rational interactions between these respiratory CPGs have been proposed, with 
evidence being provided for the influence that the preBötC (inspiratory) and pFL 
(expiratory) have on one other in a hypothetical coupled oscillator system (Mellen et al. 
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2003, Feldman and Del Negro 2006, Huckstepp et al. 2015, Huckstepp et al. 2016, 
Anderson and Ramirez 2017). However, given how recent the discovery of the PiCo (post-
inspiratory) CPG is, further work is required in order to affirm the precise interactions 
between all three. Nevertheless, these findings show great promise for our fundamental 
understanding of central respiratory networks. 
The respiratory output that determines breathing pattern does not depend solely 
on signals from CPGs, but also upon signals relayed from other, non-CPG, nucle. Often 
nuclei involved in orchestrating respiration are divided into one of three respiratory 
groups. The ventrolateral respiratory column (VLRC) is the major group with which this 
thesis is concerned and contains the CPGs mentioned above as well as many putative 
central respiratory chemoreceptors (CRCs) (see 1.2 Central respiratory chemoreception), 
Figure 1.1. It also contains inspiratory neurons that signal to premotor and motoneurons, 
and expiratory neurons that signal to control upper airway resistance. Note that the VLRC 
is also referred to as the ventral respiratory group (or VRG), however in this thesis the 
name “VRG” is reserved for the nuclei found at the caudal region of the VLRC. 
The other two respiratory groups are the pontine respiratory group (PRG) and the 
dorsal respiratory group (DRG). Since the discovery of the nuclei that make up the VLRC 
research concerning the DRG and PRG has declined massively, owing to the great 
promise that the VLRC shows for controlling respiration. That being said, the PRG and 
DRG do play some role in contributing to breathing pattern. The PRG is situated within 
the dorsolateral pons and is responsible for receiving afferents from vagal reflexes 
associated with lung volume. Notably it contains the K-F. Although the PRG is capable of 
producing respiratory activities, including generating respiratory rhythm (St John and 
Bledsoe 1985, St John 1998), its neurons are largely inhibited in conscious animals and so 
it is considered to play more of a redundant role to back up, rather than contribute to, 
respiratory control (Feldman and Gautier 1976a, Feldman, Cohen, and Wolotsky 1976b, 
Cohen and Feldman 1977, Mörschel and Dutschmann 2009). The DRG is situated within 
the nucleus tractus solitarious (NTS) of the dorsal medulla and is believed to be relay for 
peripheral inputs – receiving primary afferents from both mechanical and chemical 
peripheral signals and sending efferent neurons to respiratory premotor neurons in the 
medulla, motoneurons in the spinal cord, and down to nuclei of the VLRC. The DRG is 
also responsible for cardiovascular reflexes (Nattie 1999, Kubin 1994, Stornetta et al. 
2006, Takakura et al. 2006, Huckstepp and Dale 2011).  
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1.1.4 Why should we study central breathing networks? 
As it is so important, evolution has ensured that our ability to breath is robust and has 
the redundancy to compensate in the face of defects. In testimony to this, the 
respiratory problems that are most prevalent in the population (e.g. chronic obstructive 
pulmonary disease and asthma) are mechanical in nature, reducing airflow into or out of 
the lungs. Nevertheless, certain diseases states have been linked to the central 
components, and others may yet be linked as our understanding increases.  
Sleep apnoea (respiratory pauses) affects 3-7% of males and 2-5% of adult females 
(Punjabi 2008) and whilst many cases are mechanical in nature there are those that 
result from central dysfunctions (Fairchild et al. 2016), such as congenital central 
hypoventilation syndromes (CCHS). As it stands we poorly understand the mechanisms 
behind central sleep apnoeas, even in the case of CCHS for which a causative gene has 
been identified (PHOX2B).  
Sudden infant death syndrome (SIDS) effects around 1 in 5,000 births (Kinney and 
Thach 2009) and although it is defined as the death of an infant by unknown cause, it has 
been attributed to an inability to counteract rises in blood CO2 during sleep (Harper et al. 
2000). As it stands we are yet to make a definitive link between central respiratory 
dysfunction and SIDS, although there are ideas that warrant investigating further. Recent 
studies suggesting that inflammatory-induced release of prostaglandin E2 (PGE2), in the 
retrotrapezoid nucleus (RTN), can modify the hypercapnic ventilatory response (HCVR) 
and could have far-reaching implications in this event (Forsberg et al. 2016, Forsberg, 
Ringstedt, and Herlenius 2017).  Additionally, there have been reported cases of SIDS 
infants that showed signs of medullary serotonin dysfunction (Paterson, Hilaire, and 
Weese-Mayer 2009). Serotonin is a neurotransmitter and is released from medullary 
raphé neurons that have been proposed to play a role in chemoreception (Hodges and 
Richerson 2010) (see 1.2.6 Serotonergic neurons). It is likely that there are multiple 
defects that give rise to the diagnosis of SIDS, and therefore the more respiratory 
pathways we can connect/dismiss the closer we become to developing prevention 
measures and treatments. 
Rett syndrome affects around 1 in 10,000 female births (Neul et al. 2010) and 
results in mental and physical disability. Patients with Rett syndrome also experience 
severe breathing disturbances characterised by abnormal breathing patterns and 
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reduced CO2 sensitivity (Ramirez, Ward, and Neul 2013). This reduced CO2 
chemosensitivity has been linked to a deficiency in the expression of methyl-CpG-binding 
protein 2 (MeCP2) in glial, which is believed to be important in sensing CO2 (Garg et al. 
2015, Turovsky et al. 2015). With increased understanding we may be able to uncover 
targets to help develop therapies that could rectify or compensate for this deficiency. 
The need to study respiratory networks extends beyond disease. Opiate 
intoxication depresses respiratory activity (Stuth, Stucke, and Zuperku 2012), which can 
become dangerous and limits the safe use of opiate analgesics. With a better 
understanding of respiratory network mechanisms, we may be able to provide new 
targets to counteract these effects, thus opening the doors to new methods of pain 
relief. 
Another forward-looking reason to study central respiratory circuits is because it 
represents one of the least complex rhythmic behaviours that is common across animals 
(Feldman and Kam 2015, Feldman and Grillner 1983) and can be measured in well-
defined manner. The relationship between neural microcircuits and behaviour is subject 
to numerous confounding variables, which makes it difficult when trying to ascertain 
what components are relevant and why (Carandini 2012). Therefore, comprehension of 
the circuitry responsible for a simpler operation, like breathing, might uncover processes 
that are common to many rhythmic circuits and is likely to inspire progressive 
approaches and attitudes to further dissect the role of behavioural circuits.  
 
1.2 Central respiratory chemoreception 
	
It is important that the body has a way to sense and process chemical inputs 
(chemoreception) such as pO2 and pCO2 so that respiratory patterns can be regulated in 
order to adjust breathing to meet metabolic needs. pO2 sensing occurs centrally and 
peripherally, with ~80% of the hypoxic ventilatory response being attributed to 
peripheral sensing of pO2 (Acker 1989, Prabhakar 2006), and ~20% attributed to central 
O2 chemoreception (Powell et al. 2009, Neubauer and Sunderram 2004). Sensing of pCO2 
also occurs peripherally and centrally, however unlike pO2 it is central CO2 
chemoreception that takes precedence, being responsible for ~60-70% of the 
hypercapnic respiratory reflex, while peripheral CO2 chemoreception attributes ~30-40% 
(Carpenter, Hatton, and Peers 2000). Although it is important to monitor pO2, it appears 
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that pCO2 chemoreception is more important, and that hypercapnia (not hypoxia) is in 
fact the bigger threat to air-breathing animals (Phillipson, Duffin, and Cooper 1981, Spyer 
and Gourine 2009, Haldane and Priestley 1905). The focus of this thesis is on central 
respiratory chemoreception. 
Central chemoreception was first hypothesised over a hundred years ago when 
Winterstein suggested that CO2-stimulated breathing might be brought about through 
acidification of extracellular fluid near respiratory centres (Winterstein 1911). Central 
chemoreception was first demonstrated in 1953 when increased breathing was observed 
in response to the application of acidic solutions to the cerebral ventricles (Leusen 
1953a, 1953b). The studies that followed confirmed central chemoreception and 
identified particular areas of the VMS that are responsible; with focal acidification (to pH 
7.0) of either a caudal site (a.k.a. Loeschcke’s area) or a rostral site (a.k.a. Mitchell’s area) 
increasing respiratory activity, and acidification of a third, intermediate, region (a.k.a. 
Schlaefke’s site) reducing respiratory activity (Mitchell et al. 1963a, Mitchell et al. 1963b, 
Loeschcke et al. 1970, Schlaefke, See, and Loeschcke 1970, Trouth et al. 1973, Schlaefke, 
Kille, and Loeschcke 1979), Figure 1.1a.  
The original focal acidification experiments were performed on anaesthetised 
animals and used very high changes in pH to bring about a respiratory reflex, suggesting 
that there may be chemosensitive cells deeper within the medulla that are serviced by 
blood vessels that penetrate into the parenchyma from the surface. Since the 21st 
century our understanding of chemoreception has begun to accelerate, and there are 
now defined cell populations that have been identified as having chemosensitive 
properties. Cells with chemosensitivity that influences respiratory pattern are referred to 
as central respiratory chemoreceptors (CRCs) and some do indeed reside deeper within 
the medulla (Nattie and Li 2012, Huckstepp and Dale 2011), Figure 1.1c,d. The use of 
anaesthetised animal preparations is still a confounding problem in many of the 
experiments undertaken in the 21st century, and should be considered when interpreting 
their results.  
The chemosensitive sites that were originally defined are often still referred to, 
however the current consensus is that the rostral site lies ventral to the facial motor 
nucleus (VII), comprising of the RTN/pFRG. The caudal and intermediate sites on the 
other hand are still poorly defined. Roughly, the intermediate site lies ventral to the 
Bötzinger complex (BötC) and rostral part of the preBötC, whilst the caudal site lies 
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ventral to the ventral respiratory group (VRG) and the caudal part of the preBötC, in the 
vicinity adjacent to the hypoglossal nerve (XII) rootlets, Figure 1.1a,c. 
Currently proposed chemosensitive sites in the brainstem are usually found close 
to the brain surface, in regions richly supplied with blood vessels that have neuronal cell 
bodies or axon terminals juxtaposed (Okada, Chen, and Kuwana 2001, Okada et al. 2002). 
Below we discuss putative central respiratory chemoreceptors (CRCs):  
 
1.2.1 Locus Coeruleus (LC) 
The Locus Coeruleus (LC) is in the PRG and contains catecholaminergic neurons. It acts as 
a fear relay for the Amygdala and is involved in hypoxia-induced hyperventilation. The LC 
has been proposed as a CRC based on hypercapnia-evoked c-fos immunoreactivity, 
preservation of chemosensitivity in cultured neurons even when subjected to synaptic 
blockade (suggesting intrinsic chemosensitivity), and ablation and focal acidification 
studies in anaesthetised animals (Huckstepp and Dale 2011, Berquin et al. 2000, Stunden 
et al. 2001, Filosa, Dean, and Putnam 2002, Fabris et al. 2000, Ferreira, de Paula, and 
Branco 2004).  
This evidence does not necessarily show that the LC is a site of primary 
chemoreception, although a potential chemosensory transducer has been identified (see 
1.3 Central respiratory chemosensory transducers for pCO2). Therefore, in an intact 
animal under physiological conditions, the CRC properties reported in the literature 
might be secondary, responding instead to signals received from a primary CRC. 
Whatever the role that the LC plays in chemoreception it would appear to change 
depending on the stage of development – the percentage of chemosensitive neurons in 
the LC is highest in neonates, however in rodents this number drops dramatically 
(Nichols et al. 2008, Gargaglioni, Hartzler, and Putnam 2010). 
 
1.2.2 Nucleus tractus solitarious (NTS) 
The nucleus tractus solitarious (NTS) is more-or-less synonymous with the DRG – a relay 
for peripheral respiratory and cardiovascular stimuli, with neuronal connections to many 
respiratory-related nuclei.  The evidence for NTS chemosensitivity is similar to that of the 
LC. The NTS shows hypercapnia-evoked immunoreactivity for c-fos, and cultured NTS 
slices preserved almost-all chemosensitivity upon synaptic blockade (Berquin et al. 2000, 
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Sato, Severinghaus, and Basbaum 1992). Additionally, in unanaesthetised rats 
acidification of the NTS, especially the caudal NTS (cNTS), resulted in increased breathing 
(Nattie and Li 2002). Interestingly, bilateral lesions of the cNTS in rats increased, not 
decreased, the HCVR (Sinclair, John, and Battlett 1985). The cNTS is also the region that is 
most responsible for coordinating the effect that peripheral chemoreceptors have on 
circulation and breathing (Boscan, Pickering, and Paton 2002).  
As with the LC, this is not definitive evidence for any part of the NTS to be 
considered a primary CRC, although potential chemosensory transducers in the NTS have 
been postulated (see 1.3 Central respiratory chemosensory transducers for pCO2). 
Regardless of its role in primary chemoreception, the NTS seems to be an important 
node for integrating cardiovascular and respiratory signals during hypercapnia. 
Furthermore, because NTS properties and coupling change during early development 
(Nichols et al. 2008, Vincent and Tell 1997), like the LC its precise role in the respiratory 
network is likely to differ throughout an animal’s development. 
 
1.2.3 preBötzinger complex (preBötC) 
The preBötC is part of the VLRC. We have discussed its (confirmed) role in respiratory 
rhythmogenesis and potential role in mediating pattern (see 1.1.3 What keeps us 
breathing). Given its importance in respiratory activity it might stand to reason that the 
preBötC is itself intrinsically chemosensitive and acts as a primary site of 
chemoreception. In neonatal rat brainstem-spinal cord preparations, preBötC neurons 
showed activity in response to hypercapnic conditions, which was maintained during 
synaptic blockade (Koizumi et al. 2010, Kawai et al. 1996, Kawai, Onimaru, and Homma 
2006). Also focal acidification in anaesthetised animals increases respiratory drive 
(Solomon, Edelman, and O'Neal III 2000, Solomon, Chon, and Rodriguez 2003) and in 
awake goats caused mild tachypnoea (Krause et al. 2009). As of yet no chemosensory 
transducer molecule has been proposed for this CRC, although there is evidence of ATP 
release in the preBötC in response to hypercapnia (Thomas and Spyer 2000) and 
therefore presumably such a molecule does exist. 
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1.2.4 Retrotrapezoid nucleus (RTN)  
The retrotrapezoid nucleus (RTN) is part of the VLRC and is found rostral and ventral to 
the preBötC (Figure 1.1c,d). The RTN is widely believed to be more or less synonymous 
with the classical rostral chemosentive region. There has been confusion as to which 
region encompasses the RTN and which encompasses the parafacial group (PFG) – and 
because of this some previous studies combine them together as the RTN/PFG. The PFG 
is now believed to be synonymous with the newly determined lateral parafacial region 
(pFL), which was defined in an unbiased manner based on location. In the same manner 
the ventral parafacial region (pFV), which provides generic excitatory drive to breath, was 
coined and defined to lie within the RTN (Huckstepp et al. 2015, Huckstepp et al. 2016, 
Korsak et al. 2018). 
The RTN clearly plays a large role in relaying or integrating respiratory 
information. Selective inhibition of the RTN reduces the HCVR by 60% in conscious rats 
(Marina et al. 2010). Also, the RTN has recently been shown to be critical in the 
respiratory response during exercise, demonstrating its importance during periods of 
hypercapnia (Korsak et al. 2018). Its role as a node for integration is supported by the 
numerous connections it is has with key breathing nuclei. The RTN has neurons 
projecting to the preBötC, rostral ventral respiratory group (rVRG), caudal ventral 
respiratory group (cVRG), BötC, K-F, and to a parahypoglossal region (pXII) that likely 
relays inspiratory drive to the XII (Chamberlin et al. 2007, Rosin, Chang, and Guyenet 
2006, Huckstepp et al. 2015, Feldman, Del Negro, and Gray 2013, Takakura et al. 2006, 
Moreira et al. 2013, Takakura and Moreira 2016, Núñez-Abades, Morillo, and Pásaro 
1993, Gerrits and Holstege 1996). The RTN also receives information from various CNS 
nuclei, peripheral chemoreceptors, and local astrocytes (Huckstepp et al. 2010a, Gourine 
et al. 2010, Turovsky, Theparambil, Kasymov, Deitmer, del Arroyo, et al. 2016, Takakura 
et al. 2006).  
Given its connections and location (very close to the ventral surface and 
coinciding with the classical rostral chemosensitive site) the RTN is a strong candidate for 
a CRC with much evidence in its support. The RTN shows hypercapnia-induced c-fos 
immunoreactivity (Berquin et al. 2000) and its neurons are sensitive to CO2 both in vitro 
and in vivo (anaesthetised rats), even in the presence of synaptic blockade (Mulkey et al. 
2004). Also focal acidification of the RTN increases ventilation in conscious rats (Hewitt et 
al. 2004) and optogenetic stimulation has shown that glutamate released from Phox2b+ 
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RTN neurons is capable of stimulating breathing in conscious mice (Holloway et al. 2015). 
Furthermore, when the Phox2b gene was altered to include mutations responsible for 
causing CCHS in humans, neonatal mice completely lacked CO2 sensitivity (Ramanantsoa 
et al. 2011, Dauger et al. 2003, Dubreuil et al. 2009). 
This nucleus shows much promise as a primary site of chemoreception, although 
it is not yet clear whether the importance of RTN chemosensitivity varies over 
development. Multiple chemosensory transducers have been put forwards for RTN 
neurons, the evidence for which is discussed in the next section (see 1.3 Central 
respiratory chemosensory transducers for pCO2).  
 
1.2.5 Caudal chemosensitive site/caudal ventrolateral medullar (cVLM) 
The originally-identified caudal chemosensitive site is sometimes referred to as the 
caudal ventrolateral medulla (cVLM), as this new term reflects the importance of the 
later-found VLRC. However, calling this area the ‘cVLM’ would imply that this region is 
confined to the lateral portion of the medulla, when in truth the precise area is poorly 
defined and has been largely ignored since its discovery. In this thesis this area is referred 
to as the caudal chemosensitive site. 
In addition to early experiments (Mitchell et al. 1963a, Mitchell et al. 1963b, 
Loeschcke et al. 1970, Schlaefke, See, and Loeschcke 1970, Trouth et al. 1973, Schlaefke, 
Kille, and Loeschcke 1979) neurons in this area have since been shown to have c-fos 
immunoreactivity in response to acidic stimulation  (Ohtake et al. 1996), and to be  
stimulated by infusion of hypercapnic saline (Arita et al. 1989) and focal acidification 
(Nattie and Li 2012). In unanaesthetised rats focal acidification of this area also increases 
ventilation whilst awake (but not asleep) (da Silva, Li, and Nattie 2010). The cell type/s 
and mechanisms behind chemosensitivity in this area may be attributed to serotonergic 
neurons that (see 1.2.6 Serotonergic neurons) or glia (see 1.2.7 Glia and ATP release).  
 
1.2.6 Serotonergic neurons 
It has been suggested that chemosensitive serotonergic neurons in the ventral medulla 
are involved in chemoreception. These neurons are found closely associated with 
arteries, along the midline (the raphé nuclei) and also in more lateral regions that 
correlate fairly well with the classical rostral and caudal chemosensitive sites (Bradley et 
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al. 2002), Figure 1.1. The chemosensitivity shown from raphé neurons may not have 
been picked up in original studies because they are found in the midline region, which 
was often avoided during in vivo experimentation in order to prevent bleeding from the 
basilar artery (Bradley et al. 2002).  
There has been dispute over the chemosensitivity of medullary serotonergic 
neurons, however this discrepancy appears to have arisen due to differing experimental 
conditions and the effects of anaesthesia on these neurons (Teran, Massey, and 
Richerson 2014, Massey et al. 2015). Upon review of the data, these neurons would 
appear both intrinsically chemosensitive and greatly important in respiratory 
chemoreception. Firstly, serotonergic neurons in the medulla have connections to 
respiratory nuclei including the RTN and preBötC (Teran, Massey, and Richerson 2014, Li, 
Zhou, and Nattie 2006, Hodges et al. 2008, Pace et al. 2007, Li and Nattie 2008, Ptak et al. 
2009), and so a role in chemoreception is plausible. In vitro they maintain 
chemosensitivity during synaptic blockade (Wang and Richerson 1999) and have been 
shown to respond to pH changes from 7.4-7.2, which falls within a realistic physiological 
range (Wang, Pizzonia, and Richerson 1998). In vivo they show hypercapnia-induced c-fos 
immunoreactivity (Larnicol et al. 1994) and increased ventilation during focal 
acidification in anaesthetised rats (Bernard, Li, and Nattie 1996). In unanaesthetised 
animals hypercapnia has been shown to increase serotonin levels in the caudal medulla 
(~2.5 fold) (Kanamaru and Homma 2007) and serotonergic neuronal activity throughout 
(Veasey et al. 1995, 1997, Richerson et al. 2005). Furthermore, genetic silencing of theses 
neurons in adult mice by either preventing their differentiation (Teran, Massey, and 
Richerson 2014, Hodges et al. 2008) or activating DREADD receptors (Ray et al. 2011) 
both reduced the HCVR by 50%. Serotonergic neurons appear less important in neonates, 
suggesting that their importance in chemosensitivity matures with development (Teran, 
Massey, and Richerson 2014).  
As has been mentioned before, to be a primary site of chemoreception a 
chemosensory transducer must be identified and shown to play a role in the HCVR of 
conscious animals. A role for TASK channels was suggested but has since been dismissed 
(see 1.3.2 TASK channels) and the current proposition is that these neurons mediate a 
response via a pH sensitive calcium-activated non-selective cation (CAN) current (Teran, 
Massey, and Richerson 2014). The chemosensory transducer that mediates this current 
might prove to be GPR4 (see 1.3.3 GPR4).  
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1.2.7 Glia and ATP release 
Glial are electrically non-excitable cells found in amongst neurons throughout the brain. 
They were first described in the mid 19th century (Somjen 1988, Virchow 1858) and many 
different sub-types have been characterised; including microglia, astrocytes, and 
oligodendrocytes. However, it is only in recent years that there has been significant 
interest in glia, and exciting new functions and roles for these cells are starting to come 
to light (Jäkel and Dimou 2017, Kettenmann and Verkhratsky 2016). 
In 2005 an important role for ATP in CNS sensory transduction was uncovered. 
Using biosensors it was observed that ATP is released from sites in the VMS in response 
to an increase in inspired CO2, and that blocking ATP receptors at these regions 
attenuated the respiratory reflex to CO2 (Gourine et al. 2005). In a subsequent study 
(Gourine et al. 2010) Ca2+-imaging and biosensors were used to show that astrocytes in 
the RTN of young adult rats respond to small changes in pH (7.4 to 7.2) with an increase 
in [Ca2+]i, which propagates to other astrocytes, and that in brain slices this is 
accompanied by a release of ATP that activated nearby RTN neurons. Astrocytic Ca2+ 
activity was maintained in the presence of synaptic blockade but was diminished upon 
ATP blockade (suggesting Ca2+ propagation is ATP-dependent). Patch clamp data from 
neonatal brain slices confirmed the chemosensitivity of astrocytes, and that their effect 
on RTN neuronal firing was purinergic in manner (Wenker et al. 2010). Furthermore, 
alteration of chemosensitivity-related astrocytic activity within the RTN directly affects 
respiratory activity. For example, although a non-physiological stimulus, optogenetic 
stimulation to mimic astrocytic [Ca2+]i responses increases respiratory drive in 
anaesthetised animals and is inhibited by blocking ATP receptors (Gourine et al. 2010). 
Also, when the chemosensitivity of RTN astrocytes is compromised in mice models for 
Rett syndrome (characterised by reduced ventilatory CO2 sensitivity) animals show an 
inappropriate HCVR (Garg et al. 2015, Turovsky et al. 2015). This data demonstrates that 
the pH chemosensitivity of astrocytes may be responsible for release of a signal (i.e. ATP) 
that is capable of modulating the activity of nearby respiratory neurons in vitro, and 
respiratory drive in vivo. ATP release in this pH-mediated manner is believed to take 
place via vesicular release (Kasymov et al. 2013). 
In addition to this pH-mediated ATP release, glia of the VMS were found to 
release ATP in response to molecular CO2 directly, in a connexin-dependent manner 
thought to be mediated by Connexin26 (Cx26) (Huckstepp et al. 2010a) (see 1.3.6 
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Connexin26).  This Cx26-mediated ATP release occurs through open Cx26 hemichannels, 
although additional vesicular release has not been discounted (Huckstepp et al. 2010b).  
In the original study of ATP release (Gourine et al. 2005) many of the sites at which 
ATP release was observed lie close to the classical chemosensitive areas of the VMS 
(Figure 1.1b), and in subsequent studies hypercapnia-induced ATP release has been 
shown within the classical chemosensitive areas (Huckstepp et al. 2010a, Gourine et al. 
2010, Huckstepp, Llaudet, and Gourine 2016). Since glia are found across the VMS they 
could hypothetically act at any site, providing a primary chemosensory role and 
generating a stimulus for local respiratory-related neurons. For this reason, focal 
acidification studies that support the status of aforementioned CRCs also support a role 
for the glia within the area.  
The role of glia-dependent ATP release in chemoreception is becoming increasingly 
accepted, be it an alternative or supportive role to other proposed CRCs. There have 
been multiple chemosensory transducers that have been proposed to give rise to 
hypercapnia-evoked glial ATP release (see 1.3 Central respiratory chemosensory 
transducers for pCO2), however their relevance in the intact animal are not fully 
accepted.  
ATP release from glia may contribute to chemoreception in ways additional to 
activating P2X/P2Y receptors. For example, breakdown of released ATP into adenosine 
has been suggested to provide end-product inhibition in order to limit the 
chemoreceptive response that ATP produces (Falquetto et al. 2018). Furthermore, 
hypercapnia-evoked ATP release has been shown to mediate the release of acetylcholine 
(ACh) (Huckstepp, Llaudet, and Gourine 2016), which has been suggested to play a role in 
controlling changes in breathing (Dev and Loeschcke 1979, Fukuda and Loeschcke 1979). 
Recently another role of glia in chemoreception, which is ATP-independent, has 
been proposed. In organotypic cultures of RTN slices PGE2-ELISA revealed CO2-evoked 
release of PGE2 from a subpopulation of glia. Using Ca2+ imaging, bath application of PGE2 
was shown to stimulated RTN neurons. In organotypic cultures from Ptger-KO mice 
(which encodes for the main PGE2 receptor, EP3R) stimulation of RTN neurons was 
reduced (Forsberg et al. 2016, Forsberg, Ringstedt, and Herlenius 2017). This data 
identifies the potential of a PGE2 signalling pathway in chemoreception.  
However, the plethysmography data from these studies is inconclusive with their 
current interpretation. For example, mice with global Ptger-KO showed a blunted change 
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in tidal volume (VT) under hypercapnia, compared to wild-type mice, suggesting that 
PGE2 signalling might be involved in chemoreception. However, this change was 
normalised to normocapnia and does not identify the ~1.5 times higher baseline VT 
exhibited by Ptger-KO mice (which is higher than even the wild-type VT during 
hypercapnia). This would instead suggest that defective PGE2 signalling has resulted in 
the development of a defective respiratory system. Also, in wild-type mice under 
normocapnia intracerebroventricular injection of PGE2 showed increased tidal volume 
compared to sham injections, however these recordings were performed some time >10 
mins after PGE2 injections which, along with variation in the speed of injections, casts 
doubt on its reproducibility as a technique.  
In vitro data shows a clear potential for a role of PGE2 in chemoreception, which 
would be exciting given the links between PGE2 and inflammation, however more elegant 
in vivo experiments are required to investigate the precise effect of any PGE2 release in 
the RTN, and to discern its physiological relevance to breathing.  
 
1.3 Central respiratory chemosensory transducers for pCO2 	
For a region of the brain to be a primary source of chemoreception the cells within it 
should be intrinsically chemosensitive, containing a molecule that converts a chemical 
stimulus (e.g. changes in pO2 or pCO2) into a signal that acts on the respiratory network 
in order to cause an adaptive change in breathing. Such a molecule is known as a 
chemosensory transducer. Identifying a putative chemosensory transducer, which is 
expressed in a particular chemosensitive region, is the first step towards clarifying 
whether a CRC is involved in primary chemoreception, or whether it merely responds to 
signals from primary CRCs. After a chemosensory transducer is proposed genetic studies 
can be designed in order to test the specific role of that transducer in vivo, with the 
aspiration of showing whether or not it is responsible for chemoreception under 
physiological conditions in an intact, conscious, animal. Only in this way can we be truly 
certain that a given transducer, and the corresponding CRC, plays a relevant role in 
respiratory chemoreception, and only with such confirmation will we be able to 
rationally design and develop strategies to manipulate a biological system.  
Here we discuss central respiratory chemosensory transducers that may be 
involved in responding to increased blood pCO2. Much of the past work on respiratory 
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chemoreception has focused on “reaction theory”, which proposes that changes in blood 
pCO2 are detecting via the sensing of pH rather than CO2 directly (Loeschcke 1982, 
Winterstein 1949). This might have led to alternative mechanisms of pCO2 sensing being 
overlooked.  Owing to the presence of carbonic anhydrase in mammalian tissue, any of 
CO2, H+ (pH), or HCO3- could theoretically act as signals to detect the level pCO2 (Figure 
1.2). Following from this, there is clear evidence that CO2 regulates breathing via the 
direct detection of CO2 itself; with the effect being independent of that which is evoked 
from pH detection, (Shams 1985, Harada, Kuno, and Wang 1985, Huckstepp et al. 2010a).  
Below we discuss putative central respiratory chemosensory transducers for pCO2 
and comment on the strength of their relevance to wild-type animals based on their 
current evidence. 
 
1.3.1 ASIC1 and ASIC2 
ASIC Acid-sensing ion channels (ASICs) have been shown to be important in sensing CO2 
and electing a fear response in the amygdala (Ziemann et al. 2009) – cultured neurons 
lack chemosensitivity and KO mice have blunted fear responses. ASIC channels are also 
expressed in the NTS and broadly in the VLRC (levels higher in neonates than adults) and 
have been suggested to play a role in chemoreception (Huda et al. 2012, Song et al. 
2016). However, although these studies linked neuronal chemosensitivity to ASIC 
channels, a physiologically unrealistic pH value was required to activate these channels 
(pH <6.5). At the VMS only very small changes in pH occur in response to physiological 
changes in pCO2 (Shams 1985), with pH maintained between 7.4 and 7.25 
 
 
Figure 1.2  Equation of the reaction driven by carbonic anhydrase. Carbonic anhydrase (CA) 
converts carbon dioxide and water into carbonic acid, which dissociates into hydrogen ions and 
bicarbonate ions. Because of this, any one of CO2, H
+
 or HCO3
-
 could theoretically be a signal for 
increased levels of CO2 
CA
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(Fencl 1971, 1986) and a pCO2 >100 mmHg required for pH to drop below pH 7.1 (Katsura 
et al. 1992b, Katsura, Ekholm, and Siesjö 1992a). Furthermore, no evidence has been 
provided for the effect ASICS channels have on breathing (in either anaesthetised or 
conscious animals). Consequently, the current evidence linking ASIC channels to 
respiratory chemoreception is weak, and the proposed mechanism is not likely to occur 
under healthy physiological conditions.  
 
1.3.2 TASK channels 
The Tandem-pore acid sensing potassium (TASK) channels TASK-1 and TASK-3 had been 
implicated to be the chemosensory transducer for serotonergic neurons, which were 
then concluded to play no role in central chemoreception in the conscious animal as KO 
of TASK-1, TASK-3, or TASK-1/TASK-3 in mice resulted in a normal HCVR (Mulkey et al. 
2007). However, these studies targeted dorsal raphé neurons that have not actually been 
implicated in chemoreception and only showed a pH dependent response to a pH 
decrease from pH 7.5 to 6.9. Therefore, the serotonergic neurons in the ventral medulla 
(which respond to pH change of 7.4 to 7.2) might still play a role in chemoreception via 
another chemosensory transducer such as GPR4 (Teran, Massey, and Richerson 2014). 
TASK1 channels have been shown to play a role in peripheral chemoreception, 
contributing to the carotid body discharge that occurs in response to hypoxia or 
hypercapnia (Trapp et al. 2008). This supports the role of TASK1 as a chemosensory 
transducer for peripheral chemoreception. 
TASK-2 has been suggested to mediate RTN chemosensitivity (Wang et al. 2014, 
Kumar et al. 2015) although whether or not this should be thought of as a chemosensory 
transducer is still to be clarified. Although patch clamp data found that a subpopulation 
of RTN neurons from TASK-2-KO mice brain slices lost their pH sensitivity (Wang et al. 
2014), the pH change used was from pH 7.8 to 7.0 (not a physiologically realistic 
decrease). Furthermore, using working heart-brainstem preparations this study did not 
find any difference between the respiratory drive of global TASK-2-KO and wild-type mice 
preps in response to hypercapnia, although they did find higher baseline respiratory 
drive in TASK-2-KO mice at resting CO2 levels. Consistent with this, global TASK-2-KO mice 
showed a dysregulated HCVR in the form of hypersensitivity to low CO2 levels, and failure 
to reach appropriate levels at higher CO2 (Gestreau et al. 2010, Kumar et al. 2015). Taken 
together the current evidence might suggest that TASK-2 is indeed important for CO2 
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chemoreception, however it may not be a chemosensory transducer but rather a channel 
that is required to stabilise cellular conditions in order for a transducer molecule (e.g. 
GPR4) to function properly (Wang et al. 2014).	
 
1.3.3 GPR4 
G-protein coupled receptor 4 (GPR4) is highly sensitive to pH over the range of 6.8-7.8 
(Ludwig et al. 2003) and expression can be found in cerebrovascular endothelium and 
neurones of raphé, RTN, LC, and lateral septum (Hosford et al. 2018, Kumar et al. 2015). 
GPR4 has been suggested to be responsible for chemoreception, acting as a 
chemosensory transducer in RTN neurons. In global GPR4-KO mice hypercapnia-induced 
c-fos immunoreactivity in the RTN was significantly reduced, and in vitro neuronal 
chemosensitivity under hypercapnic conditions was reduced – although chemosensitivity 
was defined as a >30% decrease in activity from pH 7.0 to 7.8 (i.e. a big change in pH for 
a relatively small change). Nevertheless, these mice also showed a severely reduced 
HCRV, and reintroduction of GPR4 specifically into the RTN rescued the aforementioned 
phenotypes. This suggests that GPR4 is sufficient to provide adequate chemoreception in 
this global KO system, although GPR4 was never introduced into WT mice and so the 
apparent rescue could be a result of GPR4 over-expression causing hypersensitivity that 
compensates for the defects rather than rescuing them (Kumar et al. 2015). 
Interestingly the effect of global GPR4-KO presents predominantly as a 
diminished elevation in breathing frequency, with the effect on tidal volume being much 
weaker (and only significantly different once the level of CO2 was raised to 8%) (Kumar et 
al. 2015). This contradicts reports that pH acidification of the RTN elicits a HCVR that is 
almost entirely a change in tidal volume (Li, Randall, and Nattie 1999) and questions 
whether or not GPR4 is indeed acting as a primary site of chemoreception (in which case 
it would be expect to yield the same, tidal volume only, phenotype), or whether it is 
instead a component of the RTN involved in integrating signals that give rise to a HCVR.  
Although KO studies are necessary to support the role of a protein they must be 
interpreted with caution, especially when the KO has no cell-specificity (i.e. global KO’s). 
It is very difficult to understand what developmental roles a protein has, and therefore 
how the resulting mutated system differs from wild type. The drastic effect that these 
confounding factors can have was made apparent in a recent study that used in vivo 
pharmacological manipulation of GPR4 (Hosford et al. 2018). Although this study 
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confirmed that GPR4 is intrinsically chemosensitive – showing GPR4-dependent increases 
in cyclic AMP (cAMP) in cultured RTN neurons within a somewhat more physiological 
range (pH decrease from 7.4 to 7.0) – IP injection of a GPR4 antagonist presented as a 
minor reduction in both tidal volume and frequency, as opposed to the large reduction in 
tidal volume only that was previously reported. Like the GPR4-KO studies, theses 
pharmacological studies will have also affected GPR4 activity globally (i.e. not just the 
RTN) and so it is interesting to see such a different response when GPR4 activity is 
ablated after development. 
Given the differences in breathing phenotype observed between the genetic and 
pharmacological studies there are questions concerning the true contribution of GPR4. 
On the other hand, GPR4 is also expressed in ventral raphé neurons (Kumar et al. 2015). 
If GPR4 proves to be the chemosensory transducer responsible for serotonergic 
chemosensitivity then this might explain some of these discrepancies. As it stands, there 
is sufficient evidence of some role for GPR4 in central respiratory chemoreception, which 
would support its status as a chemosensory transducer, however more refined 
experiments are required in order to confirm this.  
 
1.3.4 Inwardly rectifying potassium (Kir) channels 
The Inwardly rectifying potassium (Kir) channels Kir4.1 and Kir5.1 are found in neurons 
and glia, including astrocytes in the RTN where they have been suggested to play a role in 
chemoreception. Global Kir5.1-KO mice, and inducible conditional GFAP:Kir4.1-KO mice, 
show a reduced HCVR (Trapp, Tucker, and Gourine 2011, Hawkins et al. 2014, Hawkins 
and Mulkey 2015, Hawkins et al. 2016). However, expression of Kir5.1 alone is unable to 
produce a functional channel (Bond et al. 1994, Pessia et al. 1996), and the central 
chemosensitive response in global Kir5.1-KO mice was found to be intact (Trapp, Tucker, 
and Gourine 2011). Also Kir4.1 channels are not sensitive to pH in a physiological range 
(pKa 6.1) (Xu et al. 2000). Therefore, the effect seen in these KO mice cannot be because 
these channels alone acts as chemosensory transducers, as there is no rational 
mechanism as to how either would be able to respond to physiological changes in pCO2.  
As Kir4.1 is believed to be key in establishing resting membrane potential in 
astrocytes (Olsen and Sontheimer 2008) and Kir5.1-KO mice were found to have chronic 
metabolic acidosis (Trapp, Tucker, and Gourine 2011), it is likely that these KO’s affects 
cells in other ways. For example, the GFAP:Kir4.1-KO could disrupt glial conditions that 
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are required for effective ATP release from chemosensitive mechanisms, and global 
Kir5.1-KO could alter the environment such that chemosensitive mechanisms that 
function in wild-type animals no longer operate properly. 
Although Kir4.1 and Kir5.1 channels may not have suitable properties, their 
coexpression yields a Kir5.1/4.1 heteromer which is sensitive to physiological changes in 
pH (pKa 7.45) (Xu et al. 2000). As Kir4.1 and Kir5.1 are expressed in proposed CRC – NTS, 
LC, and VII (immediately dorsal to the RTN) (Wu et al. 2004) – this heteromer could act as 
a chemosensory transducer and the effect that the individual KO’s had on HCVR could be 
explained by ablation of this heteromer. Consistent with this, in vitro patch clamp data 
has suggested that pH-driven inhibition of Kir4.1/Kir5.1-like currents in sub-pial 
astrocytes contribute to astrocytic ATP release in the RTN (Wenker et al. 2010). This 
being said, the extent to which changes in astrocytic membrane potential influence the 
chemosensitivity of these non-electrically excitable cells is debated, and it has been 
argued that Ca2+ signalling, rather than membrane potential, plays the key role in pH-
mediated astrocytic chemoreception (Gourine et al. 2010, Trapp, Tucker, and Gourine 
2011). For the time being the status of the Kir4.1/Kir5.1 heteromer as a chemosensory 
transducer, relevant in conscious animals, is uncertain. 
 
1.3.5 Electrogenic sodium bicarbonate cotransporter (NBCe1) 
Electrogenic sodium bicarbonate cotransporter (NBCe1) is a high-affinity HCO3- carrier 
responsible for fast HCO3- transport and pH buffering in glia, and is expressed in most cell 
types of the brain, including prominent expression in glia of the brainstem  (Turovsky, 
Theparambil, Kasymov, Deitmer, Del Arroyo, et al. 2016, Theparambil et al. 2014). 
Na+/HCO3- cotransport (NBC) was proposed to play a role in RTN chemoreception after 
patch clamp data showed that the pH-sensitive current of RTN astrocytes had different 
properties in HCO3--free buffer (Wenker et al. 2010).  
In vitro data has now identified a mechanism by which NBCe1 expression could 
contribute to the chemosensitivity of these glia (Turovsky, Theparambil, Kasymov, 
Deitmer, Del Arroyo, et al. 2016). This data showed that pH-induced [Ca2+]i responses 
(comparing pH 7.4 to 7.0) from RTN astrocytes were preceded by Na+ entry and were 
reduced by blocking either NBC or Na+/Ca2+ exchange (NCX) – with complete abolishment 
upon blocking both NBC and NCX. These [Ca2+]i responses were significantly reduced in 
brain slices form global NBCe1-KO mice. The suggestion has been made that, under 
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hypercapnic conditions, CO2 entry into astrocytes leads to a decrease in pH, which 
activates NBCe1 causing Na+ influx. Increasing [Na+]i in turn activates NCX to operate in 
reverse mode and bring Ca2+ into the cell, which triggers a signalling pathway that results 
in ATP release.  
The proposed mechanisms would advocate NBCe1 as a chemosensory transducer, 
translating pHi into a Na+ current that (via NCX) gives rise to pathway responsible for ATP 
release. As of yet no in vivo genetic data has been acquired for NBCe1 mice (constitutive 
KO of NBCe1 is lethal) and therefore the relevant role of this mechanisms in the animal is 
yet to be determined. As NBCe1-KO is likely to disrupt the resting conditions of cells, 
even inducible KO systems might prove difficult to interpret correctly. 
 
1.3.6 Connexin26 
Connexin 26 (Cx26) is a member of the connexin family and forms hemichannels in the 
plasma membrane that are capable of allowing the transporting of small molecules. Cx26 
is expressed in tissues throughout the body, and expression in the medulla is restricted 
the ventral surface, in sub-pial glia (and the leptomeninges) (Huckstepp et al. 2010a, 
Nagy et al. 2001, Solomon et al. 2001, Mercier and Hatton 2001). Cx26 has been 
proposed to be a respiratory chemosensory transducer, playing a role in chemosensitive 
regions to mediate glia-dependent ATP release (see 1.2.7 Glia and ATP release). 
Cx26 hemichannels were revealed to be gated by CO2, and not pH, via whole-cell 
patch clamp recordings from HeLa cells with heterologous Cx26 expression. When pH 
was maintained (at 7.5) Cx26 hemichannels partially opened at physiological pCO2 (~40 
mmHg), and there was increased hemichannel closing at lower pCO2 (20 mmHg) and 
increased opening at higher pCO2 (55 mmHg and 70 mmHg). In fact, acidification 
appeared to reduce this CO2-dependent opening. Dye-loading under similar conditions 
confirmed this CO2-depenent opening profile of Cx26 hemichannels. As inside-out and 
outside-out patches showed that Cx26 chemosensitivity to pCO2 was maintained during 
constant pH, local pH changes were ruled out as a stimulus (Huckstepp et al. 2010b). 
Furthermore, biosensor recordings showed that (if pre-loaded with ATP) HeLa cells 
release ATP upon a pH-independent stimulus. (Huckstepp et al. 2010b, Meigh et al. 2013, 
Meigh et al. 2014, de Wolf et al. 2016, de Wolf, Cook, and Dale 2017). This data confirms 
that Cx26 hemichannels can open in response to physiological levels of pCO2 and are 
sufficient to bestow upon cells the ability to release ATP in response to CO2 directly.  
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In vitro biosensor recordings from rat brain slices showed the same CO2-
dependent ATP release at chemosensitive sites of the VMS. This ATP release was 
maintained when other potential stimuli (pHi, HCO3-, adenylate cyclase) were 
maintained/blocked (Huckstepp et al. 2010a). ATP release was shown to occur 
independent of exocytosis as profound ATP release was recorded in the absence of Ca2+ 
– an ion vital for exocytosis. As hemichannels open in in the absence of Ca2+ (Müller et al. 
2002) this supports hemichannel involvement. Pharmacological blockade of pannexin-1, 
known to form hemichannels and release ATP (Bao, Locovei, and Dahl 2004, Huang et al. 
2007), did not affect ATP release however blockade of connexin channels did (Bruzzone 
et al. 2005, Huckstepp et al. 2010a).  
CO2-dependent dye loading in VMS brain slices colocalised with GFAP+ cells, with 
a distribution profile that matches Cx26 immunohistochemical- and Cx26:LacZ-labelling 
(Huckstepp et al. 2010a) – thereby suggesting that VMS glia might respond to CO2 by 
opening Cx26 hemichannels. Furthermore, In vivo recordings from anaesthetised rats 
showed the same CO2-mediated ATP release along with increased respiratory drive, both 
of which were diminished upon connexin blockade (Huckstepp et al. 2010a).  
Subsequent patch clamp and Ca2+ imaging studies from RTN slices have supported 
the involvement of glial connexins in chemoreception, reporting that RTN neuronal 
stimulation is inhibited by connexin blockade and reversed by its washout (Wenker et al. 
2012, Moreira et al. 2015, Forsberg et al. 2016). 
Cx26 is the only connexin present at the VMS that has a CO2-dependent opening 
profile that matches the CO2-dependent ATP release at the VMS chemosensitive sites 
(Huckstepp et al. 2010b). Given the location of Cx26 at the VMS, and that it is closed 
upon acidification, this protein may have finally shed light on the intermediate 
(Schlaefke) region, which was identified back in 1970  to cause a decrease in ventillatory 
response when acidified (Schlaefke, See, and Loeschcke 1970). It could be that 
acidification causes closure of Cx26 hemichannels in this region, thereby decreasing ATP 
basal tone – as has shown to occur upon connexin blockade in VMS slices (Huckstepp et 
al. 2010a).  
It has been suggested that connexins are only involved in chemoreception in 
neonates (Hewitt et al. 2004), however this conclusion was drawn from data during 
which the RTN was focally perfused with very unrealistic hypercapnic conditions (50% 
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CO2, pH 6.5) and so these results should not be considered relevant to the usual working 
mechanics of chemoreception. 
In addition to ATP release, it has been suggested that Cx26 acts as a 
chemosensory transducer for the release of PGE2 (Forsberg et al. 2016, Forsberg, 
Ringstedt, and Herlenius 2017). The hypothesis is that CO2-mediated opening of Cx26 
hemichannels in RTN glia allows for the release of PGE2 through the hemichannel, which 
stimulates RTN neurons to alter respiratory drive. However, as has been discussed (see 
1.2.7 Glia and ATP release), the precise role of PGE2 in chemoreception still needs to be 
clarified. 
Cx26 has the properties expected of chemosensory transducer and we have a 
strong understanding of the molecular mechanisms behind its CO2-sensitivity (see 1.4.4 
Connexin26 CO2-sensitivity). However, as the current evidence stands the role of Cx26 in 
chemoreception is disputed and further genetic data is required to build a certain case 
for this hypothesis. Considering constitutive KO of Cx26 is lethal, and even conditional KO 
studies have their drawbacks, ideally we require a genetic data from a technique capable 
of investigating Cx26 CO2-sensitivity in an inducible manner. To provide such genetic data 
was one of the aims of this thesis. 
 
1.4 Connexin26 
	
The protein Connexin26 (Cx26) is encoded by the GJB2 (Gap junction beta 2) gene and is 
one of 21 connexins found in humans. Connexin proteins can be found in all tissues and 
form hexameric channels (connexons) in the plasma membrane that can open and close 
in response to various stimuli in order to allow molecules into and out of a cell (Stout, 
Goodenough, and Paul 2004, Wang, De Bock, et al. 2013). Expression of Cx26 can be 
found in many tissues including the liver, uterus, skin, eyes, ears, and brain (Nicholson et 
al. 1987, Nagy et al. 2011, Dalamón et al. 2016). 
 
1.4.1 Connexin26 trafficking and assembly 
As with all connexins, Cx26 is translated as a peptide subunit that goes on to assemble 
into a hexameric connexon. Assembly into connexons is known to occur before delivery 
to the plasma membrane (Kumar and Gilula 1996, Goodenough, Goliger, and Paul 1996, 
Willecke et al. 2002), although not all connexons will be trafficked straight to the plasma 
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membrane; instead they may be added to intracellular stores for later use in connexon 
turnover from the plasma membrane (George, Kendall, and Evans 1999). The precise 
assembly and the trafficking pathway varies depending on the connexin (George, Kendall, 
and Evans 1999, Martin et al. 2001).  
Details of Cx26’s trafficking pathway have remained elusive, and we have little 
further understanding than that from fifteen years ago: Cx26 shows co-translational and 
post-translational insertion into membranes of intracellular compartments, its targeting 
from the ER to the plasma membrane can be via the Golgi pathway or a yet 
uncharacterised microtubule-dependent pathway, and assembly of Cx26 connexons 
starts in the ER – with significant assembly detectable within the Endoplasmic reticulum-
Golgi intermediate compartment (ERGIC) (Martin et al. 2001, Zhang et al. 1996, George, 
Kendall, and Evans 1999). 
 
1.4.2 Connexin26 structure  
All connexin proteins have the same general structure; an intracellular N- and C-
terminus (NT and CT, respectively), four α-helical transmembrane domains (TM1-4), two 
flexible extracellular linker loops (EL1-2), and one flexible cytoplasmic linker loop (CL), 
Figure 1.3a.  
As has been mentioned, six individual connexin subunits assemble to form a 
connexon with a central pore. Individual connexon channels are known as hemichannels 
and two hemichannels from apposing membranes are capable of docking and fusing with 
each other, creating gap junctions (Figure 1.3b). Crystal structure data (at 3.5 Å 
resolution) has shown Cx26 gap junctions to be 9.1 nm at its widest point and 15.4 nm in 
length (Maeda et al. 2009). Although hemichannel docking is very likely to induce a 
conformational change, Cx26 hemichannels can be assumed to have a similar maximum 
width, and a length of ~7.7 nm (half that of a gap junction). 
One of the most interesting properties of connexins is their ability to coassemble 
with other members of the connexin family, forming heteromeric connexon 
hemichannels. On top of this, connexons with different compositions to one another are 
able to dock to form heterotypic gap junctions. Heteromeric compatibility depends upon 
a specificity motif between CL and TM3, whilst heterotypic compatibility depends upon a 
specificity motif in EL2. Cx26 is known to have heteromeric compatibility with Cx30, 
Cx30.3, Cx31 and Cx32. Cx26 is known to have heterotypic compatibility with Cx30, Cx32, 
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Cx46 and Cx50, and there is conflicting data as to its compatibility with Cx31 (which does 
not contain the same specificity motif as the others listed). The functional versatility that 
heteromeric/heterotypic interactions could provide for connexins is vast, and probably 
accounts for their widespread expression and evolution (Koval, Molina, and Burt 2014). 
 
 
 
Figure 1.3  Connexin26 structure a) Cartoon structure of the connexin protein expressed in the 
plasma membrane. b) Cartoon showing the arrangement of connexin subunits when arranged as 
connexon hemichannels, and when connexons from apposing membranes fuse to form gap 
junctions. TM, transmembrane region; EL, extracellular loop; CL, cytoplasmic loop. 
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1.4.3 Connexin26 gating 
Connexin hemichannels and gap junctions, including Connexin26 (Cx26), have 
widespread functions in many different cell types. Connexin channels provide their 
function by opening or closing in response to various stimuli, thus controlling the 
movement of small molecules into and out of the cell. Permeability varies between 
connexins but is based on size (<1 KDa) and charge (although precise properties are 
uncertain) (Kanaporis, Brink, and Valiunas 2010). Sweeping statements are often made 
about the properties of Connexins; grouping together results from vastly different family 
members (e.g. Cx26 and Cx43). Although these statements are correct and demonstrate 
the physiological importance of connexins, for studies trying to dissect the key players in 
a particular pathway, or those focusing on the function of one particular connexin (such 
as this thesis), it is important to make the reader aware of the evidence that links 
specifically to the connexin of interest.  
 The same is true for the comparison between hemichannels and gap junctions. 
Connexin hemichannels are often thought of as half a gap junction, a belief that can lead 
to assumptions and studies that do not provide the true story. Another confounding 
factor is the myriad of heteromeric connexon hemichannels and heterotypic gap junction 
channels that can form across the connexin family of proteins, e.g. Cx26/Cx32 
heteromeric hemichannels are sensitive to pH-dependent taurine gating, whereas Cx32 
homomeric hemichannels are not (Locke et al. 2011). Here, the various stimuli that are 
capable of controlling homomeric/homotypic Cx26 gating are discussed; with distinctions 
made between hemichannel and gap junction gating 
 Extracellular Ca2+ [Ca2+]e decreases connexin hemichannel and gap junction 
activity at physiological levels (Müller et al. 2002, Bennett et al. 2016, Gómez-Hernández 
et al. 2003, Chen et al. 2005, Kamermans et al. 2001, Unwin and Zampighi 1980, Unwin 
and Ennis 1984, Burra and Jiang 2011). On the other hand, [Ca2+]e activation of connexin 
channels can occur under millimolar [Ca2+]e, which occurs in the cochlear and under 
various conditions such as inflammation, ischemia, extracellular alkalinisation (Bao, 
Altenberg, and Reuss 2004, Orellana et al. 2012, Schalper et al. 2010, Scheckenbach et al. 
2011). The mechanism behind connexin [Ca2+]e is debated, however one explanation is 
that electrostatic interactions between residues D50 and E47 physically block 
hemichannel pores (Müller et al. 2002, Lopez et al. 2016), and that the residues E42, G45, 
and E47 play a role in forming an electrostatic barrier in gap junctions (Bennett et al. 
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2016). No intracellular Ca2+ [Ca2+]i effect on gating has been reported. 
Cx26 gap junctions and hemichannels have been shown to exhibit voltage-gating 
opening, with voltage sensitivity varying from cell to cell. It used to be thought that gap 
junctions had a single, transjunctional, voltage gating mechanism however it is now 
understood that a given connexon hemichannel, and each of the two connexons that 
make up a gap junction, have two distinct voltage gating mechanisms – fast and slow 
(loop) gating. (Bargiello et al. 2012, Bukauskas and Verselis 2004, González, Gómez-
Hernández, and Barrio 2006, Kojima et al. 2001).   
Perhaps the most confusing Cx26 gating property that is reported in the literature 
is gating via pH changes. Cx26 gap junctions were shown to undergo pH-sensitive gating 
in response to changes in intracellular pH (pHi), with a lower pH resulting in lower 
conductance (no conductance at pH < 6.5 and max conductance at values > 7.4) 
(Stergiopoulos et al. 1999). However, there is now evidence suggesting that the story 
may be more complicated. A pH dependent interaction has been shown to occur 
between the C-terminus (CT) and cytoplasmic loop (CL), however it is only upon the 
disruption of this interaction by aminosulphonates, such as taurine, that Cx26 channels 
close. In other words, at higher pH values aminosulphonates are not able to disrupt any 
part of Cx26, however once pH drops the interaction can be disrupted, potentially 
leaving the CT free to physically occlude the channel pore. This finding has been shown 
to be comparable between both gap junctions and hemichannels (Locke et al. 2011, Yu et 
al. 2007). 
Cx26 has also been shown to have temperature-sensitive gating, with small 
molecule conductivity increasing upon exceeding a temperature of 230C. This gating is 
thought to involve the TM1/EL1 310 helix (parahelix) and TM4 helix, with indications of 
additional involvement from the plug domain (Steffens et al. 2008, Kniggendorf et al. 
2014). It is assumed, but not confirmed, that this gating property is relevant to both Cx26 
hemichannels and gap junctions. 
Interestingly, pathogen-induced opening of Cx26 hemichannels has also been 
reported. In epithelial cells expressing Shigella, actin- and phospholipase C-dependent 
opening of Cx26 hemichannels caused the release of ATP into the medium (which 
increased bacterial spreading). Any such effects on gap junctions could not be discerned, 
however blocking of all gap junctions did reduce Shigella spread (Van Nhieu et al. 2003). 
The most recent stimuli found to gate Cx26 (amongst other connexins) is CO2. 
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Dye-loading and molecular simulations show that, at hypercapnic conditions (55mmHg 
CO2), K125 is carbamylated and forms a salt bridge with the R104 residue of the closest 
adjacent subunit. Formation of all 6 possible bridges fully stabilise the connexon 
hemichannel in an open state (Huckstepp et al. 2010b, Meigh et al. 2013, Meigh et al. 
2015b, Meigh 2015a). Additionally, acidification has been shown to reduce the opening 
sensitivity of Cx26 hemichannels in response to a CO2 stimulus (with alkalisation 
increasing this CO2-sensitivity) (Huckstepp et al. 2010b). Excitingly, patch clamp and dye-
transfer studies have revealed that CO2 has the opposite effect on Connexin26 gap 
junctions – closing them as pCO2 increases (personal communication with Nicholas Dale). 
The benefit of CO2 opening hemichannels but closing gap junctions is yet to be 
understood. 
Other gating properties that have been documented in other members of the 
connexin family (but not in Cx26) include sensitivity to mechanical stimulation, metabolic 
stimulation, phosphorylation, and [Ca2+]i (De Vuyst et al. 2006, Bao, Sachs, and Dahl 
2004, Gomes et al. 2005, Li et al. 1996, Bruzzone et al. 2001, Bao, Altenberg, and Reuss 
2004).  
As stated at the beginning of this section, it is important to make the reader 
aware of which results are relevant to the study at hand. For many of the stimuli 
discussed above their physiological relevance for many in vivo systems is debatable. For 
example, although Cx26 is found in many different environments throughout the body, 
only in the cochlear of the ear does [Ca2+]e reach a level at which [Ca2+]e-mediated 
activity can occur. This thesis seeks to investigate the role of Cx26 hemichannel-mediated 
ATP release in response to hypercapnia, and it seeks to do so by specifically manipulating 
Cx26 within glial cells of a restricted area of the VMS. Glial cells are non-excitable and 
within the VMS pH and temperature are tightly regulated (Shams 1985, Fencl 1971, 
Katsura et al. 1992b), therefore these stimuli are unlikely to have any gating influence on 
the Cx26 hemichannels under study. 
 
1.4.4 Connexin26 CO2-sensitivity 
Given the significance that Cx26 CO2 gating has to this thesis, this section outlines the 
discovery of this property and the evidence that provides the basis of our understanding 
for the mechanisms behind CO2 gating.  
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Cx26 was first found to be sensitive to CO2 (along with Cx30 and Cx32) less than a 
decade ago, when Huckstepp et al. found that Cx26 hemichannels open in response to 
molecular CO2 directly, which results in ATP release at chemosensitive sites of the VMS 
(Huckstepp et al. 2010a, Huckstepp et al. 2010b) (see 1.3.6 Connexin26) 
To uncover the mechanisms underlying Cx26 CO2-sensitivity Meigh et al. 
performed a number of molecular and structural studies investigating the interaction 
between CO2 and Cx26. Cx26, Cx30, and Cx32 (all CO2-sensitive) contain a carbamylation 
motif (KVREI) that is absent from Cx31, which is CO2-insensitive (Meigh et al. 2013, 
Huckstepp et al. 2010b). Carbamylation involves the nucleophilic attack of CO2 to an 
amine, which can occur at lysine side chains, or the N-terminus, and introduces a novel 
negative charge (Meigh 2015a). The lysine residue (K125) of the carbamylation motif is 
orientated towards an arginine (R104) of a neighbouring subunit (both on which are 
found on the cytoplasmic loop), and the distance between them is only 6.5Å (Maeda et 
al. 2009) - Figure 1.4. Coarse-grained model simulations showed that carbamylation of 
K125, and subsequent inter-subunit bridging with R104, stabilises the hemichannel and 
biases it towards an open state (Meigh et al. 2013).  
There is much evidence from dye-loading and patch clamp experiments that supports 
carbamylation bridge formation between K125 and R104:  
 
• Insertion of the carbamylation motif into 
the Cx31 gene (CO2-insensitive) 
generated a CO2-sensitive mutant and 
when an additional mutation was 
introduced, exchanging K125 for A125, 
the resulting hemichannel was CO2-
insensitive; as the higher pKa of arginine 
prevents its carbamylation and thus 
formation of a bridge at residue number 
125 (Meigh et al. 2013) 
• Point mutations to disrupt the ability of 
K125 or R104 to form carbamate bridges 
in Cx26 (yielding Cx26K125R and Cx26R104A, 
respectively) were enough to remove 
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CO2 sensitivity from Cx26 (Meigh et al. 2013) 
• By utilising the analogy that glutamate has to carbamylated lysine, substitution of 
either K125 or R104 with glutamate yielded constitutively open hemichannels – 
rationalised to be a result of glutamate (in either position) being sufficient to form 
a salt bridge under normocapnia, in the same way that carbamylated K125 does 
under hypercapnia (Meigh et al. 2013) 
• The K125C mutation provided for the formation of inter-subunit S-Nitrosothiol 
(SNO) bridges (between C125 and R104 residues), and the additional R104C 
mutation provide for disulphide bridges (between C125 and C104 residues), both 
of which triggered channel opening – implying that the formation of any inter-
subunit bridge at these residues is what causes hemichannel opening (Meigh 
2015a) 
 
The CO2-sensing property of Cx26 explains and supports the role of Cx26 as a 
chemosensory transducer (see 1.3.6 Connexin26); during hypercapnia Cx26 expressed at 
the VMS undergoes carbamylation, resulting in inter-subunit bridge formation that 
stabilise hemichannels in the open state, and subsequently increases ATP release (which 
goes on to stimulate respiratory drive). 
 
1.4.5 Connexin26 in disease 
Cx26 is responsible for ~50% of non-syndromic sensorineural hearing loss (NSHL) 
(Petersen and Willems 2006), with over 70 different mutations reported (Mishra et al. 
2018). Deafness-linked Cx26 mutations resulting in a premature STOP codon give rise to 
profound hearing loss and have been reported to have a pathophysiology related to a 
lack of gap junctions. Deafness-linked Cx26 mutations resulting in missense mutations 
tend to be associated with less sever hearing loss and have been suggested to reduce 
channel permeability (Petersen and Willems 2006, Beltramello et al. 2005). We have not 
yet identified the underlying cause for all of the Cx26 mutations involved in hearing loss, 
and with the fairly recent discovery of Cx26 CO2-sensitivty it will be interesting to see if 
consideration of this property leads to novel links being made between hearing loss and 
CO2 gating. 
Another human pathology linked to Cx26 is Keratitis-Ichthyosis Deafness (KID) 
syndrome. KID syndrome is a rare disorder characterised by a combination of deafness, 
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visual impairment, and dermatological defects (Caceres-Rios et al. 1996). There are nine 
known missense mutations that that cause KID syndrome (Xu and Nicholson 2013, 
Yotsumoto et al. 2003). Mutations predominantly arise through de novo mutations and 
act in a dominant negative manner (Sbidian et al. 2010).  
As of yet we are not clear of the mechanisms underlying KID syndrome pathology 
and given the complexity of this syndrome it is likely to be a result of multiple 
dysfunctions. Theories have been made suggesting that some of the pathophysiology 
arises due to ‘”leaky” hemichannels (Mhaske et al. 2013, Gerido et al. 2007). Another 
hypothesis, and one of relevance to this thesis, is that aberrant CO2 gating plays a role in 
KID syndrome pathology.  
The KID syndrome mutation A88V renders the Cx26 hemichannel insensitive to 
CO2, and furthermore Cx26A88V subunits act in a dominant negative manner to remove 
CO2 sensitivity (just as KID mutations act in a dominant manner in patients) (Meigh et al. 
2014, Sbidian et al. 2010). Furthermore, in one case study a patient with A88V-linked KID 
syndrome exhibited a respiratory pattern that suggests a diminished central respiratory 
drive (Meigh et al. 2014). Whilst it has not been proven if the lack of CO2 sensitivity is to 
blame for this deficiency in respiratory drive, such an explanation is consistent with 
current evidence for Cx26 in central CO2 chemoreception (see 1.3.6 Connexin26) and 
brings to light a possible connection between Cx26 CO2 sensitivity and human pathology. 
In fact, there are multiple cases in which KID syndrome patients have been reported to 
suffer from severe breathing problems (Meigh et al. 2014, Koppelhus et al. 2011, Janecke 
et al. 2005, Sbidian et al. 2010), however given that KID syndrome is a rare disorder with 
severe skin, eye and hearing afflictions, the effect that this disorder has on breathing 
may be overshadowed, resulting in failure to report/test the respiratory system.  
  A recent study (part of which is included in this thesis) has further investigated 
whether there might be an undiscovered a role for Cx26 CO2 sensitivity in human 
pathophysiology. In this study the CO2 sensitivity of a range of pathological Cx26 mutants 
were tested in vitro. From the results two more KID syndrome mutants, N14K and N14Y, 
were shown to be insensitive to CO2 whereas two recessive deafness mutants, M34T and 
V84L, had lesser effects on CO2-sensitivity of cells. It was suggested that the severity of 
the effect a mutant has on CO2 sensitivity could correlate with the severity of the 
pathological effect the mutant has in humans (de Wolf et al. 2016). 
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More research into Cx26 is required in order to ascertain the precise nature of 
the pathophysiology that presents in patients expressing certain Cx26 mutants, and to 
identify new targets or therapies that could be of benefit to patients.  
 
1.4.6 Connexin26 as a conduit for evolutionary adaptions of air breathing animals 
Given the proposed role for Cx26 in central respiratory chemoreception (see 1.3.6 
Connexin26) the CO2-sensing properties have been tested and compared across the Cx26 
homologs in human, rat, mole rat, and chicken. In human and rat the pCO2 is maintained 
~40mmHg and Cx26 hemichannels show significant opening at 55mmHg, which is 
expected if Cx26 hemichannel opening acts to signal an excess of CO2. In contrast, mole 
rat Cx26 CO2-sensitivty was shifted towards a higher pCO2 (not showing significant 
opening until 70mmHg) and chicken Cx26 CO2 sensitivity was shifted to lower pCO2 
(showing significant opening at 35mmHg) (de Wolf, Cook, and Dale 2017). 
Evolutionarily this contrast across different species, based upon the environments 
their ancestors were accustomed to, supports the role for Cx26 in respiratory 
chemoreception. The pCO2 underground, where mole rats reside, is greater than above it 
and so sensitivity to CO2 would need to be lower so that the animal is not receiving 
constant signals that they are under hypercapnic conditions. On the other hand, birds 
have a lower resting pCO2 compared to mammals (~30 mmHg compared to ~40 mmHg). 
When birds (including flying ancestors of the chicken) fly at high altitudes they breathe 
more frequently thereby lowing their pCO2. Therefore, sensitivity to CO2 would need to 
be higher in order to correctly regulate breathing and cerebral blood flow (which might 
also be controlled by Cx26).  
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1.5 Experimental aims 
	
The hypothesis of this thesis is that the Cx26 hemichannel CO2 sensitivity, in GFAP+ cells 
of the VMS, plays a role in central respiratory chemoreception. 
 
The three main aims of this thesis are to: 
1. Further our understanding of the CO2-mediated Cx26 hemichannel opening that 
might take place within physiological systems or be altered in disease states. 
2. Characterise an artificially engineered Cx26 mutant (Cx26DN) to determine if it is 
appropriate for in vivo use to investigate Cx26 CO2-sensitivity. 
3. Develop a strategy for using the Cx26DN mutant in mice to determine the role that 
Cx26 CO2-sensitivity plays in central respiratory chemoreception. 
  
	 50	
2 GATING DETERMINANTS OF CONNEXIN26 HEMICHANNELS: 
INTRACELLULAR CALCIUM AND CO2 SENSITIVITY OF A PATHOLOGICAL 
MUTATION  	
2.1 Introduction 
	
The gating of Connexin26 (Cx26) hemichannels and gap junctions is multifaceted, being 
regulated by Ca2+, pH, temperature, membrane potential, and CO2. Additional complexity 
arises when considering the gating of heteromeric connexon hemichannels or 
heterotypic gap junctions (see 1.4.3 Connexin26 gating). Perhaps understandably 
characterisation of Cx26 gating is far from complete; with many gating mechanisms 
remaining elusive, antagonism/synergism between stimuli being almost unmentioned, 
and the physiological relevance of many stimuli being uncertain.  
The finding that CO2 opens Cx26 hemichannels is a fairly recent discovery 
(Huckstepp et al. 2010a, Meigh et al. 2013), and shows that CO2 must be thought of as 
more than a waste product. Interestingly, CO2 also closes Cx26 gap junctions by acting at 
the same residues that open the hemichannel (personal communication from Nicholas 
Dale). As Cx26 expression is widespread throughout the body – being found in the liver, 
uterus, skin, eyes, ears, and brain (Nicholson et al. 1987, Nagy et al. 2011, Dalamón et al. 
2016) – this finding may have widespread signalling implications throughout the body. 
Such a novel and exciting finding demands further study of this new found characteristic, 
in order to fully document its physiological importance in animals and to investigate any 
possible involvement in pathologies. Currently, Cx26 CO2 sensitivity has been implicated 
in respiratory chemoreception at the ventral medullary surface (VMS), where Cx26 
hemichannel opening, in glia, results in the release of ATP that acts to increase 
respiratory activity (Huckstepp et al. 2010a, Huckstepp et al. 2010b). Also, all currently 
tested Cx26 mutations that are linked to Keratitis, Ichthyosis, and Deafness (KID) 
syndrome lack CO2 sensitivity – and a novel link may be made to reduced respiratory 
drive experienced in some KID syndrome patients (Meigh et al. 2014, de Wolf et al. 
2016). 
Intracellular Ca2+ concentration ([Ca2+]i) has the potential to be another Cx26 
gating stimulus, however it has not yet been investigated. It is well documented that 
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connexin hemichannels and gap junctions are involved in Ca2+ wave signalling through a 
combination of gap-junction coupling and hemichannel-mediated ATP release (Pearson 
et al. 2005, Anselmi et al. 2008, Cotrina et al. 1998, Ceriani, Pozzan, and Mammano 
2016); however the role of Cx26 in such signalling is unclear. As Cx26 expression is so 
widespread and Ca2+ signalling is all-but universal (Clapham 2007, Bootman et al. 2001, 
Bootman and Berridge 1995, Lodish et al. 2008, Berg, Tymoczko, and Gatto Jr 2002), this 
alone provides reason to investigate [Ca2+]i gating of Cx26. However, of particular 
interest to this thesis, changes in [Ca2+]i have been shown to occur in chemosensitive glia 
of the VMS when they respond to hypercapnic conditions (Gourine et al. 2010). VMS glia 
have also shown CO2-mediated ATP release that acts to increases respiratory drive 
(Huckstepp et al. 2010a). If [Ca2+]i opens Cx26 hemichannels then it could serve as a 
mechanism to augment their CO2-mediated opening, thereby increasing Cx26-mediated 
ATP release in the VMS. If Cx26 is gated by [Ca2+]i we hypothesise that  an initial influx of 
Ca2+ via CO2-induced opening of Cx26 hemichannels, or alternative mechanisms, will 
enhance Cx26 opening (Figure 2.1).  
In this chapter we aimed to further understand Cx26 hemichannel properties that 
might influence Cx26-mediated release at the VMS. To investigate the role that [Ca2+]i  
 
 
 
Figure 2.1  Hypothesis for enhanced CO2-mediated ATP release via [Ca
2+]i. It is possible that 
connexin26 (Cx26) hemichannels are opened by increases in [Ca
2+
]i. If so, then opening of Cx26 
hemichannels by CO2 could cause an influx of Ca
2+
 that acts to enhance this opening and the 
subsequent ATP release.  
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might have in CO2-mediated Cx26 hemichannel opening (and in Cx26 channel gating 
more generally) this chapter also investigates whether or not, in the absence of 
extracellular messengers, [Ca2+]i is sufficient for Cx26 channel opening. Following on from 
this, to help characterise the link between Cx26 CO2 gating and pathology (including 
respiratory defects) this chapter investigates the CO2 sensitivity of the Cx26 N14K mutant 
– a KID syndrome mutant.  
The Cx26N14K data presented in this chapter has been published as part of de 
Wolf, E., van de Wiel, J., Cook, J., & Dale, N., 2016. 
 
2.2 Materials and methods 
2.2.1 HeLa cell culture and sample preparation 
HeLa DH cells were maintained in Dulbecco’s modified Eagle’s medium (DMEM) 
supplemented with 10% fetal calf serum (FCS), 50μg/mL Penicillin Streptomycin, and 
3mM CaCl2. Cells were grown at 370C in a 5% CO2 humidified incubator.  
HeLa cells stably expressing Mus musculus Cx26 (Cx26-HeLa cells) were obtained 
from the laboratory of Dr Klaus Willecke, Bonn, and were maintained in Dulbecco’s 
modified Eagle’s medium (DMEM) supplemented with 10% fetal calf serum (FCS), 
50μg/mL Penicillin Streptomycin, 3mM CaCl2. Cx26-HeLa cells were also grown in 1μg/mL 
Puromycin to maintain selection pressure. Cells were grown at 370C in a 5% CO2 
humidified incubator.  
All cells were plated onto coverslips at densities such that cells were not too 
confluent by the time of experiments. For whole-cell patch clamp (intracellular Ca2+) 
experiments cells were plated at 1 x 104 per well (9cm2) and experiments carried out 3 
days later. For dye loading experiments involving single expression of a Cx26 constructs 
in parental HeLa cells, plating was at 1 x 104 per well and experiments carried out 4 days 
later (3 days post transfection). For dye loading experiments involving coexpression into 
Cx26-HeLa cells, plating was at 1 x 104 per well and experiments carried out 7 days later 
(6 days post transfection). When appropriate, transfection of cells occurred 24hrs after 
plating. Cells were transiently transfected with 1μg of appropriate DNA using the 
GeneJuice transfection agent protocol (Merck Millipore).  
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2.2.2 Photoactivation of intracellular Ca2+ 
NP-EGTA (Thermo Fisher, UK) loading was achieved by incubating glass coverslips 
containing Cx26-HeLa cells in 15 μM NP-EGTA AM for 20 mins, followed by 10 μM Rhod-2 
loading for 20mins, followed by a 20 min de-esterification in 35 mmHg CO2 aCSF (see 
2.2.6 – Experimental aCSF solutions) – during which intracellular esterases remove the 
acetoxymethyl ester allowing NP-EGTA direct contact with the cytosol). All loading steps 
were performed at room temperature. Suspension and dilution of NP-EGTA AM was 
achieved via dissolving in DMSO containing 20% Pluronic F-127 solution (Life 
Technologies, UK) to a concentration of 6 mM, and then diluted in 35 mmHg CO2 aCSF to 
a final concentration of 15 μM. 
UV field illumination (375 nm) during 2 s (alternating 50 ms exposure, 50 ms 
closed shutter) was used to photolyse NP-EGTA and release Ca2+ across a filed of view of 
NP-EGTA-loaded cells on glass coverslips. NP-EGTA exhibits a high affinity for Ca2+ (Kd = 
80 nM), however upon illumination with UV light the NP-EGTA chelator is cleaved, and 
the resulting iminodiacetic acid photoproducts have a very low affinity for Ca2+ (Kd > 1 
mM) – thus releasing sequestered Ca2+ (Ellis-Davies and Kaplan 1994). In this way 
changes in [Ca2+]i, and its effect on Cx26 gating, can be assessed.   
 
2.2.3  Ca2+ imaging data capture and analysis 
Rhod-2 (Thermo Fisher, UK) loading was achieved in the same manner as NP-EGTA 
loading: incubation of glass coverslips containing Cx26-HeLa cells in 15 μM NP-EGTA AM 
for 20 mins, followed by 10 μM Rhod-2 loading for 20mins, followed by a 20 min de-
esterification in 35 mmHg CO2 aCSF, all performed at room temperature. Suspension and 
dilution of Rhod-2 AM was achieved via dissolving in DMSO containing 20% Pluronic F-
127 solution (Life Technologies, UK) to a concentration of 4 mM, and then diluted in 35 
mmHg CO2 aCSF to a final concentration of 10 μM.  
Cells were imaged using epifluorescence (Scientifica Slice Scope, Cairn Research 
OptiLED illumination, 60x water Olympus immersion objective, NA 1.0, Hamamatsu 
ImageEM EMCCD camera, Metafluor software). Rhod-2 was excited with a 535nm LED, 
and its emission recorded between 570-640 nm (0.25 fps).  Rhod-2 undergoes > 100 fold 
increase in fluorescence intensity upon binding Ca2+ – thus allowing the detections of 
even small changes in [Ca2+]i (Minta, Kao, and Tsien 1989). In these experiments Rhod-2 
was used to assess the increase in [Ca2+]i. 
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2.2.4 Patch clamping data capture and analysis 
Patching of cells was performed by Nicholas Dale, all other parts of the experiments and 
analysis were performed by Joseph van de Wiel. 
HeLa cells stably expressing Cx26 and loaded with NP-EGTA and Rhod-2, were 
subjected to whole-cell patch clamping, with a change in whole cell conductance 
interpreted as channel opening. Whole-cell patching records channel opening 
throughout the entire cell, as opposed to other forms of patch clamping that only record 
channel activity from a small section of membrane. 
Glass coverslips containing Cx26-HeLa cells were perfused in a bath chamber with 
35mmHg CO2 aCSF (see 2.2.6 – Experimental aCSF solutions), to keep cells oxygenated 
and viable. For whole cell patching a glass electrode, filled with a buffer solution 
mimicking cytosolic conditions and a platinum wire to register electrical currents, makes 
a seal with the plasma membrane of a selected cell. Suction is then applied to rupture 
the membrane and cause it to form a seal around the electrode. Electrode buffer 
solution (sterile filtered and pH adjusted to 7.2 with KOH): 120 mM K-gluconate, 10 mM 
TEACl, 10 mM EGTA, 10 mM CsCl, 3 mM ATP, 1 mM CaCl2, 1 Mm MgCl2. 
Analysis was performed on an application purposely written for patch clamp 
analysis (MacAnalysis, Nicholas Dale), with the step change in current being measured 
before, at the peak of, and after a stimulus (Ca2+ release, or hypercapnia). Measurements 
before and after were averaged to provide a value used for baseline, which was 
subtracted from measurements obtained at peak response and converted to 
conductance (nS). Conductance was calculated as: ΔI/V were ΔI is the current change in 
Amps and V is the voltage step applied (10 mV). Calculation of conductance change is 
summarised in Figure 2.2. A one-way ANOVA with post hoc testing was carried out in the 
statistical package SPSS. 
 
2.2.5 Construction of connexin gene constructs 
Connexin26 DNA sequence from Rattus norvegicus (accession number NM_001004099.1) 
was synthesised by Genscript USA (omitting the STOP codon) and subcloned into a Puc19 
vector such that the transcript would form a fusion protein with the mCherry 
fluorophore we engineered to be 3’ (downstream) of Cx26. For subsequent experiments, 
this vector was cloned to yield different Connexin-fluorophore fusion protein constructs, 
using a combination of Kpn1, Xho1, Age1, and Nde1 restriction site digests.  
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Whenever mutations were required the Agilent Quikchange method protocol was 
followed. Guided by the Quikchange manual, the PCR reaction was performed over 16 
cycles to achieve a single amino acid change. The extension time was 6 minutes, allowing 
for 1 minute per Kb of DNA; with the vector, mCherry and Cx26 gene accounting for ~5.1 
 
 
 
Figure 2.2  Measurements and calculation for conductance change. Whole-cell patch recordings 
were taken by voltage clamping with a 10 mV step (ΔV). Baseline measurements of conductance 
were averaged from measurements made before (B1) and after (B2) the response to a stimulus. 
Peak conductance in response to a stimulus was taken at point showing largest current change 
(S). Conductance change was calculated by subtracteing baseline conductance from conductance 
at S. 
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 Kb. The PCR reaction was then digested for 1 hr at 370C with 1 μl Dpn1. This enzyme 
digests methylated DNA and thus removes the template, leaving only the newly 
synthesised, mutated DNA. Agarose gel electrophoresis confirmed that synthesised DNA 
was present – showing that the PCR reaction had been successful. For Cx26N14K mutation 
the following primers were used: forward, 5’ ATC CTC GGG GGT GTC AAG AAG CAC TCC 
ACC AGC 3’; reverse, 5’ GCT GGT GGA GTG CTT CTT GAC ACC CCC GAG GAT 3’. 
All subcloning steps were confirmed by DNA sequencing (GATC Biotech). To 
amplify DNA, plasmids were (heat shock) transfected into Top 10 E.Coli cells, which were 
grown up overnight before harvesting and purifying transfected DNA via a miniprep kit 
(Thermo Fisher). For mammalian cell expression, all constructs were subcloned into the 
pCAG-GS vector (which contains the CAG mammalian promoter).  
 
2.2.6 Experimental aCSF solutions 
Artificial cerebrospinal fluid (aCSF) was made and used to imitate fluid environments in 
the brain. Listed below are the aCSF solutions used during dye loading, ester loading, and 
patch clamping (writing in brackets refer to the solution’s purpose in dye loading 
experiments): 
 
35 mM HCO3- aCSF without dye (Wash aCSF)  
124 mM NaCl, 26 mM NaHCO3, 1.25 mM NaH2PO4, 3 mM KCl, 10 mM D-glucose, 1 mM 
MgSO4, 1 mM CaCl2. 
This solution was saturated with 95% O2/5% CO2 in order to provide the cells with oxygen 
throughout experimentation. This solution had a final pH of 7.4 and a pCO2 of 35 mmHg.  
 
35 mM HCO3- aCSF with dye (Control aCSF)  
124 mM NaCl, 26 mM NaHCO3, 1.25 mM NaH2PO4, 3 mM KCl, 10 mM D-glucose, 1 mM 
MgSO4, 1 mM CaCl2, and 200 μM 5(6)-Carboxyfluorescein (dye). 
This solution was saturated with 95% O2/5% CO2 in order to provide the cells with oxygen 
throughout experimentation. This solution had a final pH of 7.4 and a pCO2 of 35 mmHg.  
 
50 mM HCO3-
 Isohydric aCSF with dye (Hypercapnic aCSF)  
100 mM NaCl, 50 mM NaHCO3, 1.25 mM NaH2PO4, 3 mM KCl, 10 mM D-glucose, 1 mM 
MgSO4, 1 mM CaCl2, and 200 μM 5(6)-Carboxyfluorescein (dye). 
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This solution was saturated with ~91%O2/9% CO2 to provide the cells with oxygen and 
match the final pH to that of the control aCSF (pH 7.4). This removes any potential effects 
of changes in extracellular pH. The final pCO2 of this solution is 55 mmHg.  
 
Zero Ca2+ aCSF with dye (Positive Control aCSF) 
124 mM NaCl, 26 mM NaHCO3, 1.25 mM NaH2PO4, 3 mM KCl, 10 mM D-glucose, 2 mM 
MgSO4, 1 mM MgCl2 1 mM EGTA, and 200 μM 5(6)-Carboxyfluoroscein (dye). 
This solution was saturated with 95% O2/5% CO2 in order to provide the cells with oxygen 
throughout experimentation. This solution had a final pH of 7.4 and a pCO2 of 35 mmHg. 
The absence of Ca2+ opens hemichannels. 
 
2.2.7 Dye loading assay 
The dye loading assay used in this study is based off that used in published literature 
(Huckstepp et al. 2010a, Meigh et al. 2013, Meigh et al. 2014, Meigh 2015a, de Wolf et 
al. 2016, de Wolf, Cook, and Dale 2017). Coverslips of HeLa cells, at sub-confluent levels, 
were placed in a flow chamber for dye loading analysis and exposed to 
carboxyfluorescein dye - a membrane impermeable dye (molecular mass, 380 Da). In this 
assay, carboxyfluorescein can only enter HeLa cells when connexin hemichannels are 
expressed in the membrane and open to some stimulus (in this case CO2). When the 
stimulus is removed the connexin channels close, trapping molecules of 
carboxyfluorescein inside the cells. Carboxyfluorescein is then visualised using 
epifluorescence microscopy.  
Dye loading was performed 3 days post transfection for transfections into 
parental HeLa cells, and 6 days post transfection for transfections into Cx26-HeLa cells. 
Dye loading was tested under 35mmHg CO2 (control), 55mmHg CO2 (hypercapnic), and 
zero Ca2+ conditions. To investigate the CO2 sensitivity of homomeric hemichannels dye 
loading was performed on parental HeLa DH cells transfected with either Cx26WT-
mCherry or Cx26N14K-mCherry. To investigate the effect that Cx26N14K has when 
coexpressed with Cx26WT, dye loading was performed on Cx26-HeLa cells that had either 
been transfected with Cx26N14K-mCherry or untreated. 
During control experiments cells were exposed to control aCSF (35 mM HCO3- 
aCSF with dye – 200 μM carboxyfluorescein) for 15 minutes before being washed with 
wash aCSF (35 mM HCO3- aCSF without dye) for 30 minutes to remove external 
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carboxyfluorescein, which would increase background fluorescence.  
To investigate CO2 sensitivity, cells were exposed to the hypercapnic aCSF (50 mM 
HCO3- Isohydric aCSF with dye) for 10 minutes, followed by 5 minutes of control aCSF. 
The 5 minute step gives time for any open hemichannels to close, ensuring that any 
loaded dye is not washed away as the channels are closing. After hemichannels are given 
the chance to close, cells are washed with control aCSF for 30 minutes (as with control 
experiments).  
To confirm functional expression of hemichannels in the membrane, a positive 
control was performed; exposing cells to zero Ca2+ aCSF for 10 minutes, followed by 5 
minutes of control aCSF and then 30 minutes of wash aCSF (as with CO2 experiments). As 
low extracellular calcium is known to fully open Cx26 hemichannels (see 1.4.3 Gating of 
Connexin26), we used the zero Ca2+ aCSF as a measure of maximum dye loading. The zero 
Ca2+ aCSF was supplemented with MgCl2, rather than Ca2+, and contains 1 mM EGTA for 
Ca2+ chelation.  
Each experiment involved testing these three conditions on cells that resulted 
from the same transfection. The experiment was repeated 5 times, with each repeat 
performed on cells resulting from a different transient transfection.  
The dye loading protocol is summarised in Figure 2.3.  
 
 
 
Figure 2.3  Dye loading protocol. The control-background loading protocol accounts for any 
fluorescence that is brought about through anything other than CO2-dependent dye loading 
through hemichannels. Hypercapnic dye loading tests carboxyfluorescein loading brought about 
through the presence of 55mmHg CO2. The positive control uses zero Ca
2+
 conditions as a test to 
confirm the presence of functional hemichannels. Grey boxes represent time periods during 
which cells are exposed to wash aCSF (not containing carboxyfluorescein. Green boxes represent 
time periods during which cells are exposed to aCSF solutions containing carboxyfluorescein. 
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2.2.8 Dye loading data capture and analysis 
Dye loading experiments in this chapter were performed in conjunction with Elizabeth de 
Wolf and Jonathan Cook. 
Cells were imaged using epifluorescence (Scientifica Slice Scope, Cairn Research 
OptiLED illumination, 60x water Olympus immersion objective, NA 1.0, Hamamatsu 
ImageEM EMCCD camera, Metafluor software). Carboxyfluorescein was excited with a 
470 nm LED, and its fluorescence emission was recorded between 507-543nm. The Cx26-
mCherry constructs used in these experiments (and experiments in future chapters,  
unless otherwise stated) yields a fusion protein of Cx26XX with a C-terminal mCherry tag. 
mCherry was excited with a 535 nm LED, and its emission recorded between 570-640 
nm.  
After cells had been exposed to one of the three conditions (control, hypercapnic, 
or Zero Ca2+), multiple images of carboxyfluorescein loading were acquired to obtain 
many fields of view, each containing a different set of cells. To check for connexin 
expression in the cells selected for analysis, mCherry images were taken for each field of 
view that was selected. 
Images were analysed using Image J. Fluorescence intensity from background-
subtracted cells were obtained by drawing regions of interest (ROIs) around individual 
cells and measuring the mean pixel intensity for individual cells. For each experimental 
repeat at least 40 cells for each condition were measured. The mean pixel intensities 
across all repeats were plotted as cumulative probability distributions for each condition. 
Also, the Mann Whitney test was used to compare the median differences in pixel 
intensity across selected groups.  
 
2.3 Results 
2.3.1 Increased intracellular Ca2+ can be evoked through photolysis of NP-EGTA  
Although it is established that even low levels of extracellular Ca2+ (0.05 mM) closes Cx26 
channels (Unwin and Ennis 1984), the effects of intracellular Ca2+ have not been 
reported. To investigate the effect that increasing [Ca2+]i has on Cx26 channels, HeLa cells 
stably expressing Cx26 (Cx26-HeLa cells) were loaded with NP-EGTA – a Ca2+ chelator that  
can be photolysed upon demand in order to release sequestered Ca2+ – and Rhod-2 – a 
calcium indicator that exhibits an increase in fluorescence upon Ca2+ binding (Figure 2.4). 
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Using Rhod-2 fluorescence intensity as a measure, UV-photolysis of NP-EGTA produced 
robust increases in [Ca2+]i during our experiments – mean increase over baseline, 
79.5%±33.7 (n = 25),  Figure 2.4b.  
Initial experimental attempts to investigate the effect that [Ca2+]i involved loading 
cells with a fluorescent dye, in addition to NP-EGTA and Rhod-2, and then to observe dye 
efflux. Both calcein and carboxyfluorescein were tried as the dye, but due to a 
combination of bleaching, and unusual fluorescence changes (in both the florescent dye 
and Rhod-2) no valid data could be collected. Instead, patch clamp recordings were used 
to measure the opening of Cx26 channels in response to increased [Ca2+]i. 
 
2.3.2 CO2-dependent opening of Connexin26 hemichannels causes an influx of Ca2+  
Cx26 hemichannel permeability to Ca2+ has been demonstrated in preps of purified Cx26 
hemichannels reconstituted in liposomes (Fiori et al. 2012), however it has not been 
witnessed in living cells. During our patch-clamp experiments, Rhod-2 recordings 
revealed a rise in intracellular Ca2+ upon opening of Cx26 hemichannels by CO2. (Figure 
2.5d, Figure 2.6b). This suggests Ca2+ influx through the expressed Cx26 hemichannels, 
which is consistent with our hypothesis that similar influx in vivo could occur and result in 
augmented Cx26 hemichannel opening.  
 
 
Figure 2.4  Experimental rationale: Increased [Ca2+]i can be evoked through photolysis of NP-
EGTA. Cells loaded with NP-EGTA and Rhod-2 show normal [Ca2+]i until exposure to UV light. a) 
Photolysis of NP-EGTA releases caged-Ca
2+
 which is then available to act as a signalling molecule 
and interact with cytoplasmic proteins. The increase in [Ca
2+
]i is detected via the calcium 
indicator Rhod-2, which increases fluorescence upon Ca
2+
 binding. b) Average Rhod-2 intensity 
upon flashing with 405nm light (blue triangular arrow). Photolysis of NP-EGTA results in a rapid 
increase in [Ca
2+
]i followed by an exponential decay back towards baseline. Trace was averaged 
from experimental cells; n = 25 (from 11 preparations). 
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Figure 2.5  Connexin26 gap junctions but not hemichannels open in response to [Ca2+]i. HeLa 
cells stably expressing Cx26 were loaded with NP-EGTA and Rhod-2 before whole-cell patch 
recordings were taken. Patched cells were voltage clamped, being held at a potential of -50mV, 
with 10mV step. a) Representative trace from a coupled cell showing a robust change in whole-
cell current upon release of [Ca
2+
]i (blue triangular arrows). b) corresponding Rhod-2 trace for 
experiment shown in (a). c) Representative trace from an isolated cell showing no change in 
whole-cell current upon release of [Ca
2+
]i (blue triangular arrows), despite functional Cx26 
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hemichannels being present – as seen by an increase in current upon bath perfusion with 
hypercapnic aCSF. d) corresponding Rhod-2 trace for experiment shown in (c). e) Example 
brightfield image showing a patched cell that was considered to be coupled due to apposing 
membranes with another cell. f) Example images (from the Rhod-2 channel) showing a patched 
cell that was considered to be isolated due to no apposing membranes from neighbours. g) Box 
and whisker plot showing conductance change upon release of [Ca
2+
]i. Almost no change in 
conductance is seen in isolated cells or parental cells, however cells that were coupled showed a 
clear conductance change. Coupled, n = 12; isolated, n = 8; parental; n = 5. One-way ANOVA 
(represented by the top bar) was carried out in the statistical package SPSS. Post-hoc testing 
revealed the coupled dataset to be significantly different (p < 0.001) from the isolated and 
parental datasets. Conductance change (S) was calculated as: ΔI/V were ΔI is the current change 
in Amps and V is the voltage step (10 mV). Boxes show the interquartile range. The median is 
indicated as a horizontal line within the box, and the mean is represented by a cross within the 
box. Range bars show minimum and maximum values. Scale bar 40μM,  Cx, Connexin; aCSF, 
artificial cerebrospinal fluid 
 
2.3.3 Connexin26 gap junctions, but not hemichannels, exhibit a whole cell 
conductance change in response to [Ca2+]i   
Changes in the whole-cell conductance of Cx26-HeLa cells was used to measure Cx26 
channel opening in response to increased [Ca2+]i. Upon photolysis of cytosolic NP-EGTA, 
transient conductance changes were only recorded in Cx26-HeLa cells that had 
membranes apposed to other cells (termed coupled) – mean conductance change, 
1.44±1.23 nS (n = 12), Figure 2.5a,e,g. The time taken from the start of UV illumination to 
the onset of a conductance change was ~3.5 s, however the time at which Rhod-2 
intensity increased and conductance change increased were all-but indistinguishable, 
Figure 2.5a,b. Cx26-HeLa cells that were clearly isolated from others showed no such 
change – mean conductance change = 0.04±0.06 nS (n = 8), Figure 2.5c,f,g – despite their 
expression of functional Cx26 hemichannels; shown by a prolonged conductance change 
in response to hypercapnic conditions (Figure 2.5c). Parental HeLa cells (not expressing 
Cx26) were also tested and showed no such response to increased [Ca2+]i – , mean 
conductance change, 0.00±0.04 nS  (n = 5), Figure 2.5g. Mean conductance change was 
compared by a one-way ANOVA (p < 0.001), with post hoc testing revealing a significant 
difference between coupled and both isolated and parental cells.  
Patch clamp recordings record current flow across the membrane and the result 
(on transmembrane current flow) of opening hemichannels or gap junctions is almost 
indistinguishable from the point of view of the recorded cell. If either gap junctions or 
hemichannels open, more current will flow across the membrane in response to a given 
	 63	
voltage step (because the membrane conductance has increased). Given that large 
conductance changes in response to intracellular Ca2+ were never seen in the parental 
HeLa cells, any large conductance changes seen in the transfected cells must be due to 
the presence of Cx26. The only difference between “coupled” and “isolated” cells is the 
presence/absence (respectively) of gap junctions. This makes it most likely that the 
conductance change observed in coupled cells is due to the presence of gap junctions. 
Similarly, the lack of conductance change in isolated cells must be due to the absence of 
gap junctions. Therefore, the simplest interpretation of this data is that intracellular Ca2+ 
opens Cx26 gap junctions, but does not open Cx26 hemichannels.  
 
2.3.4 Whole cell conductance change evoked by [Ca2+]i  does not occur after exposure 
to hypercapnia 
Lack of Cx26 hemichannel opening by [Ca2+]i disproves our hypothesis and rules out the 
potential for synergistic CO2/[Ca2+]i hemichannel opening. However, it is possible that 
during these experiments we witnessed an interaction between Cx26 gap junction 
opening by [Ca2+]i and closing by CO2. 
In the protocol used, coupled Cx26-HeLa cells usually contained sufficient NP-
EGTA for at least two robust Ca2+ releases, and subsequent changes in conductance – 
mean conductance change, 1.36±1.48 nS (n = 7), Figure 2.6c-e. However, a second 
conductance change was not observed when NP-EGTA was photolysed after perfusion of 
the chamber bath with aCSF containing 55 mmHg CO2 – mean conductance change, 
0.08±0.12 nS (n = 5), Figure 2.6a,b,e. The timing of photolysis was at the point cell 
conductance returned to baseline (Figure 2.6a, second blue triangular arrow), and 
Rhod2 intensity values showed that a substantial rise in intracellular [Ca2+]i still occurred 
upon this second uncaging on Ca2+ (Figure 2.6b). Mean conductance changes in response 
to a second release of intracellular Ca2+ were compared between coupled Cx26-HeLa 
cells before or after perfusion with 55mmHg (Figure 2.6e). Comparisons were made 
using an independent t-test and showed a significantly lower change in whole-cell 
conductance when the second Ca2+ release occurred after hypercapnic conditions. This 
hints at a possible Cx26 gating hierarchy/antagonism between [Ca2+]i and the CO2 
stimulus, in which gap junction closing in response to CO2 prevents opening by Ca2+. 
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Figure 2.6  Connexin26 gap junction opening via [Ca2+]i may be blocked by CO2-dependent 
closing of Connexin26. HeLa cells stably expressing Cx26 were loaded with NP-EGTA and Rhod-2 
before whole-cell patch recordings were taken. Coupled cells were were voltage clamped, being 
held at a potential of -50mV, with 10mV step. a) Representative trace from a coupled cell 
showing a robust change in whole-cell current upon first release of [Ca
2+
]i (first blue triangular 
arrow) but not upon a second release that occurs after perfusion with hypercapnic aCSF (second 
blue triangular arrow). b) corresponding Rhod-2 trace for experiment shown in (a).  c) 
Representative trace showing that, in the absence of hypercapnia, a second release of [Ca
2+
]i is 
sufficient to cause a second change in whole-cell conductance. d) corresponding Rhod-2 trace for 
experiment shown in (c). e) Box and whisker plot showing conductance change in coupled cells 
upon a second release of [Ca
2+
]i. Almost no change in conductance is seen when the second 
release occurs after perfusion with hypercapnic aCSF, however if cells were not subjected to 
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hypercapnia a clear conductance change was seen. No hypercapnia, n = 7; post-hypercapnia, n = 
5. Independent t-test was carried out in the statistical package SPSS, revealing a significant 
different (p < 0.001) between cells exposed to hypercapnic aCSF and those exposed to standard 
aCSF (35 mmHg CO2). Conductance change (S) was calculated as: ΔI/V were ΔI is the current 
change in Amps and V is the voltage step (10 mV). Boxes show the interquartile range. The 
median is indicated as a horizontal line within the box, and the mean is represented by a cross 
within the box. Range bars show minimum and maximum values. Release of [Ca
2+
]i (blue 
triangular arrows) was brought about via photolysis of NP-EGTA upon UV excitation. Scale bar 40 
μm,  Cx, Connexin; aCSF, artificial cerebrospinal fluid. 
 
2.3.5 Connexin26 N14K hemichannels do not open in response to CO2  
Upon finding that intracellular Ca2+ does not open Cx26 hemichannels, and therefore 
does not contribute to their CO2-dependent gating, our attention turned to the 
pathological implications of Cx26 hemichannel CO2 gating. This thesis aims to investigate 
the role that Cx26 hemichannels play in producing a breathing response. As an extension 
from this, any pathological roles for the CO2 gating of Cx26 hemichannels are of interest 
as they may have the respiratory implications.  
Of specific interest to this thesis is the lack of CO2 sensitivity that has been 
reported in all KID syndrome mutations that have been tested (Meigh et al. 2014, de 
Wolf et al. 2016). KID syndrome is a complex disorder affecting the skin, eyes, and ears, 
however several patients present with respiratory problems, which for some was the 
reported cause of death (Meigh et al. 2014, Koppelhus et al. 2011, Janecke et al. 2005, 
Sbidian et al. 2010). This suggests that KID mutations might affect the hypercapnia-
induced release of ATP that occurs at the VMS via Cx26 hemichannels. Such a finding 
could help further characterise this syndrome, and might identify more focused 
treatments for patients. It would also help consolidate the importance of Cx26 in 
chemoreception. In light of this, it is prudent to characterise the effect KID mutations 
have on the CO2 gating of Cx26 hemichannels and to see how they affect a cells response 
to hypercapnia.  
One KID syndrome mutation is N14K. To test the CO2 sensitivity of Cx26N14K 
hemichannels, parental HeLa cells were transient transfected with either Cx26WT or 
Cx26N14K constructs (each tagged with a C terminal mCherry fusion). 3 days post-
transfection, cells were loaded with dye under 35mmHg CO2 aCSF (control), 55mmHg 
CO2 aCSF (hypercapnic), or zero Ca2+ conditions. Consistent with previous studies, cells 
expressing Cx26WT showed greater dye loading in response to hypercapnic conditions (p  
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Figure 2.7   Connexin26 N14K hemichannels do not open in response to CO2. HeLa cells were 
transfected with either Cx26
WT
 or Cx26
N14K
, and dye-loading experiments were carried out 3 days 
post-transfection. a) Representative images showing expression of mCherry tagged to Cx26 
protein (left), and dye loading under 35mmHg PCO2 (control, middle) and 55mmHg PCO2 
(hypercapnic, right) conditions – insert shows dye loading under zero Ca
2+
 conditions; a positive 
control showing functional Cx26 hemichannels. HeLa cells expressing Cx26
WT
 show an increase in 
dye loading under hypercapnic conditions (top panels), however cells expressing Cx26
N14K
 do not 
(bottom panels). b) Cumulative probability distributions comparing mean pixel intensity for each 
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condition (Cx26
WT
, top; Cx26
N14K
; bottom). c) Median change between 35mmHg and 55mmHg, 
and 35mmHg and Zero Ca
2+
, median pixel intensities. Cells expressing Cx26
N14K 
hemichannels do 
not to respond to CO2, whilst cells expressing Cx26
WT
 hemichannels do. n > 50 cells per treatment 
repeat, with 5 independent repeats for each treatment. Error bars show the first and third 
quartiles. Median pixel intensities (from independent repeats) were compared using the Mann-
Whitney U test. Scale bars, 40μm. Figures reproduced from de Wolf, E., van de Wiel, J., Cook, J., & 
Dale, N., 2016. 
 
= 0.003, compared to Cx26WT control). In contrast to this, cells expressing Cx26N14K 
showed no such increase in dye loading in response to hypercapnia conditions, Figure 
2.7a,b. Protein-tagged mCherry confirmed expression of the connexin variants (Figure 
2.7a, left panels). To confirm that this expression included functional hemichannels in 
the plasma membrane, we used extracellular zero Ca2+ conditions as a means of 
measuring dye loading when hemichannels are fully open (Sánchez et al. 2010). Dye 
loading above control conditions was no different when comparing hypercapnic and zero 
Ca2+ conditions in cells expressing Cx26WT, however there was a difference in those cells 
expressing Cx26N14K (p = 0.004), Figure 2.7c. These results suggest that, whilst Cx26WT 
hemichannels open in response to CO2, the N14K mutation results in hemichannels that 
do not. 
 
2.3.6 The Connexin26 N14K mutant acts to drastically reduce CO2 sensitivity from 
cells expressing wild-type Connexin26  
Cx26 mutants that cause KID syndrome are dominant in nature (Yotsumoto et al. 2003, 
Janecke et al. 2005, Kelly et al. 2008, Koppelhus et al. 2011, Sbidian et al. 2010, Terrinoni 
et al. 2010, Terrinoni et al. 2010a, Terrinoni et al. 2010b, Van Geel et al. 2002, Sonoda et 
al. 2004, Mazereeuw‐Hautier et al. 2007, Lazic et al. 2008, de Zwart‐Storm et al. 
2011). It has previously been demonstrated that another KID mutant, A88V, is not 
sensitive to CO2 (like the N14K mutant). Furthermore, A88V was shown to have a 
dominant negative action on CO2 sensitivity (Meigh et al. 2014). Cx26A88V took 6 days 
from transfection (into Cx26-HeLa cells) to impose its dominant negative action and 
remove CO2 sensitivity from the Cx26-HeLa cells. Using the same assay, we transfected 
Cx26-HeLa cells with the Cx26N14K construct (containing an mCherry-tag) and the CO2 
sensitivity was assessed 6 days post-transfection. mCherry fluorescence shows abundant 
Cx26N14K expression at 6 days (Figure 2.8a, bottom left), and extracellular zero Ca2+  
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Figure 2.8   The Connexin26 N14K mutant acts in a dominant negative manner to remove CO2 
sensitivity from cells expressing wild type Connexin26. HeLa cells stably expressing Cx26WT 
(Cx26-HeLa cells) were either untreated or transfected with Cx26
N14K
, and dye-loading 
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experiments were carried out 6 days post-transfection. a) Representative images showing 
expression of Cx26 variants (left: immunostaining shows stable expression of Cx26 in Cx26-HeLa 
cells, top; mCherry tagged to Cx26
N14K
 shows expression of Cx26
N14K
 at 6 days post-transfection, 
bottom), and dye loading under 35mmHg PCO2 (control, middle) and 55mmHg PCO2 
(hypercapnic, right) conditions – insert shows dye loading under zero Ca
2+
 conditions; a positive 
control showing functional Cx26 hemichannels. Untreated Cx26-HeLa cells show an increase in 
dye loading under hypercapnic conditions (top panels), however cells also expressing Cx26
N14K
 do 
not (bottom panels). b) Cumulative probability distributions comparing mean pixel intensity for 
each condition (untreated Cx26-HeLa cells, top; Cx26
N14K
-transfected, bottom). n > 50 cells per 
treatment repeat, with 5 independent repeats for each treatment. c) Median change between 
35mmHg and 55mmHg, and 35mmHg and Zero Ca
2+
, median pixel intensities. Cells expressing 
Cx26
N14K 
hemichannels loose their ability to respond to CO2, whilst cells stably expressing Cx26
WT
 
hemichannels maintain CO2 sensitivity throughout the time course. Error bars show the first and 
third quartiles. Median pixel intensities (from independent repeats) were compared using the 
Mann-Whitney U test. Scale bars, 40μm. Figures reproduced from de Wolf, E., van de Wiel, J., 
Cook, J., & Dale, N., 2016 
 
controls showed that this expression included functional hemichannels in the plasma 
membrane. 
Consistent with previous work, Cx26-HeLa cells were still sensitive to CO2 at 6 days, 
however coexpression of Cx26N14K subunits (with the stably expressed Cx26WT) was found 
to profoundly reduce the CO2-sensitivity of these cells, Figure 2.8a,b.  Dye loading above 
control conditions was no different when comparing hypercapnic and zero Ca2+ 
conditions in non-transfected Cx26-HeLa cells, however there was a difference in cells 
expressing Cx26N14K (p = 0.006), Figure 2.8c. These results suggest that Cx26N14K acts in a 
dominant negative manner to remove CO2 sensitivity from Cx26-HeLa cells. However, 
unlike coexpression of Cx26A88V and Cx26N14Y (Meigh et al. 2014, de Wolf et al. 2016), 
complete removal of hypercapnia-evoked dye loading was not seen, with ~20% 
remaining (Figure 2.8c).  
 
2.4 Discussion 
2.4.1 Differential opening of Connexin26 hemichannels and gap junction  
Although the absence of extracellular Ca2+ is well known to open Cx26 hemichannels, the 
effects of intracellular Ca2+ have not been reported. By comparing coupled and isolated 
Cx26-HeLa cells (HeLa cells stably expressing Cx26WT), it was demonstrated that Cx26 gap 
junctions, but not hemichannels, open in response to increased [Ca2+]i (Figure 2.5). This 
	 70	
contrasts the response shown by Cx32 hemichannels, which open in response to an 
[Ca2+]i of ~500nM (De Vuyst et al. 2006). It would be interesting to test the response of 
Cx26/Cx32 heteromeric hemichannels to [Ca2+]i. 
It must be noted that cells assigned to the “coupled” group did not have coupling 
confirmed (e.g. via dual patch clamping), however patching was performed on cells 
stably expressing Cx26WT, which readily form gap junctions with neighbouring cells 
(Figure 2.8a, top left panel), and cells for the “coupled” group were only selected if they 
had apposing membranes with their neighbours.  
The observed conductance change was transient in nature. Ca2+ released from 
NP-EGTA photolysis cannot re-associated with the photolysed NP-EGTA and so will be 
pumped out of the cell through efflux pumps, or taken up into intracellular stores. For 
this reason there was usually only sufficient NP-EGTA within cells for two clear NP-EGTA-
mediated responses. 
Owing to the design of the experiment, and the knowledge that extracellular Ca2+ 
closes hemichannels and gap junctions, it can be assumed that there is a cytoplasmic 
domain on Cx26 gap junction connexons that is responsible for this [Ca2+]i gating. As 
photolysis was applied across the field of view, we cannot ascertain whether an increase 
in [Ca2+]i is required in both cells that share a gap junction, or just in one. As the change 
in conductance was very rapid in response to increased [Ca2+]i, it is likely that Ca2+ 
modulate gating directly, rather than causing the release of another messenger molecule 
that acts on Cx26 gap junctions. 
Given the extensive use of Ca2+ signalling throughout the body, and widespread 
expression of Cx26, this result has far-reaching implications. Our result that Cx26 gap 
junctions open in response to [Ca2+]i may help explain, in part, the well-established roll of 
connexin gap junctions in the propagation of Ca2+ waves (Cotrina et al. 1998, Hassinger et 
al. 1996, Leinonen et al. 2007, Sáez et al. 2003). It remains to be confirmed whether or 
not the magnitude of [Ca2+]i release that was achieved in these experiments is of 
physiological relevance – however similar NP-EGTA studies in Cx32-expressing cells 
increases [Ca2+]i to ~500nM (within physiological range) (De Vuyst et al. 2006), and it is 
likely we achieved comparable concentrations. It might be that the opening of Cx26 gap 
junctions by [Ca2+]i only occurs at very high concentrations of [Ca2+]i that don’t often 
occur in cells, or that only occur after initial stimulation (e.g. from extracellular ATP) – 
thus being capable of augmenting Ca2+ signalling but rarely initiating it. Whether opening 
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only occurs at very high [Ca2+]i or not, it is interesting that this gating mechanism exists, 
as it suggests that cells prioritise [Ca2+]i-mediated Cx26 gap junction opening over 
uncoupling from cells with high [Ca2+]i – which can cause cell death (Neher and Sakaba 
2008, Clapham 2007, Hajnóczky et al. 2006).  
Of importance to this thesis, a large part of the Ca2+ wave cell-to-cell signalling in 
glia, amongst other cells, is contributed by ATP release rather than intercellular coupling 
(Cotrina et al. 1998, Anselmi et al. 2008, Gourine et al. 2010, Cotrina, Lin, and 
Nedergaard 1998, Hassinger et al. 1996). The mechanisms behind hemichannel ATP 
release are still being elucidated (see 1.3 Central respiratory chemosensory transducers 
for pCO2), however the data presented in this chapter rules out a [Ca2+]i stimulus in the 
opening of Cx26 hemichannels. Subsequently, this disproves our initial hypothesis that 
[Ca2+]i could act to augment the Cx26-mediated ATP release that is known to mount a 
respiratory response. However, our finding that Ca2+ influx occurs through CO2-opened 
Cx26 hemichannels might prove important for other ATP release mechanisms in glial, 
which have been shown to be reliant on [Ca2+]i signalling (Gourine et al. 2010).    
 
2.4.2 Blocking of [Ca2+]i-mediated Connexin26 gap junction gating by CO2: possible 
stimuli interactions 
Although speculative, the lack of a second conductance change after perfusion with 55 
mmHg CO2 hints that there could be some interaction occurring between the Cx26 gating 
modulated by [Ca2+]i and CO2 (or pH, owing to the carbonic anhydrase-driven reaction). If 
this is true, one explanation would be that each stimuli competes to exert its action on 
the gap junctions, and that in our experiments the CO2 stimulus outcompeted that of 
intracellular calcium. However, the timing of the second Ca2+ release (i.e. when the 
hypercapnic aCSF had been washed out) might suggest that it is not a straight forward 
competitive interaction. Given that the opening of Cx26 hemichannels by CO2 is quickly 
reversible (Meigh et al. 2013, Huckstepp et al. 2010b) but the closing of Cx26 gap 
junctions by CO2 has a longer lasting effect (personal communication from Nicholas 
Dale), it could be that until the effects of CO2-mediated gap junction closing wear off, the 
channels are insensitive to the mechanism by which intracellular calcium opens them. 
With this explanation, I propose the CO2-mediated closing of gap junctions was not 
reversed at the point of a second Ca2+ release, and thus no response was seen. 
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2.4.3 A hemichannel is not half of a gap junction 
For a long while connexin hemichannels were largely ignored with focus being given to 
gap junctions, and hemichannels simply thought of as half a gap junction. In the last 
couple of decades hemichannels have received much more attention and now, with the 
recent development of peptides that suppress hemichannel but not gap junction activity 
(by binding connexon cytosolic loop regions), we are starting to be able to explore the 
roles of endogenously expressed hemichannels (Sáez and Leybaert 2014, Vinken 2015, 
Iyyathurai et al. 2013, Abudara et al. 2014, Wang, De Vuyst, et al. 2013). However, there 
is still an underlying impression that hemichannels, although now accepted to play a 
variety of roles themselves, act in a mechanistically comparable manner to gap junctions. 
However, it is becoming apparent that this is not always the case.  
Our finding that [Ca2+]i likely mediates opening of Cx26 gap junctions, but has no 
effect on hemichannels, further illustrates the difference between these two channel 
conformations. The docking of two connexon hemichannels forces a conformational 
change as the channels fuse, and regions that were previously exposed to a soluble 
environment are instead exposed to peptide or lipid environments, which could consist 
of a vastly different hydrophobicity or charge. Considering this, it can be assumed that 
the formation of a gap junction does more than simple connect two cells; it might 
significantly change the tertiary and quaternary structure of the involved connexins. This 
difference between hemichannels and gap junctions could be expected to play an 
integral role in why the body is able to use the same protein within the same cell, and in 
many different tissues, for completely different processes/signalling pathways. Careful 
structural studies are required to discern what motifs are important for the difference 
seen between hemichannel and gap junction responses to [Ca2+]i.  
Another stimulus that has different gating properties on Cx26 hemichannels and 
gap junctions is CO2. The recently discovered modulator of Cx26 opens Cx26 
hemichannels (Huckstepp et al. 2010b) but closes Cx26 gap junctions (personal 
communication with Nicholas Dale). Such complex gating characteristics could be 
considered of great evolutionary advantage, enabling one protein to have many different 
functions within and across different tissues. The differential gating of hemichannels and 
gap junctions may further contribute to the multifunctionality of Cx26 when taking into 
consideration the heteromeric connexons and heterotypic gap junctions that it forms 
with other members of the connexin family, and when considering potential interactions 
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between gating stimuli (such as the dominance of CO2 over intracellular Ca2+ that we 
have proposed). Studying heteromeric and heterotypic channels is difficult, and little is 
known about their characteristics. However, many inter-connexin interactions are known 
to form in native tissue (Koval, Molina, and Burt 2014), and as such the true power of 
connexin gating is yet to be revealed.  
This discussion highlights the importance for continued characterisation of Cx26 
in order to help us better understand its function in the body and its role in pathologies; 
including those that are well-established to be linked to Cx26, such as non-syndrome 
hearing loss (Kelsell et al. 1997) and KID syndrome (Kelly et al. 2008), and those that Cx26 
might yet prove play a key role in, such as SIDS (Harper et al. 2000) and central sleep 
apnoea’s. 
 
2.4.4 Possible mechanisms by which the N14K loss of function mutant prevents 
Connexin26 hemichannel gating by CO2 
In order to better understand the role that Cx26 CO2-sensitivty plays in KID syndrome 
pathologies, we used a published assay to analyse the CO2-dependent channel opening 
of Cx26N14K, one of the 9 known KID syndrome mutations. This assay is suitable for 
investigating hemichannels, but not gap junctions, and as such caution should be taken 
when extrapolating results in the context of gap junctions. In this chapter, it is shown 
that, unlike Cx26WT, homomeric C26N14K hemichannels did not open in response to 
hypercapnic conditions, showing it to be a loss of function mutant (for CO2 sensitivity). 
Furthermore, this mutant drastically reduced opening of channels in cells coexpressing 
Cx26WT and Cx26N14K.  
The N14 residue is located within the cytoplasmic linker region, between the N-
terminus and TM1 and in close proximity to the site where K125 is carbamylated; which 
subsequently forms a salt bridge with R104 from an adjacent subunit, stabilising the 
hemichannel in an open state. The N14K mutation is 6.6 Å from R104 and 9.3 Å from 
K125 (Figure 2.9) and as such it could interfere with the formation of a carbamate bridge 
– possibly via a change in environment resulting from the introduction of a novel positive 
charge and larger sidechain where there once was a polar residue (Asparagine à Lysine). 
Alternatively, this mutation could hinder the conformational change that usually occurs 
upon carbamate bridge formation.  
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Interestingly, the N14Y mutation also causes KID syndrome, and has also been 
shown to lack CO2 sensitivity (de Wolf et al. 2016). It is tempting to stipulate that either 
mutation at the N14 locus prevents CO2 sensitivity via disruption of the same 
mechanism, although if these mutations acted through different mechanisms it might 
help to better explain why complete abolishment of CO2 sensitivity is seen from 
Cx26N14Y/Cx26WT coexpression, but not Cx26N14K/Cx26WT coexpression. Tyrosine is bulky 
and may be expected to hinder conformational changes more than the N14K mutation 
(thus having less of an effect on the carbamylation event). Furthermore, it is known that 
the N14Y mutation changes the local structural flexibility of the cytoplasmic N-terminal  
 
 
 
Figure 2.9  Location of the N14K Keratitis, Ichthyosis, and Deafness (KID) syndrome mutation. 
Molecular cartoon structure of a connein26 hemichannel (central pore, *) viewed from the 
cytoplasmic side. The N14K, A88S, M34T, and V84L KID syndrome mutations (red) on the green 
subunit. Shown also are the R104 and K125 residues that are involved in CO2-binding and 
carbamate bridge formation (blue). Insert shows an alternative view, highlighting the close 
proximity of the N14K mutation to the K125 and R104 residues (carbamate bridge is represented 
by dotted white line). Molecular model drawn from the PDB structure 2zw3. NTH, N terminal; *, 
hemichannel pore. Figures reproduced from de Wolf, E., van de Wiel, J., Cook, J., & Dale, N., 2016  
	 75	
domain, subsequently interfering with Cx26N14Y gap junction channel function (Arita et al. 
2006). This mechanism could be extrapolated to explain the CO2 insensitivity reported in 
homomeric and heteromeric Cx26N14Y hemichannels – i.e. steric hindrance of the 
conformational change that results from carbamylation.  
A recent study has suggested that hemichannel voltage-dependent loop gating is 
shifted towards higher opening probabilities in Cx26N14K, due to altered electrostatic 
interactions between the N-terminus and the cytoplasmic end of TM2 from the adjacent 
subunit, but is shifted to lower opening probabilities in Cx26N14Y hemichannels, due to 
different electrostatic interactions (Sanchez et al. 2016). This may seem to contrast our 
suggestion that both N14K and N14Y mutants exhibit a loss-of-function however the 
truth may lie somewhere in-between, with a tendency for higher opening probabilities 
explaining why Cx26N14K/Cx26WT coexpression did not completely remove dye loading 
from cells.    
As it stands, there is no robust rationale as to why the N14K or N14Y mutants 
render Cx26 hemichannels insensitive to CO2. The other KID mutant reported to lack CO2 
sensitivity, A88V, has no evidence-based suggestions for its CO2-insensitive aetiology. 
This residue is not particularly close to either K125 or R104, and so it seems more likely 
to cause steric hindrance than affect CO2 binding. Clearly, better structural 
understanding is required to fully elucidate the mechanism by which these mutations 
prevent gating via CO2. 
As it is highly likely that Cx26 KID mutants coassemble with Cx26WT subunits, it is 
also highly likely that whatever mechanisms prevent mutant hemichannel opening in 
response to CO2 is also capable of disrupting opening in coassembled (heteromeric) 
connexons. This hypothesis would explain the dominant effect seen when Cx26WT is 
coexpressed with Cx26N14K, Cx26N14Y, or Cx26A88V. 
 
2.4.5 Implications for KID syndrome 
In this chapter it is shown that the Cx26N14K mutant lacks any CO2 sensitivity when 
expressed as homomeric hemichannels and has a severe negative action on CO2 
sensitivity when coexpressed with Cx26WT. This parallels that of the severe pathology 
shown in patients with the N14K mutation; whereas the N14K mutation is dominant in 
causing KID syndrome (Lazic et al. 2008), two other Cx26 mutations (M34T and V84L), 
that are only linked to hearing loss, were found to have much less of an affect on CO2 
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sensitivity – with Cx26V84L retaining CO2 sensitivity when expressed alone and Cx26M34T 
showing reduced CO2 sensitivity when expressed alone, but no affect on CO2 sensitivity 
when coexpressed with Cx26WT (de Wolf et al. 2016). Furthermore, Cx26N14K did not show 
complete removal of CO2 sensitivity when coexpressed with Cx26WT. This also parallels 
pathology when comparing it to other KID mutations. The A88V and N14Y mutants do 
show complete removal of sensitivity when coexpressed with Cx26WT (Meigh et al. 2014, 
de Wolf et al. 2016), and both of these mutations result in more severe forms of KID 
syndrome than Cx26N14K – Cx26A88V is fatal at infancy (Koppelhus et al. 2011, Haruna et al. 
2010) and Cx26N14Y presents with a complete array of symptoms  (Arita et al. 2006). On 
the other hand, Cx26N14K has been suggested to cause a modified version of the disease 
(Lazic et al. 2008, Steijlen, Bladergroen, and Hoefsloot 2004). The CO2 sensitivity of the 
other 6 KID mutations is yet to be investigated. 
The leading hypothesis for why dominant missense Cx26 mutations cause 
syndromes is a gain of function increase in hemichannel activity (Sanchez and Verselis 
2014, Sanchez et al. 2014, Levit et al. 2015, Levit and White 2015, Lilly et al. 2016). The 
emerging data on KID mutant CO2-sensitivity (discussed here) provides another 
hypothesis – that losing CO2-mediated Cx26 hemichannel gating plays a part in KID 
pathology. 
Cx26 mutations that remove CO2 sensitivity from cells (such as the N14K, N14Y, 
and A88V KID mutants) are also likely to affect respiratory chemoreception. Cx26 is 
involved in the respiratory response to increases pCO2 (Huckstepp et al. 2010a, 
Huckstepp et al. 2010b) breathing. Furthermore, KID syndrome patients have been 
reported to suffer respiratory problems (Janecke et al. 2005, Sbidian et al. 2010, 
Koppelhus et al. 2011, Meigh et al. 2014), and in some cases it was the cause of death. 
One such patient presenting with deceased respiratory drive carried the A88V mutation, 
which has subsequently been shown to lack CO2-sensitivity thereby making the first 
connection between Cx26 CO2 sensitivity and human pathology (Meigh et al. 2014). It is 
possible that many KID syndrome patients present with respiratory problems that are 
overshadowed by other characteristics of the disease and have thus not been reported in 
the literature.  
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2.4.6 A gateway to studying Connexin26 CO2 sensitivity in vivo  
The identification of Cx26 variants that are not only CO2-insensitive when expressed 
alone, but also act in a dominant negative manner to remove the CO2 sensitivity from 
cells stably expressing Cx26WT, inspires a theoretical application in which this 
characteristic could be used to elegantly investigate the role of Cx26 CO2 sensitivity in 
different cells in vivo.  
The experimental design of an in vivo study to specifically remove Cx26 CO2 
sensitivity raises the question of which mutant Cx26 variant to use. Although we have 
shown that the N14K, N14Y, and A88V KID syndrome mutations are capable of removing 
CO2-insensitivity (de Wolf et al. 2016, Meigh et al. 2014), there is no solid rationale as to 
why these mutants do not respond to CO2, nor why they remove CO2-sensitivity from 
Cx26WT expressing cells. Furthermore, we also had problems expressing these mutants 
and as such consistent viable expression was not possible, making their use for continued 
investigations undesirable. Reconcilable with this, other groups have reported cell death 
as a result of the expression of KID mutants (Gerido et al. 2007, Mhaske et al. 2013, Lee, 
DeRosa, and White 2009, Montgomery et al. 2004, Stong et al. 2006, Terrinoni et al. 
2010, Sánchez et al. 2010). For these reasons, currently characterised KID mutants are 
unsuitable to use in the proposed in vivo experiments. Instead, we required a mutant for 
which there was a robust rationale explaining its dominant negative CO2-insensitivity, 
and that could be viably expressed for characterisation (and other experimentation) 
purposes. An intelligently designed and engineered Cx26 variant – referred to as the 
Dominant Negative mutant, or Cx26DN – could provide such a tool. This mutant has two 
mutations, K125R and R104A. The rationale is that these mutations will prevent the K125 
carbamylation, and subsequent K125-R104 carbamate bridge formation, which is 
required for hemichannel opening in response to CO2 (Meigh et al. 2013). This mutant 
needs to be characterised, and the rationale confirmed, before advancing it to in vivo 
experimentations. 
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3 CHARACTERISATION OF CO-ASSEMBLY AND CO2-INSENSITIVITY OF A 
CONNEXIN26 DOMINANT NEGATIVE MUTANT  	
3.1 Introduction 
 
The recently discovered gating of Connexin26 (Cx26) hemichannels by molecular CO2 
may have implications in any cells expressing Cx26 – including the liver, uterus, skin, 
eyes, ears, and brain (Nicholson et al. 1987, Nagy et al. 2011, Dalamón et al. 2016). The 
next step in assessing the physiological importance of this property is to develop a 
technique that inhibits or removes Cx26 CO2 gating, whilst maintaining the expression of 
functional Cx26 hemichannels. One solution may come from Cx26 mutants that are 
dominant negatively CO2-insensitive, such as the A88V, N14Y, and N14K mutants that are 
linked to KID syndrome (Meigh et al. 2014, de Wolf et al. 2016). These mutants remove 
CO2-mediated Cx26 hemichannel opening in cells expressing wild type Cx26, despite the 
expression of functional hemichannels being retained. As we do not fully understand the 
mechanisms by which these mutants remove CO2 sensitivity (see 2.4.4 - Possible 
mechanisms by which the N14K loss of function mutant prevents Connexin26 
hemichannel gating by CO2), their direct use in vivo would leave questions as to what is 
really going on to bring about a hypothetical phenotype. Furthermore, viably expressing 
any KID mutant in vitro is difficult (Gerido et al. 2007, Mhaske et al. 2013, Lee, DeRosa, 
and White 2009, Montgomery et al. 2004, Stong et al. 2006, Terrinoni et al. 2010, 
Sánchez et al. 2010, de Wolf et al. 2016), and made any further studies involving 
Cx26A88V, Cx26N14Y, or Cx26N14K unfeasible.              
This chapter presents the investigation of a Cx26 mutant that has been rationally 
designed and engineered for the purpose of removing CO2 sensitivity in a dominant 
negative fashion. The mutant – dubbed “Dominant Negative” (DN) – has the mutations 
K125R, and R104A (Figure 3.1a). These two residues are vital components for CO2 gating, 
and both the K125R or R104A mutations individually yield homomeric hemichannels that 
are insensitive to CO2 (the effect of the mutants when coexpressed with Cx26WT has not 
been tested) (Meigh et al. 2013).  
Within a connexon hemichannel, CO2 acts on the lysine at position 125 of a given 
subunit, forcing a carbamylation event, which results in a carbamate bridge forming 
between the K125 residue and the R104 residue of the adjacent subunit. Such bridge 
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formation across all six subunits fully stabilises the hemichannel in an open state (Meigh 
et al. 2013). We hypothesise that the DN alterations will yield a mutant that is unable to 
 
		
Figure 3.1  Hypothesis for Removal of Hemichannel Opening by the Dominant Negative 
Connexin26 mutant . a) Ribbon diagram, showing a single Connexin 26 subunit, highlighting the 
two amino acid residues vital for CO2 sensing - R104 and K125 (Cx26
WT
, left). In the Cx26
DN
 
mutant peptide, these two residues are mutated - R104àK and K125àR (Cx26
DN
, right) - and will 
therefore be unable to undergo carbamylation and unable to form a salt bridge with adjacent 
connexin subunits. b) Whole-cell patch clamp conductance change from HeLa cells stably 
expressing Cx26
WT
. The sigmoidal relationship between CO2 concentration and conductance 
change suggests a strong level of cooperative binding between CO2 molecules and Cx26 
hemichannels. Therefore, it is likely that hemichannel opening requires most of the total six 
carbamate bridges to form in order to sufficiently stabilise the protein in an open state. c) We 
predict that Cx26
WT
 and Cx26
DN
 subunits will coassemble into heteromeric connexon 
hemichannels, and render the hemichannel insensitive to CO2. The presence of DN subunits in 
the hemichannels will prevent the K125 carbamylation, and subsequent carbamate bridge 
formation, that usually occurs between neighbouring subunits under hypercapnic conditions 
(blue circles). A DN subunit would prevent the formation of a bridge with either neighbouring 
subunit. Without sufficient bridge formation it is expected that the characterised hypercapnia-
induced conformational change will no longer occur, and thus the hemichannels will not open. 
Figures a and b were produced by Nicholas Dale		
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form bridges with either neighbouring connexin subunit. If this is the case, the resulting 
hemichannels should be insensitive to CO2.  
Considering that the K125R and R104A mutations do not disrupt the heteromeric 
specificity motif (Koval, Molina, and Burt 2014), which sits in TM3 (just after the CL) and 
dictates connexin coassembly compatibility, we expect that coassembly will occur 
between Cx26WT and Cx26DN subunits. If this happens, the presence of just one mutant 
subunit, in an otherwise WT connexon, would prevent two of the six intersubunit 
carbamate bridges from forming. If more Cx26DN subunits were present, then even more 
bridges would be disrupted (with the exact number depending on the number and 
stoichiometric positions of Cx26DN subunits). The sigmoidal relationship between CO2 
concentration and conductance change suggests a strong level of cooperative binding 
between CO2 molecules and Cx26 hemichannel, Figure 3.1b. Because of this it is likely 
that hemichannel opening requires most (of the total six) carbamate bridges to form in 
order to sufficiently stabilise the protein in an open state; and therefore the presence of 
just one or two DN subunits may be sufficient to prevent such an open state being 
reached (Figure 3.1c). Based on this rationale, if Cx26WT/Cx26DN coassembly occurs, we 
further hypothesise that the Cx26DN mutant will show a dominant negative effect and 
cause heteromeric hemichannels to be insensitive to CO2 (like we expect from 
homomeric Cx26DN hemichannels).  
If our hypotheses prove to be true, then the Cx26DN mutant could be introduced 
in vivo (e.g. through a Lentivirus) as a tool to remove CO2 sensitivity from certain cell 
populations in animals of any age. The targeted cells would still express functional Cx26 
(albeit a mix of endogenous WT and mutant subunits). In this way, this technique would 
provide the means to specifically investigate the CO2 sensitivity property of Cx26 whilst 
limiting the confounding effects that that may come from KO of the Cx26 gene – namely 
compensation and disruption of other Cx26-related pathways. As system-wide Cx26 KO is 
lethal, owing to reduced nutrient and glucose uptake (Gabriel et al. 1998), such a tool 
would also provide an alternative to timely and costly cross-breeding KO studies. 
Before the Cx26DN mutant is packaged into a viral vector and introduced into 
animals, it was important that proof of principle was provided so that we would 
understand the mechanism via which a potential phenotype arose. This chapter aims to 
characterise Cx26DN/Cx26WT coassembly, through the use of Förster Resonance Energy 
Transfer (FRET), as well as the effect that the DN mutant has on Cx26 CO2 sensitivity, 
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through the use of dye-loading techniques as described and discussed previously (see 2 
Gating determinants of Connexin26 hemichannels: intracellular calcium and co2 
sensitivity of a pathological mutation).			
3.2 Materials and Methods 
3.2.1 HeLa cell culture and sample preparation 
HeLa DH and Cx26-HeLa cells for dye loading experiments were maintained and 
transfected as described previously (see 2.2.1 HeLa cell culture and sample preparation). 
To ensure appropriate confluency for Cx26DN time course experiments, cells were plated 
at 3 different densities: 5x104, 1x104 and 5x103 cells per well. 
For FRET experiments, HeLa DH cells were maintained in Dulbecco’s modified 
Eagle’s medium (DMEM) supplemented with 10% fetal calf serum (FCS), 50 μg/mL 
Penicillin Streptomycin, and 3mM CaCl2. Cells were grown at 370C in a 5% CO2 humidified 
incubator. Cells were plated onto 35mm glass-bottomed dishes at 5x104 cells per dish 
(9cm2) 24hrs prior to transfection. HeLa cells were transiently transfected with 0.5μg of 
DNA of each pCAG-Connexin-fluorophore construct to be co-expressed (1μg total), using 
the GeneJuice transfection agent protocol (Merck Millipore). 72hrs post-transduction, 
cells were washed 3x with PBS, fixed with 4% PFA (paraformaldehyde) for 20-30 mins, 
washed a further 3x with PBS, and then stored in PBS at 40C. FRET studies were carried 
out within 2 weeks of fixation. PFA fixation is commonplace in FRET studies, and whilst it 
has been shown to significantly affect FRET efficiency when two flourophores are fused 
in the same protein (intramolecular FRET), it has no significant affect on FRET efficiency 
when fluorophores are in separate molecule (intermolecular FRET) (Anikovsky et al. 
2008). 
 
3.2.2 Construction of connexin gene constructs 
All connexin-fluorophore constructs used in this chapter were constructed as described 
previously (see 2.2.5 Construction of connexin gene constructs).  
Connexin43 DNA sequence from Rattus norvegicus was purchased from Addgene 
(mCherry-Cx43-7, plasmid #55023, gifted by Michael Davidson) and subcloned into a PUC 
19 vector such that the transcript would form a fusion protein with whichever 
fluorophore we engineered to be 3’ (downstream) of Cx43 (as with Cx26 constructs).  
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Dominant Negative mutant Cx26 (Cx26DN) DNA - with R104A K125R mutations 
was produced through two steps. First, Cx26 DNA with the K125R mutation and omitted 
STOP codon (to allow for fusion proteins) was synthesised by Genscript USA from the 
Cx26 sequence (accession number NM_001004099.1), and subsequently subcloned into 
a PUC 19 vector such that the transcript would form a fusion protein with mCherry at the 
C-terminus of Cx26. Second, the R104A mutation was introduced by Agilent Quikchange 
site directed mutagenesis, using PUC19-Cx26(K125R) DNA as the template. Primer 
sequences for the mutagenesis were as follows: Cx26(R104A) forward 5’GGC CTA CCG 
GAG ACA CGA AAA GAA AGC GAA GTT CAT GAA GG 3’, Cx26(R104A) reverse 5’CCT TCA 
TGA ACT TCG CTT TCT TTT CGT GTC TCC GGT AGG CC 3’. PCR reactions were carried out 
as described previously (see 2.2.5 Construction of connexin gene constructs). 
Design and characterization of the Clover and mRuby2 protein fluorophores used 
in these experiments was published by (Lam et al. 2012). mRuby2 DNA was purchased 
from Addgene (mRuby2-C1, plasmid #54768, gifted by Michael Davidson) and subcloned 
into a PUC 19 vector so that it was 3’ of whichever connexin we engineered to be 5’ 
(upstream) of mRuby2. Clover DNA was a gift from Sergey Kasparov, Bristol, and was 
subcloned into a PUC 19 vector so that it was 3’ of whichever connexin we engineered to 
be 5’ (upstream) of Clover. 
Amplification and subcloning were preformed as described previously (see 2.2.5 
Construction of connexin gene constructs). 
 
3.2.3 Acceptor depletion FRET assay 
Förster Resonance Energy Transfer (FRET) describes a specific type of energy transfer 
that occurs through nonradiative diploe-dipole coupling between two appropriate 
chromophores (Cheng 2006, Helms 2008, Förster 1948). This form of energy transfer is 
very sensitive to distance; with transfer efficiency being inversely proportional to the 
sixth power of the distance between the two chromophores (Harris 2010). In biology, this 
phenomenon can be exploited to determine if two molecules are within a certain 
distance of one another (typically 1-10nm) (Zheng 2006). If a given two flourophores 
have complementary characteristics (namely an overlap in the emission spectrum of one 
and the excitation spectrum of the other) they may be used as a FRET-pair. Within a FRET 
pair, electron excitation of the donor fluorophore (e.g. by light at a specific wavelength) 
may cause the transfer of energy to the acceptor fluorophore, rather than the emission 
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of photons, as the electrons drop back to their unexcited state. The transferred energy 
excites acceptor electrons, which do emit photons (within the acceptor’s usual emission 
spectrum) as the electrons drop back to their unexcited state. 
FRET can be detected by various approaches (Eidne, Kroeger, and Hanyaloglu 
2002, Lippincott-Schwartz, Snapp, and Kenworthy 2001, Wouters et al. 1998), with FRET 
efficiency (%E) being the favoured measurement. %E is the percentage of excited 
photons that contribute to FRET. One common technique is acceptor depletion FRET 
(adFRET), which looks at the change in donor fluorescence intensity before and after 
photobleaching of the acceptor. If two fluorophores that constitute a FRET-pair are 
within 10nm of one another and the donor is excited, then some of the donor emission 
will be quenched by the acceptor as FRET occurs. This results in the donor emission 
intensity being lower than it would in the absence of acceptor. By photobleaching the 
acceptor the molecule is rendered permanently unable to fluoresce or undergo FRET 
(Diaspro et al. 2006). Subsequently, after photobleaching, there is no quenching of 
acceptor emission and the measured acceptor fluorescence intensity increases. If donor 
and acceptor molecules are not within FRET range (10 nm) then there will be no 
quenching and no change in acceptor intensity after photobleaching of the donor.  
The adFRET assay used in experiments described in this chapter was based on the 
linear unmixing adFRET (u-adFRET) assay used by Gu et al. (Gu et al. 2004, Di et al. 2005, 
Yum et al. 2007), but was modified to remove the need of spectral unmixing. The FRET-
pair used in the studies presented here were Clover (donor) and mRuby2 (acceptor). For 
adFRET studies, Clover/mRuby2 is the best FRET-pair yet characterised (Lam et al. 2012). 
It can be noted that, since the start of the studies presented here, the same group has 
developed mClover3 and mRuby3 variants, which are brighter and more photostable 
than Clover and mRuby2 (Bajar et al. 2016). However, these newer versions are no more 
spectrally advantageous than Clover/mRuby2, and the increased photostablity shown in 
mRuby3 would not be advantageous for the photobleaching required during adFRET. 
Unlike previous FRET-pairs (such as ECFP/EYFP), Clover/mRuby2 have very good 
separation in their emission spectra. In fact, it is possible to record channels with no 
spectral bleed-through, yielding separate measurements of pure Clover and pure 
mRuby2 emission (Figure 3.2a). Although adFRET only relies on donor intensity 
measurements in order to calculate FRET efficiency, and therefore a channel yielding 
pure clover emission is sufficient for this result, there is only so much that can be  
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Figure 3.2  Acceptor depletion Förster Resonance Energy Transfer rational. Connexin variants 
constructs were C-terminally tagged with ether Clover or mRuby2 and co-expressed for acceptor 
depletion Förster Resonance Energy Transfer (ad-FRET). a) Excitation and emission spectra of 
Clover and mRuby2. Two channels recording fluorescence between 495-545nm and 650-700nm 
are appropriate to yield pure fluorescence from Clover and mRuby2, respectively. By imaging 
sequentially with 458nm and 561nm lasers, these parameters ensure that there is no spectral 
bleed-through in the recorded images. Photobleaching during ad-FRET was carried out using the 
561nm laser. Image modified from Lam et al. 2012. b) Diagrammatic representation showing a 
Connexin26 (Cx26) hexameric connexon made up of Cx26-Clover and Cx26-mRuby2 fusion 
proteins. The Clover and mRuby2 fluorophores attached to the C-terminus of the connexin 
subunits should be close enough for FRET to occur between Clover (donor) and mRuby2 
(acceptor) fluorophores regardless of their assembled position. Blue squiggly arrow; excitation 
wavelength (458nm), red squiggly arrow, emission from mRuby2 due to FRET, green arrows; FRET 
after Clover excitation. Connexin43 fusion proteins are also C-terminal, with the fluorophore 
located on the cytoplasmic face. Diagram not to scale. Molecular structure from Maeda 2009. c) 
FRET will occur between subunits of heteromeric but not homomeric connexons. The measured 
FRET efficiency will be greatest when there is a low donor-acceptor ratio, however as the donor-
acceptor ratio increases so does acceptor saturation. Increased acceptor saturation lowers the 
amount of energy that acceptor molecules sequester from any given donor molecule 
(represented by less solid lines) – thus yielding a lower FRET efficiency measurement.  
 
interpreted from %E values. On the other hand, the collection of relative acceptor 
and donor intensity values allows for semi-quantitative analysis, and subsequent insight 
into the assembly of the two flourophores. Measuring mRuby2 fluorescence between 
650-700nm was insufficient to observe FRET via sensitised emission (i.e. exciting clover 
and looking for mRuby2 emission) – presumably as insufficient signal could be detected 
within this range. However, measuring mRuby2 fluorescence between 650-700nm was 
sufficient to gather relative mRuby2 intensity values when exciting at 561nm argon, thus 
allowing for semi-quantitative analysis.  
If two connexins coassemble into heteromeric hemichannels then by tagging one 
connexin variant with Clover and the other with mRuby2, cells will produce and express 
heteromeric hemichannels tagged with a mixture of Clover and mRuby2 (Figure 3.2b). In 
this case, the C-terminal Clover and mRuby2 fluorophores will be sufficiently close for 
FRET to occur (Figure 3.2c). In our adFRET studies a FRET signal can be seen as an 
increase in Clover emission intensity post mRuby2 photobleaching.  
 
3.2.4 FRET data capture and analysis 
PFA-fixed cells co-transfected with Cx-Clover (donor) and Cx-mRuby2 (acceptor) were 
examined with a Zeiss LSM 710 Confocal microscope; C-Apochromat 63x/1.20 W Korr 
	 86	
M27. Two channels were recorded: 495-545nm (clover) and 650-700nm (mRuby2), and 
images were acquired sequentially with 458nm and 561nm argon lasers (respectively) – 
Figure 3.2a. Imaging parameters for the Clover channel are as follows: power, 30.0; 
pinhole, 78.5; gain (master), 700; digital offset, 0; digital gain, 1.0. Imaging parameters 
for the mRuby2 channel are as follows: power, 30.0; pinhole, 78.5; gain (master), 750; 
digital offset, 0; digital gain, 1.0.  Photobleaching was performed using the 561nm laser 
(as it only excites mRuby2) for 80 frames at 100% power, targeting ROI’s. Image 
acquisition was as follows: ROIs were selected and drawn, including a background region 
and a ROI that was not to be bleached; pre-bleaching images were acquired for each 
channel; mRuby2 was photobleached; post-bleaching images were acquired for each 
channel. By keeping acquisition parameters identical across samples, it is possible to 
compare results.  
Pixel intensities from each background-adjusted ROI were used to calculate FRET 
efficiency (E), bleaching efficiency (B), donor abundance relative to total fluorophore 
flourescence (D), acceptor abundance relative to total fluorophore flourescence (A), 
relative donor-acceptor ratio (DA ratio), relative acceptor quantity (A level), and donor-
acceptor distance (R) as follows: 
 𝐸	 = 	𝐶𝑙𝑜𝑣𝑒𝑟*+,- − 𝐶𝑙𝑜𝑣𝑒𝑟*/0𝐶𝑙𝑜𝑣𝑒𝑟*+,-  
  %𝐸	 = 𝐸	 × 	100 
 𝐵	 = 	𝑚𝑅𝑢𝑏𝑦2*/0 − 	𝑚𝑅𝑢𝑏𝑦2*+,-𝑚𝑅𝑢𝑏𝑦2*/0  
 𝐷	 = 	 𝐶𝑙𝑜𝑣𝑒𝑟*+,-	𝐶𝑙𝑜𝑣𝑒𝑟*+,- + 𝑚𝑅𝑢𝑏𝑦2*/0	 
 𝐴	 = 	 𝑚𝑅𝑢𝑏𝑦2*/0	𝐶𝑙𝑜𝑣𝑒𝑟*+,- + 𝑚𝑅𝑢𝑏𝑦2*/0	 
 𝐷𝐴	𝑟𝑎𝑡𝑖𝑜	 = 	 𝐶𝑙𝑜𝑣𝑒𝑟*+,-𝑚𝑅𝑢𝑏𝑦2*/0 
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𝐴	𝑙𝑒𝑣𝑒𝑙	 = 	𝑚𝑅𝑢𝑏𝑦2*/0 
 𝑅 = 	𝑅B(1 − 𝐸)EF          where R0 is the effective FRET distance for clover/mRuby2 
 (6.3nm) (Lam et al. 2012).  
 
Colocalisation threshold calculations were carried out in ImageJ using the Costes 
method (Costes et al. 2004); 100 iterations, omitting zero-zero pixels in threshold 
calculation. The Costes method takes into account the Numerical Aperture (NA) of the 
objective lens and the fluorescence emission wavelength in order to calculate how many 
pixels the point spread function covers in the image. Then it sets up a new random image 
by taking the image in one of the channels and moving point spread function sized 
sections of the image to random locations in the new (random) image. It then calculates 
the Pearson's correlation coefficient between the random image and the real image of 
the other channel; if they correlated as well as, or better than, the two real images, then 
the correlation that you have measured is no better then what you would have got by 
chance. This randomisation is iterated for as many times as is commanded (100 in these 
analyses).  For the Costes colocalisation test a p-value = 1 indicates that none of the 
randomised images had a better correlation than the real image, thus the significance 
threshold is p = 0.95, with values < 0.95 being significant (i.e. no colocalisation). For box-
whisker plots P-values were calculated using the Mann-Whitney U test in the statistical 
package R.  
By obtaining relative Clover and mRuby2 abundances (through acquisition of pure 
Clover and mRuby2 signals) it is possible to perform semi-quantitative analysis in order 
to gain insight into the assembly of the co-expressed proteins.  Using the FRET cluster 
model (Dewey and Hammes 1980), assessment of %E vs DA ratio and %E vs A-level plots 
can suggest whether a FRET signal has been brought about through the coassembly of 
the two fluorophores into clusters (which in this case would be heteromeric connexons), 
and whether the FRET signal has been brought about through random association of the 
two fluorophores (which in this case would be homomeric connexons clustering/packing 
tightly enough for FRET to occur between connexon hemichannels). For proteins that 
coassemble a negative correlation is expected between %E and DA ratio, with no 
correlation between %E and A-level. A positive correlation between %E and DA ratio 
suggests that random association was sufficient to yield FRET. It is possible for a FRET 
signal to be yielded by a combination of coassembly and random association. Here, this 
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analysis is referred to as “semi-quantitative” because only relative, not absolute, Clover 
and mRuby2 abundances are calculated; as such comparisons should only be made 
between experiments carried out with exactly the same parameters. Linear regression 
analysis was carried out in GraphPad Prism. 
 
3.2.5 Experimental aCSF solutions 
Experimental solutions used for experiments in this chapter have been described 
previously (see 2.2.6 – Experimental aCSF solutions)  
 
3.2.6 Dye loading assay 
The dye loading assay used for experiments in this chapter have been described 
previously (see 2.2.7 – Dye loading assay). For experiments involving co-expression of 
Cx26DN in Cx26-HeLa cells, dye loading was performed with control, hypercapnic, and 
zero Ca2+ conditions being tested over a 3 day period, beginning at 4 days post-
transfection. These dye loading experiments were performed for Cx26-HeLa cells 
transiently transfected with Cx26DN-mCherry and Cx26-HeLa cells that had not been 
transiently transfected. 
  
3.2.7 Dye loading data capture and analysis 
Time course Cx26DN dye loading experiments in this chapter were performed by Louise 
Meigh. 
Data capture and analysis for the dye loading experiments in this chapter have 
been described previously (see 2.2.8 – Dye loading data capture and analysis). 
 
3.3 Results 
3.3.1 Connexin26 WT colocalises with Connexin26 DN and Connexin43 WT when 
expressed in vitro 
In order to study coassembly of Cx26WT and Cx26DN subunits, fusion protein constructs 
were developed to consist of a connexin variant (Cx26WT, Cx26DN, or Cx43WT) with a C-
terminal tag of Clover or mRuby2. Despite successful cloning of all six fusion protein 
combinations (confirmed by sequencing), only four of the resultant constructs showed 
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expression upon transfection of HeLa cells (confirmed by visible Clover/mRuby2 
emission): Cx26WT-Clover, Cx26WT-mRuby2, Cx26DN-mRuby2 and Cx43WT-Clover. 
HeLa cells were co-transfected with two of the connexin-fluorophore fusion 
constructs: Cx26WT-Clover + Cx26WT-mRuby2, Cx26WT-Clover + Cx26DN-mRuby2 or Cx43WT-
Clover + Cx26WT-mRuby2. When coexpressed, all constructs showed some level of 
fluorescence in the plasma membrane (Figure 3.3), the most obvious of which is usually 
seen as gap junction plaques (observed as lines of fluorescence where two cells meet, 
Figure 3.4). This shows proteins are indeed being expressed in the membrane.  
Expression can also be seen throughout the stages of trafficking, including areas where it 
might be stored as vesicular reserves. In all co-expression combinations, very strong 
colocalisation (p-value = 1 for all images, with significance attributed to tests with p-value 
> 0.95) was found between both constructs – as determined by the Costes method for 
calculating colocalisation threshold (Costes et al. 2004). Such noticeable colocalisation 
shows that coexpressed protein subunits are within the same vicinity of one another 
(based on pixel limitations) and lays the foundation for FRET experiments to determine 
just how close the subunits are; and discern whether or not they are coassembling. 
 
3.3.2 Connexin26 WT and Connexin26 DN subunits more closely interact than 
Connexin26 WT and Connexin 43 WT 
In order the determine whether or not Cx26WT and Cx26DN subunits coassemble into 
heteromeric connexons, connexin variants tagged with either Clover or mRuby2 were 
coexpressed and the Förster Resonance Energy Transfer (FRET) between these two 
flourophores was measured. FRET is very sensitive to distance (decreasing at a rate of r6, 
where r is the distance between donor and acceptor fluorophores), and does not occur 
beyond a separation of 10 nm (100 Å). As the largest cytoplasmic width of a connexon is 
~9 nm (Maeda et al. 2009), if connexin subunits coassemble then the tagged 
fluorophores will be within FRET range of other subunits and a signal should be detected 
(Figure 3.2b,c). There are various techniques to assess FRET in biological systems, with 
measurements usually expressed as FRET efficiency (%E) – the percentage of excited 
photons that contribute to FRET. To remove issues of spectral bleed-through, acceptor 
depletion FRET (adFRET) was used to obtain the data reported here, with %E calculated 
as the % change in clover intensity. For a more detailed explanation of the adFRET assay 
see 3.2.3 acceptor depletion FRET assay. 
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Following photobleaching of mRuby2 (acceptor), ROIs in Cx26WT-Clover + Cx26WT-
mRuby2 and Cx26WT-Clover + Cx26DN-mRuby2 samples showed enhanced Clover (donor) 
fluorescence intensity, and reduced mRuby2 fluorescence intensity (Figure 3.3, top four 
rows). As Cx26 and Cx43 do not coassemble into heteromeric connexons (Gemel et al. 
2004), we also investigated adFRET in cells that co-expressed Cx26 and Cx43. Following 
photobleaching of mRuby2 ROIs from samples coexpressing Cx43WT-Clover + Cx26WT-
mRuby2 showed little change in the fluorescence intensity of Clover, despite reduced 
mRuby2 fluorescence intensity (Figure 3.3, bottom two rows).  
The FRET efficiency of Cx26WT + Cx26WT (24±10%) and Cx26WT + Cx26DN (23±8%) 
were statistically greater than that of Cx43WT + Cx26WT (7±5%, p < 0.001), indicating the 
Cx26 variants have a higher degree of interaction compared to Cx26 + Cx43. The FRET 
efficiency between Cx26WT + Cx26WT and Cx26WT + Cx26DN was not statistically different. 
 
 
 
Figure 3.4  Dominant Negative Connexin 26 localises to gap junction plaques. HeLa cells were 
co-transfected with equal amounts of Cx26
WT
-Clover and Cx26
DN
-mRuby2. Cells were fixed after 
48hrs and experiments were carried out on a Zeiss 710 Confocal microscope; C-Apochromat 
63x/1.20 W Korr M27. Two channels were recorded: 495-545nm (Clover, green pseudocolour) 
and 650-700nm (mRuby2, magenta pseudocolour), and images were acquired sequentially with 
458nm and 561nm argon lasers (respectively). Fluorescence of expressed fusion-proteins is 
shown before bleaching. Colocalisation is shown in white in the merged images (right channel). 
Two fields of view are shown as examples. Gap junction plaques is shown, white arrow. Scale bar, 
20μm.  
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Table 3.1  Summary statistics for connexin co-expressions 
Connexin 
Combination  
Number 
of Cells 
Number 
of ROIs 
Mean FRET 
Efficiency 
±s.d. (%)a 
Mean Bleaching 
Efficiency  
±s.d. (%)b 
Mean D-A 
Distance 
±s.d. (nm)c  
Cx26WT-Clover/ 
Cx26WT-mRuby2 30 95 24±10 81±5 7.6±0.8 
Cx26WT-Clover/ 
Cx26DN-mRuby2 26 74 23±8 79±5 7.8±0.6 
Cx43WT-Clover/ 
Cx26WT-mRuby2 34 84 7±5 79±4 10.2±2.0
d 
a 
FRET efficiency was calculated from background-adjusted ROIs as: E = (cloverpost - 
cloverpre)/dpost .  %E = E X 100 
b 
Bleaching efficiency was calculated from background-adjusted ROIs as: Bleaching = (1 - 
(mRuby2post/mRuby2pre)) 
c 
D-A distance was calculated as: R = R0((1-E)/E)
1/6
 where R0 is the effective FRET distance for 
Clover/mRuby2 (6.3nm) and E is the measured FRET efficiency. 
d 
5 ROIs with a FRET Efficiency < 0% (which only occurred during Cx26
WT
 + Cx43
WT
 
experiments) were omitted from D-A distance calculations as a negative efficiency 
(representing clover intensity fluctuations in an area where no FRET occurred) would not be 
appropriate for such a calculation. Therefore, the reported value is calculated only from 
ROIs that contained Cx43
WT
-Clover and Cx26
WT
-mRuby2 subunits in close enough proximity 
for FRET to occur. 
 
As expected, unbleached regions showed FRET efficiency close to 0 (Figure 3.5 and Table 
3.1). Standard deviation values were no larger than those seen in similar studies (Di et al. 
2005, Gu et al. 2004, Yum et al. 2007). 
The contrast between the Cx26 coexpressions and the Cx26/Cx43 coexpression 
suggests that Cx26WT-Clover and Cx26DN-mRuby2 subunits assemble much closer than 
Cx43WT-Clover + Cx26WT-mRuby2 subunits – resulting in a greater FRET signal. It is highly 
likely that this greater FRET signal is a result of Cx26WT and Cx26DN subunit coassembly 
into heteromeric connexons. 
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3.3.3 Connexin26 WT and Connexin26 DN constructs show a negative correlation 
between FRET efficiency and donor-acceptor ratio 
For each connexin pairing, fluorescence intensity values were used to calculate relative 
donor-acceptor (DA ratio) and relative acceptor intensity level (A-level). From these 
calculations, distribution plots of FRET efficiency (%E) vs. DA ratio and %E vs. A-level were 
produced (Figure 3.6). The distributions between ROIs from gap junctions and ROIs not 
from gap junctions appear to be equivalent for all comparisons (Figure 3.7), with the only 
observable difference seen when comparing gap junction and non gap junction ROIs in 
the Cx26WT/Cx43WT %E vs. DA ratio plot, which shows that gap junction ROIs tended to 
have a greater DA ratio than non gap junction ROIs (however the variation/correlation is 
not different, just the shift in DA ratio). 
 
 
 
Figure 3.5  FRET efficiency of coexpressed Connexin variants. a) Box and whisker plot showing 
the difference in FRET efficiency (%E) across different connexin co-expression connexin samples. 
FRET efficiency was calculated from background-adjusted ROIs as: %E = 100 X (cloverpost - 
cloverpre)/cloverpost. One-way ANOVA (represented by the top bar) was carried out in the 
statistical package SPSS. Post-hoc testing revealed all individual comparisons to be significant, at 
p<0.001, with the exception of the comparison between Cx26
WT
 + Cx26
WT
 and Cx26
WT
 + Cx26
DN
 
datasets, which were not significantly different. b) Box and whisker plot showing mRuby2 
bleaching efficiency during the acceptor depletion step. Whilst a small amount of bleaching 
occured in untargeted regions (presumably due to light scattering and/or reflection), targeted 
ROI’s recieved drastically greater, but not complete, bleaching. Importantly all targeted regions 
showed highly similar bleaching efficiencies. Bleaching efficiency was calculated from 
background-adjusted ROIs as: Bleaching = (1 – (mRuby2post/mRuby2pre)). Boxes show the 
interquartile range. The median is indicated as a horizontal line within the box, and the mean is 
represented by a cross within the box. Range bars show minimum and maximum values. Cx, 
Connexin; ROI, region of interest. 
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Figure 3.6  Connexin26 variants coassemble into heteromeric connexons. Acceptor depletion 
Förster Resonance Transfer (ad-FRET) was performed on HeLa cells coexpressing different 
combinations of connexins. Mean FRET efficiency (%E) is plotted as a function of relative donor-
acceptor ratio (D-A ratio) or acceptor emission (A-Level). For proteins that coassemble a negative 
correlation is expected between %E and D-A ratio, with no correlation between %E and A-level. A 
positive correlation between %E and D-A ratio suggests that random association was sufficient to 
yield FRET. FRET measurements from cells co-expressing Cx26WT-Clover + Cx26WT-mRuby2 or 
Cx26
WT
-Clover + Cx26
DN
-mRuby2 show a negative correlation between %E and D-A ratio; 
	 96	
suggesting the two proteins interact in complexes – i.e. heteromeric connexons. However, these 
measurements also show a positive correlation between %E and A-level; suggesting that some of 
the interaction between the proteins was due to random association. FRET measurements from 
cells co-expressing Cx43
WT
-Clover + Cx26
WT
-mRuby2 showed no correlation between %E and D-A 
ratio, but a positive correlation between %E and A-level; suggesting that all of the FRET observed 
was a product of random association between homomeric connexon hemichannels. Each mark 
represents 1 ROI. As %E values < 0 do not make sense, they were plotted as 0. Linear regression 
analysis was carried out in GraphPad Prism. 
 
FRET measurements from cells co-expressing Cx26WT-Clover + Cx26DN-mRuby2 
show a clear negative correlation between %E and DA ratio, however also show a 
positive correlation between %E and A-level. FRET measurements from cells co-
expressing Cx26WT-Clover + Cx26WT-mRuby2 show a weaker negative correlation 
between %E and DA ratio, and a very weak positive correlation between %E and A-level.  
FRET measurements from cells co-expressing Cx43WT-Clover + Cx26WT-mRuby2 showed 
no correlation between %E and DA ratio, and a very weak positive correlation between 
%E and A-level. Comparing these distributions, it is clear that the interactions between 
Cx26WT/Cx26WT and Cx26WT/Cx26DN are different to the interactions between 
Cx26WT/Cx43WT. The greater variation seen in Cx26WT/Cx26WT indicates that there may be 
some bias in assembly/packing compared to Cx26WT/Cx26DN.  
Based upon the membrane cluster model (Dewey and Hammes 1980), the 
negative correlation between %E and DA ratio indicates the presence of heteromeric 
connexons in Cx26WT/Cx26WT and Cx26WT/Cx26DN samples (i.e. coassembly), whilst any 
positive correlation between %E and A-level indicates that some level of random 
association (i.e. tight clustering of connexons) has taken place. 
There is much variability in %E (represented by R2 values), especially within the 
Cx26WT/Cx26WT results. Other studies show similar variability (Di et al. 2005, Yum et al. 
2007). This level of variability might be expected from these studies given the nature of 
the recordings taken; namely, the variability that can be expected from the transfection 
of different cells, and from the expression within different regions of different cells.  
 
3.3.4 Connexin26 DN hemichannels do not open in response to CO2  
As with the Cx26N14K mutant (see 2.3.5 Connexin26 N14K hemichannels do not open in 
response to CO2), the hemichannel CO2-sesntivity of the Cx26DN mutant (K125R, R104A) 
was also assessed using the same dye-loading technique. Parental HeLa cells expressing  
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Figure 3.7  Gap junction ROIs vs. non-gap junction ROIs. Acceptor depletion Förster Resonance 
Transfer (ad-FRET) was carried out in HeLa cells coexpressing different combinations of 
connexins. Mean FRET efficiency (%E) is plotted as a function of relative donor-acceptor ratio (D-
A ratio) or acceptor emission (A-Level). Distributions are split between ROIs recorded from 
regions clearly visible as gap junction plaques, black filled circles, and ROIs recorded from non-
gap junction plaques (i.e. protein aggregates in plasma membrane hemichannel plaques or 
cytoplasmic vesicles), empty cirlces. All distributions can be seen to show no difference between  
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gap junction ROIs and non-gap junction ROIs, with the exception of cells co-expressing Cx43
WT
-
Clover + Cx26
WT
-mRuby2; which showed gap junction ROIs shift, with respect to %E, towards 
higher D-A ratio (however there is no change in correlation of the two populations). Each mark 
represents 1 ROI. As %E values < 0 do not make sense, they were plotted as 0. Linear regression 
analysis was carried out in GraphPad Prism. 
 	
 
Figure 3.8   The Dominant Negative Connexin26 mutant (Cx26DN) does not open in response to 
CO2.  HeLa cells were transfected with either Cx26
DN
, and dye-loading experiments were carried 
out 3 days post-transfection. a) Representative images showing expression of mCherry tagged to 
Cx26
DN
 protein (left), and dye loading under 35mmHg PCO2 (control, middle) and 55mmHg PCO2 
(hypercapnic, right) conditions – insert shows dye loading under zero Ca
2+
 conditions; a positive 
control showing functional Cx26 hemichannels. HeLa cells expressing Cx26
DN
 show no increase in 
dye loading under hypercapnic conditions. b) Cumulative probability distributions comparing 
mean pixel intensity for ROIS each condition. c) Median change in pixel intensity from baseline 
(35mmHg). Cells expressing Cx26
DN 
hemichannels are insensitive to CO2 whilst cells expressing 
Cx26
WT
 hemichannels are sensitive to CO2. Median pixel intensities (from independent repeats) 
were compared using the Mann-Whitney U test, n > 50 cells per treatment repeat, with 5 
independent repeats for each treatment. Error bars show the first and third quartiles. Scale bars, 
40μm. 	
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Cx26DN showed no increase in dye loading in response to hypercapnic conditions (Figure 
3.8), despite the expression of functional hemichannels in the plasma membrane 
(determined via extracellular zero Ca2+ control). These results suggest that, like Cx26N14K, 
Cx26DN hemichannels do not open in response to CO2. 	
3.3.5 Expression of Connexin26 DN removes CO2-sensitive dye loading in cells stably 
expressing Connexin 26 WT 
Similar to the Cx26N14K investigations (see 2.3.5 The Connexin26 N14K mutant acts to 
drastically reduce CO2 sensitivity from cells expressing wild-type Connexin26) HeLa cells 
stably expressing Cx26WT (Cx26-HeLa cells) were transiently transfected with Cx26DN-
mCherry DNA. Cell CO2 sensitivity was then monitored at 4, 5, and 6, days post-
transfection by comparing dye loading under control and hypercapnic conditions. As 
transfections were made into cells stably expressing Cx26WT it was assumed that loss of 
CO2-sensitivity would not be immediate, with time being needed for co-assembly with 
native Cx26, depletion of any native Cx26WT stores, and insertion into the membrane. As 
such, this time course was chosen in an attempt to document the onset of the dominant 
negative action. Un-transfected Cx26-HeLa cells were monitored over the same time 
period as a control.  
Dye loading under hypercapnic conditions remains clear over the time course in 
untransfected Cx26-HeLa cells (Figure 3.9a,b). In contrast, Cx26-HeLa cells expressing 
Cx26DN show hypercapnia-induced dye loading at days 4 and 5, however by day 6 there is 
complete abolishment of dye-loading (Figure 3.9c,d). Dye loading above control 
conditions was significantly different when comparing hypercapnic conditions between 
non-transfected Cx26-HeLa cells and expressing Cx26N14K (p = 0.001), Figure 3.9e. 
Nevertheless, the continued presence of functional Cx26 hemichannels at day 6 is 
confirmed by a zero Ca2+ control – which exhibited increased dye loading compared to 
control conditions (Figure 3.9c,d). These results support our hypothesis, and suggest that 
Cx26DN acts in a dominant negative manner to completely remove CO2 sensitivity from 
Cx26-HeLa cells.  
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Figure 3.9   The Dominant Negative Connexin26 mutant (Cx26DN) removes CO2-sensitivity in 
HeLa cells stably expressing Cx26WT (Cx26-HeLa cells).  Dye-loading under 35mmHg PCO2 
(control) or 55mmHg PCO2 (hypercapnic) conditions revealed how the CO2 sensitivity of Cx26-
HeLa cells changes over time after transfection with Cx26
DN
. a, c) Representative dye-loading 
images of Cx26-HeLa cells at day 4 and day 6 days after cells were either untreated (a) or 
transfection with Cx26
DN.
 (c). At day 4 a significant increase in dye uptake can be seen in response 
to hypercapnic conditions, as compared to control conditions. In Cx26-HeLa cells transfected with 
Cx26
DN
 (c) very little difference in dye uptake can be seen between control and hypercapnic 
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conditions by day 6 – however an increase in dye uptake is visible in the zero ca
2+
 positive control  
(insert in bottom right panel), showing that functional Cx26 hemichannels are still present. b, d) 
Cumulative probability distributions comparing mean pixel intensity for each condition at day 4 
and day 6 (untreated, b; transfected with Cx26DN, d). n > 40 cells per treatment repeat, with 5 
independent repeats for each treatment. e) Median change in pixel intensity from baseline 
(35mmHg) over days 4, 5, and 6 post-transfection. By 6 days post-transfection cells co-expressing 
Cx26
WT
 and Cx26
DN 
loose their ability to open in response to CO2 but still open in response to Zero 
Ca
2+
. In contrast, cells only expressing Cx26
WT
 maintain CO2-sensitivity during the time course. 
Median pixel intensities (from 7 independent repeats) were compared using the Mann-Whitney 
U test. Scale bars, 40μm. 
 
3.4 Discussion 
3.4.1 Connexin26 DN is capable of trafficking to the membrane in the presence of 
wild-type Connexin26 
When expressing fluorophore-tagged fusion proteins, such as the Connexin-fluorophore 
proteins expressed during our FRET studies, fluorophore fluorescence may be detected 
at the moment of peptide translation and throughout its assembly and trafficking. This 
includes possible storage as reserves in vesicles, and all the time it is present within the  
plasma membrane. Only once the protein is turned over and broken down will it 
definitely become undetectable. Because of this, it can be hard to discern which regions 
show expression in the membrane and which regions are showing some form of 
cytoplasmic residence, a problem that could be of consequence when choosing ROIs to 
measure during FRET experiments. As assembly of connexins into connexons is known to 
start in the ER, with significant assembly detectable within the ER-Golgi intermediate 
compartment ERGIC and Golgi (Martin et al. 2001, Zhang et al. 1996, George, Kendall, 
and Evans 1999), any intercellular regions of fluorescence that are recorded should yield 
results comparable to regions of fluorescence in the membrane – an assumption that has 
been confirmed in comparable adFRET studies (Di et al. 2005). That being said, Cx26 is 
also known to traffic by a non-golgi, microtuble-dependent, pathway (Martin et al. 2001, 
George, Kendall, and Evans 1999) and so added care should be taken when interpreting 
its expression within a cell.  
In this study an equal number of ROIs were selected from regions of fluorescence 
within gap junctions and regions of fluorescence from non-gap junctions. Addressing the 
emphasis that this thesis has put on not treating hemichannels and gap junctions as the 
same entities, it must be noted that these FRET studies are an exception; the interest in 
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these studies lies in whether connexin variants coassemble into connexons, therefore 
measurements from gap junctions will still provide the same information as connexon 
docking (whilst affecting channel properties) does not alter the presence or properties of 
the fused fluorophores (the moiety being measured). Furthermore, because the 
fluorophores are cytoplasmic, the distance between the fluorophores in apposed cells is 
far too large for any FRET to occur.  
As in the study by Di et al., FRET efficiency (%E) distributions were compared 
between gap junction and non-gap junction regions (Figure 3.7), and it was also 
concluded that both have equivalent distributions. The only observable difference seen 
in our studies was a shift (with respect to %E) towards higher DA ratio values for gap 
junction ROIs in Cx26WT/Cx43WT samples – however there is no change in correlation of 
the two populations. This difference might reflect a difference in how Cx26 and Cx43 
connexons aggregate during trafficking and plasma membrane expression. As there was 
no difference in FRET efficiency distributions, and only fully assembled connexons are 
present in gap junctions (Martin et al. 2001, Zhang et al. 1996, George, Kendall, and 
Evans 1999), it can be inferred that the protein clusters recorded from non-gap junction 
ROIs are assembled connexons; be they midway through trafficking to the membrane, 
present in the membrane as hemichannel plaques, or potentially stored in vesicles as 
reserves. 
Trafficking of connexins seems to vary greatly depending on the connexin variant 
and the system transfected into. For example, whilst wild-type connexins expressed in 
vitro show effective trafficking to the plasma membrane, some mutant connexins appear 
to show localisation primarily to the cytoplasm with limited trafficking to the plasma 
membrane (Di et al. 2002, Common et al. 2002, Marziano et al. 2003). Although we do 
not show data for individual expression of the Cx26DN mutant, our studies clearly show 
that in vitro coexpression of this mutant with Cx26WT results in its trafficking to the 
membrane, where it will be expressed in both gap-junctions and hemichannel.  
 
3.4.2 Connexin26 WT and Connexin26 DN subunits coassemble into heteromeric 
connexon hemichannels 
The membrane-clustering model (Dewey and Hammes 1980) has been used to explain 
molecular complex formations that are found in the plasma membrane and ER 
(Kenworthy, Petranova, and Edidin 2000, Lippincott-Schwartz, Snapp, and Kenworthy 
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2001, Silvius 2003, Wallrabe et al. 2003), and has since been functionally tested against 
connexin gap junction plaques with regular matrix structures (Unger et al. 1999, Yum et 
al. 2007, Di et al. 2005), where their FRET efficiency distributions provided the same 
interpretation of the cluster model. Applied to connexin studies, this model shows that 
an inverse correlation between %E and DA ratio reflects coassembly into clusters 
(heteromers). This is because with increasing amounts of donor relative to acceptor, the 
acceptor becomes saturated with energy from FRET and cannot accept more energy. The 
energy that would have been transferred, had there been additional acceptor molecules 
within its vicinity (10 nm), is emitted from the donor as photons pre-bleaching – thus 
reducing the calculated %E. The membrane cluster model also shows that a positive 
correlation between %E and A-level reflects randomly arranged molecules (homomeric 
connexons). This is because with increasing amounts of overall acceptor, more of the 
excitation energy is sequestered pre-bleaching – thus increasing %E. 
Comparisons between mean %E strongly indicate coassembly of Cx26WT and 
Cx26DN subunits – there was no difference in mean FRET signal between Cx26WT/Cx26WT 
and Cx26WT/Cx26DN coexpressions, which were both significantly different to Cx26/Cx43 
and unbleached regions (Figure 3.5a). By applying the membrane-clustering model this is 
confirmed. Cx26WT-Clover/Cx26DN-mRuby2 coexpressions showed a decrease in %E with 
DA ratio (Figure 3.6). This demonstrates the presence of FRET within clusters; i.e. that 
Cx26WT/Cx26DN connexins coassemble into heteromeric connexons. 
If we assume that there is no bias in the stoichiometric positioning of subunits 
within the heteromeric connexons formed then, at any given ROI, there will be a mix of 
stoichiometries within the population of connexons that is present – including 
homomeric Cx26WT-Clover and Cx26WT-mRuby2 connexons. If this is the case, it is 
interesting that our data shows less FRET efficiency (%E) variation in Cx26WT/Cx26DN 
samples. This indicates that Cx26DN may favour an interaction with Cx26WT, perhaps due 
to improved stability/trafficking, which would lead to a greater likelihood of heteromeric 
Cx26WT-Clover/Cx26DN-mRuby2 connexons being assembled (as opposed to homomeric 
connexons). Further to this, it could be speculated that the presence of homomeric 
connexons in Cx26WT/Cx26WT samples, but not Cx26WT/Cx26DN samples, is reflected by 
some low %E values at low DA ratios (Figure 3.6). In support of this, other studies, in 
HeLa cells and Keratinocytes, have also reported mutant connexins showing improved 
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plasma membrane trafficking when in the presence of wild type connexins (Di et al. 
2005, Marziano et al. 2003, Thomas, Telford, and Laird 2004(de Wolf et al. 2016).  
To try and get a sense of how accurate our results are let us assume the following 
conditions are true: i) all recorded FRET signal arises from coassembly (i.e. none is a 
result of homomeric connexon clustering), ii) all stoichiometric configurations within a 
heteromeric connexon have an equal probability of forming and ROIs contain sufficiently 
high numbers of connexons to reflect this non-bias, iii) connexin subunits are completely 
rigid and form equilateral hexagon structures, iv) the channel undergoes no 
conformational change, v) the chromophores responsible for FRET are positioned at the 
final amino acid residue of Connexin 26 (i.e. not somewhere within a fluorophore 
attached to the C-terminal end). In this scenario the mean DA ratio is equal to the mean 
distance between the corners of an equilateral hexagon, with lengths equal to those of 
Cx26, as determined by its crystal structure (Maeda et al. 2009). This is calculated to be 
6.9 nm. The mean DA distances calculated from our data for Cx26WT/Cx26WT (7.6±0.8 nm) 
and Cx26WT/Cx26DN (7.8±0.6 nm). Although there are too many variables to make a direct 
comparison, it is not far-fetched to infer that, upon relaxing some of the assumptions 
made above, the experimental values plausibly reflect the mean distance as calculated 
from the crystal structure. 
To conclude, by discerning FRET signals within connexons, we have shown that 
Cx26WT and Cx26DN subunits coassemble to form heteromeric connexons, which are 
subsequently expressed in the plasma membrane. This result meets the first criteria 
required for the creation of a well-understood dominantly negative CO2-insensitive Cx26 
mutant.  
 
3.4.3 Connexin26 connexons can be found within 10nm of each other 
A positive correlation between %E and A-level was also seen in Cx26WT/Cx26DN 
coexpressions. Based on the membrane-clustering model this shows that some FRET 
occurred between clusters. FRET occurring between clusters indicates that connexons 
formed from Cx26WT/Cx26DN also randomly cluster close enough for FRET to occur (this is 
in addition to inter-connexon FRET). Given that tight packing of Cx26 connexons into 
structured lattices has been observed in vertebrate gap junction plaques (Unger et al. 
1997, 1999, Müller et al. 2002, Skerrett and Williams 2017, Makowski 1988, Leitch 1992), 
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some amount of inter-connexon FRET might be expected due to the close proximity of 
subunits in juxtaposed connexons.  
Inter-connexon FRET was witnessed in all ROIs (not just gap junction ROIs), with 
no difference in the distributions obtained from gap junction and non-gap junction ROIs 
(Figure 3.7). This suggests that the structure of connexon packing in gap junction regions 
could be similar to that in non-gap junction regions (i.e. hemichannel aggregates and 
cytoplasmic vesicles). 
Precisely how much FRET might be occurring between connexons is hard to 
gauge, as an estimate for the inter-connexon distance is difficult to predict. Despite X-ray 
diffraction and atomic force microscopy (AFM) studies that have viewed and calculated 
Cx26 centre-to-centre pore distance in vertebrate gap junction plaques (Müller et al. 
2002, Oshima et al. 2013, Caspar et al. 1977, Revel and Karnovsky 1967, Robertson 1963, 
Makowski et al. 1984, Gogol and UNWIN 1986, Goodenough and Revel 1970, Hirokawa 
and Heuser 1982), resolution is still a limiting factor, and it is not known how the 
preparation of Cx26 plaques in these studies affects the in vivo structure (e.g. freeze-
fracture preparations might cause membrane contraction). Furthermore, it has been 
acknowledged that: “caution must be exercised in generalizing information related to size 
and spacing of channels from different preparations. Variations are evident within 
preparations, between preparations from the same organism, and between preparations 
from different organisms” (Skerrett and Williams 2017). As such, although good 
structural measurements may be known for a single Cx26 connexon (Maeda et al. 2009), 
we do not know the true inter-connexon distance in our Cx26/Cx26 samples, neither are 
we able to predict it.  
The mean DA distances calculated from our data for Cx26WT/Cx43WT (10.2±2.0 
nm) may provide insight into the average distance between the Cx26 and Cx43 plaque 
domains that have been observed in previous studies (Nagy et al. 2001, Rash et al. 2012, 
Gemel et al. 2004); however caution must be taken due to the different experimental 
conditions and sample preparations. 
 
3.4.4 Connexin26 and Connexin43 connexons can be found within 10nm of each 
other 
Cx26 and Cx43 do not coassemble into heteromeric connexons (Gemel et al. 2004) – 
which was confirmed in our study by the lack of correlation between %E and DA ratio 
	 106	
across the Cx26WT/Cx43WT samples (Figure 3.6). Ex vivo studies have suggested that 
membrane expression of Cx26 and Cx43 connexons tend to aggregate into separate 
domains (within plaques or otherwise) based on the connexin/s subunits they are made 
from (Nagy et al. 2001, Rash et al. 2012, Gemel et al. 2004). However, these same studies 
show evidence that the domains juxtapose and overlap in places. 
In our in vitro studies, at least some level of FRET signal is observed in all 
coexpressed connexin combinations. This included Cx26WT/Cx43WT coexpression, 
although the values were significantly lower than Cx26/Cx26 coexpressions (Figure 3.5) 
and some ROIs yielded a %E ≤ 0. As FRET efficiency is not detectable at distances much 
greater than 10 nm (100 Å), the observation of a FRET signal in our Cx26WT/Cx43WT 
samples shows that, in vitro, homomeric connexon packing in gap junction plaques, 
hemichannel plaques, and intracellular vesicles, can be within 10 nm of each other. In 
fact, only a few ROIs were calculated to have FRET efficiency ≤ 0, implying that ROIs in 
this study contained many regions in which Cx26 and Cx43 connexons were clustered 
amongst one another. 
The lower FRET efficiency seen in Cx26WT/Cx43WT samples (compared to 
Cx26WT/Cx26WT and Cx26WT/Cx26DN samples) shows either that packing of Cx26WT and 
Cx43WT connexons is less tight than Cx26/Cx26 connexon packing, or that the Cx26/Cx26 
subunits coassembled into connexons (thus decreasing the distance between 
flourophores and increasing FRET efficiency), or both. The larger donor-acceptor distance 
calculated from Cx26WT/Cx43WT samples (Table 3.1) reflects this difference in 
packing/coassembly.  
 
3.4.5 Refinement of a previously published quantitative adFRET approach 
The adFRET assay used in this chapter was based on the linear unmixing adFRET (u-
adFRET) assay used by Gu et al. (Gu et al. 2004, Di et al. 2005, Yum et al. 2007). In these 
studies data is collected across the entire emission spectra of both fluorophore, and 
spectral unmixing is used to tackle spectral bleed-through and separate out donor and 
acceptor fluorophore signals. After unmixing, mean intensity values were measured from 
ROIs, and %E, DA ratio, and A-level were calculated based on relative acceptor and donor 
abundance values. The process of spectral unmixing can be tricky, and depend on 
algorithms that make certain assumptions. To unmix a population of flourophores, most 
approaches require tightly controlled preparation and acquisition of reference and test 
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samples; with all samples being prepared using the same technique (mounting medium, 
cell type, etc.), and recorded using identical parameters (gain, filters, objective, laser 
power, etc.). It is widely accepted that, because of this, acquisition of images is no trivial 
matter (McNamara et al. 2017, Zhang et al. 2015, Haraguchi et al. 2002, Lansford, 
Bearman, and Fraser 2001). The algorithms underlying spectral unmixing rely on binning 
the spectrum range and acquiring non-overlapping contiguous spectral channels, which 
are then used to fit the reference spectra to. With newer microscopes, allowing for 
multi-channel acquisition, this can be done fairly accurately however still introduces 
some level of error. Also, when spectrally unmixing flourophores capable of FRET the 
emission measured in unbleached regions will not include some donor signal that would 
be present in the absence of an acceptor. This is due to some of the signal being 
quenched by the interacting acceptor (i.e. FRET is occurring). Gu et al. recognised the 
presence of an invisible donor signal pre-photobleaching and corrected for it based on 
the assumption that this missed signal comes from a population of donors that are 
entirely non-radiative (Gu et al. 2004, Di et al. 2005). However, the invisible signal cannot 
be assumed to be the total quenching of a population of donors, and as such introduces 
error into the spectral unmixing calculations. Furthermore, it is known that FRET can 
alter the shape of a fluorophore’s emission spectrum (McNamara et al. 2017, Thaler et al. 
2005), something that is not addressed in the u-adFRET unmixing calculations. This has 
the potential to be a highly confounding factor, as reference spectra cannot be assumed 
to be suitable for a fluorophore that is undergoing FRET. 
For FRET studies in this chapter, the u-adFRET assay was modified to remove the 
need to spectral unmixing. Rather than ECFP and EYFP, the FRET-pair Clover (donor) and 
mRuby2 (acceptor) was used. Unlike previous FRET-pairs (such as ECFP/EYFP), 
Clover/mRuby2 have very good separation in their emission spectra. In fact, it is possible 
to record channels with no spectral bleed-through, yielding separate measurements of 
pure Clover and pure mRuby2 emission (Figure 3.2a). These measurements provide 
relative abundance values that can then be used in calculations to determine DA ratio, 
and A-level.  
The measurements obtained using the u-adFRET approach are reported as being 
quantitative (Gu et al. 2004, Di et al. 2005, Yum et al. 2007), however this method does 
not actually yield values for molecular abundancies of flourophores (just an abundance 
factor for each). As such, the DA and A-level values that are quantified in one experiment 
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cannot be compared to the values quantified in an experiment performed with different 
parameters. Without being able to calculate the actual values for proteins it may be 
fairer to call this approach semi-quantitative. This being said, quantitative analyses can 
still be performed on data yielded from this assay, and the %E can be compared across 
experiments. The mean %E reported from Cx26/Cx26 coexpressions in this chapter 
(24±10%) matches that reported in previous literature (24±13%) (Di et al. 2005). The 
distribution patterns for %E vs. DA ratio and %E vs. A-level can also be compared across 
results however, as explained, the values for DA ratio and A-level cannot. Therefore, 
these plots may see value shifts when comparing against different experimental 
parameters. 
In the studies by Di, Gu, and Yum et al. only ROIs with a DA ratio of 0.33-3 are 
included to “avoid calculation errors caused by low by low signal-to-noise ratio, and FRET 
efficiency saturation owing to high concentrations of donor/acceptor” (Di et al. 2005). 
However, a low signal-to-noise ratio can be overcome through appropriate selection of 
ROIs; so that both fluorophore pixel intensities were sufficient for measurements, but 
not overexposed too the extent that they cap out at the maximum measureable 
intensity. Also, by restricting the ROIs by DA ratio there is the risk of cutting out data that 
contributes to the very relationships you are trying to discern; namely, the increase in DA 
ratio with decreasing FRET efficiency. This is because the DA ratio is only a relative ratio 
based on fluorescence intensities - it is not an actual value of the number of donor and 
acceptor molecules present within the ROI. As such, for each set of experimental 
parameters, you cannot be sure what DA ratio range will be relevant and should only 
omit this data after careful consideration. 
By utilising Clover/mRuby2, and sacrificing the potential to collect light across the 
flourophores’ entire spectra, it was possible to develop an approach that still maintains 
the (semi-)quantitative benefits of that developed by Gu, whilst removing the need for 
spectral unmixing calculations. This creates a more accessible assay that minimizes errors 
that may be introduced from experimental design/execution, as well as removing any 
errors that are inherent to the assumptions that are made during the spectral unmixing 
step. 
 
	 109	
3.4.6 Connexin 26 DN acts in a dominant negative fashion to eliminate CO2-Sensitivity 
from connexon hemichannels 
In an attempt to develop a tool that could be used to eradicate CO2-mediated Cx26 
hemichannel opening, a Cx26 mutant with K125R and R104A mutations was created, and 
it’s effect on CO2 sensing was tested. The design of this DN mutant was in such a way 
that any given Cx26DN subunit would be incapable of forming a carbamate bridge with 
either of its neighbours in a connexon.  
In this chapter, dye-loading analysis has shown that homomeric Cx26DN 
hemichannels are insensitive to CO2 (Figure 3.8). Furthermore, it was demonstrated that 
the CO2 sensitivity of cells stably expressing Cx26WT is completely removed 6 days after 
the coexpression of this mutant (Figure 3.9). Therefore, Cx26DN acts in a dominant 
negative fashion, removing the cells ability to respond to CO2 even when cells are stably 
expressing CO2 sensitive Cx26. This result supports the carbamylation model of CO2-
dependent opening of Cx26; i.e. that the K125 and R104 residues are involved in CO2 
dependent channel opening of Cx26 (Meigh et al. 2013, Meigh et al. 2014, Meigh et al. 
2015b). 
Taken together with our FRET data, which shows that Cx26WT and Cx26DN 
connexin subunits readily coassemble into heteromeric connexons, we conclude that this 
dominant negative action occurs because Cx26DN and Cx26WT connexins form 
heteromeric hemichannels, which subsequent lose the ability to open in response to CO2. 
Due to the deliberate design of this mutant we conclude that, in any given 
Cx26WT/Cx26DN heteromeric hemichannel, this loss of CO2 gating is due to the removal of 
a sufficient number of sites that are required for the carbamate bridge formation (i.e. 
K125 and R104 residues) that is responsible for channel opening. The incorporation of 
one Cx26DN subunit, into an otherwise Cx26WT connexon, would maintain four of the six 
bridges that are required for fully stabilising the hemichannel in its open state. 
Depending of the stoichiometric organisation of the connexins, the incorporation of two 
Cx26DN connexins could maintain a maximum of three interactions (if the Cx26DN subunits 
were adjacent to each other). The incorporation of three Cx26DN connexins could 
maintain a maximum of two interactions. The incorporation of four Cx26DN connexins 
could maintain a maximum of one interaction. The incorporation of five or six Cx26DN 
connexins would prevent any carbamylation-mediated interactions from occurring. The 
composition of the heteromeric connexons that are formed is unknown, however based 
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on our FRET distributions, we believe that there is no difference between assembly and 
packing of Cx26WT with either Cx26WT or Cx26DN – other than a potential bias away from 
the formation of homomeric Cx26DN connexons. Although we are not able to put a 
number on it, the level of cooperative binding between CO2 molecules and Cx26 
hemichannel (Figure 3.1b) suggests that the presence of just one or two DN subunits 
might be sufficient in preventing the open state being reached (Figure 3.1c). The number 
of intersubunit interactions required for channel opening could be further explored with 
elastic network modelling. 
The loss of CO2-sensitivity observed upon Cx26DN transfection into Cx26-HeLa 
cells was not immediate, occurring approximately 6 days post transfection (Figure 3.9). 
Single expression of Cx26 variants into parental HeLa cells yields functional hemichannels 
in the plasma membrane by 72 hrs (Meigh et al. 2013, Meigh et al. 2014, Meigh 2015a, 
de Wolf et al. 2016, de Wolf, Cook, and Dale 2017). Cx26 turnover has a half-life of ~5 
hours in mouse hepatocytes (Fallon and Goodenough 1981). Although the cellular 
dynamics in HeLa cells will differ somewhat, a turnover of 5 hours equates to ~99-100% 
turnover of plasma membrane connexins in a 48 hr period. As we did not see the action 
of Cx26DN until 6 days post-transfection, this suggests that turnover of Cx26 may occur 
from a pool or reservoir of connexons that reside within cytoplasmic vesicles. In this way, 
unlike transfections into parental cells, during which hemichannels would be transported 
to the plasma membrane and become functional more or less immediately, transfections 
into cells already expressing Cx26WT could require an additional 3 days for heteromeric 
assembly, sufficient replacement of reservoir connexons, and subsequent 
trafficking/turnover of non-functional connexons into the plasma membrane. 
This chapter has shown that, as predicted, Cx26WT and Cx26DN subunits 
coassemble into heteromeric connexon hemichannels, and that the introduction of 
Cx26DN subunits into cells stably expressing Cx26WT completely removes the cells Cx26-
mediated response to CO2. As such, it is concluded that the formation of Cx26DN/Cx26WT 
heteromeric hemichannels results in insufficient carbamate bridge formation under 
hypercapnic conditions (which would usually stabilise the channel in an open state), and 
that with enough time this effect will become widespread in cells natively expressing 
Cx26WT – thus resulting in cell-wide Cx26-mediated CO2 insensitivity. 
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3.4.7 Dominant Negative Connexin 26 could be used for in vivo experiments to 
investigate the CO2 sensitivity of connexin 26 expressing cells 
The FRET experiments in this chapter have demonstrated that our engineered Cx26DN 
mutant readily coassembles with Cx26WT to form heteromeric connexons that are 
expressed in gap junction plaques, hemichannel plaques, and cytoplasmic vesicles. Our 
dye loading experiments in this chapter have demonstrated the ability of Cx26DN 
expression to remove native CO2-sensitivity from cells with stable Cx26WT expression. 
Furthermore, owing to the design of the mutant, we have a very clear understanding as 
to how this dominant negative effect is brought about. Consequently, introduction of 
Cx26DN into CO2-sensitive cells in vivo could provide a method of manipulating certain 
cells in living animals in order to remove CO2-dependent Cx26 channel opening, whilst 
leaving otherwise functional Cx26 protein. 
By engineering the Cx26DN gene into a Lentivirus (LV) or Adeno-associated virus 
(AAV) construct, expressed on a tissue specific promoter, it would be possible to test the 
importance of Cx26 CO2 sensitivity in any number of tissues. This has the benefit of 
testing a specific gating characteristic (CO2), which limits any confounding effects that 
that may be brought about from the complete KO of the Cx26 gene (e.g. compensation, 
or disruption of other Cx26-related pathways). Also, as system-wide Cx26 KO is lethal 
(Gabriel et al. 1998), this would provide an alternative to timely and costly cross-
breeding KO studies that targets. 
One use of this technique would be to investigate the role and mechanism of 
Cx26 in respiratory chemoreception. Specifically, such a construct could be generated 
with a GFAP promoter, with targeted viral transduction at chemosensitive sites of the 
VMS. This would result in the expression of Cx26DN in glial cells of the VMS that are 
believed to be involved in a Cx26-mediated breathing response and would subsequently 
remove Cx26 CO2 sensitivity. The manipulated system would lose the ATP release that 
usually occurs upon CO2-dependent Cx26 hemichannel opening (Huckstepp et al. 2010a), 
allowing the role that glial Cx26 plays in the breathing response to be investigated. By 
using the Cx26DN tool in this manner, removal of Cx26 CO2 sensitivity can take place post-
natal, i.e. after the developmental stages during which compensation is likely to occur. 
Because the Cx26DN gene can be genetically introduced into cells it would enable in vivo 
breathing measurements to be taken from unanaesthetised animals, i.e physiological 
conditions.  
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4 PROGRESS TOWARDS TESTING THE ROLE OF CO2-SENSING VIA 
CONNEXIN26 IN GLIAL CELLS AS A CHEMOSENSORY REGULATOR OF 
BREATHING 
 
4.1 Introduction 
 
Breathing enables the body to maintain blood pCO2 and pO2 levels: a vital function 
required to supply O2 for cellular respiration and remove CO2 to prevent respiratory 
acidosis. In order to adjust breathing, the body needs to be able to sense changes in 
these blood gases and respond in some way to bring about a change in breathing. Such 
modulation of breathing is known as respiratory chemoreception. This chapter focuses 
on central CO2 chemoreception. CO2 chemoreception takes precedence over O2 
chemoreception (Haldane and Priestley 1905, Phillipson, Duffin, and Cooper 1981, Spyer 
and Gourine 2009), with central CO2 chemoreception responsible for around twice as 
much of the hypercapnic ventilatory response (HCVR) as peripheral CO2 chemoreception 
(Forster et al. 2008).  
It has been clearly demonstrated that the ventral medullary surface (VMS) 
contains sites important for central CO2 chemoreception – in particular the rostral and 
caudal areas. These two areas were first identified based upon their acidification causing 
increased respiratory activity (Loeschcke 1982, Schlaefke, See, and Loeschcke 1970, 
Mitchell et al. 1963a, Mitchell et al. 1963b, Trouth et al. 1973, Schlaefke, Kille, and 
Loeschcke 1979). The general consensus is that the rostral chemosensitive area can be 
defined as the RTN/pFRG, however the caudal area is much less defined. In the search to 
understand which cells are responsible for chemoreception there has recently been 
much focus on the RTN, where a population of neurons have been found to respond to 
physiological changes in pH (Mulkey et al. 2004, Mulkey et al. 2006, Guyenet, Stornetta, 
and Bayliss 2008, Kumar et al. 2015). There has also been interest in the serotonergic 
raphé neurons, which run medial to the traditionally defined rostral and caudal sites 
(Figure 1.1b-d) and also play a role in detecting changes in pH (Richerson 2004, Ray et al. 
2011, Brust et al. 2014). Alongside these players, and the focus of this chapter, there is 
also a chemoreceptive role for ATP signalling along the VMS (Figure 1.1b), which is 
released from sub-pial GFAP+ cells in response to hypercapnia and mediates respiratory 
	 113	
activity by acting on respiratory neurons via P2X and P2Y receptors (Gourine et al. 2003, 
Gourine et al. 2005, Lorier et al. 2007, Gourine et al. 2010, Huckstepp et al. 2010a, 
Mulkey and Wenker 2011, Wenker et al. 2010, Wenker et al. 2012, Moreira et al. 2015). 
In order for chemosensitive cells (like those reported in the RTN, raphé, and 
GFAP+ cells) to be considered respiratory chemoreceptors, they must be capable of 
intrinsically detecting and responding to physiological changes in pCO2. This requires a 
chemosensory transducer molecule that will sense a change in pCO2 (be it via molecular 
CO2, pH, or bicarbonate) and initiate a signalling pathway to adjust respiration. Potential 
chemosensory transducers have been suggested to play a role at certain VMS 
chemosensitive sites, with GPR4, TASK2, Kir4.1, NBCe1, and Cx26 all proposed to have an 
action in the RTN – some of which have accompanying KO studies showing decreased 
HCVR in conscious animals (see 1.3 Central respiratory chemosensory transducers for 
pCO2). Although some of these molecules may be relevant for responding to changes in 
pH only Cx26 has the ability to respond to CO2 directly. Therefore, Cx26 is currently the 
strongest candidate to account for the pH-independent adaptive changes in breathing 
that have been reported (but are often overlooked) (Shams 1985, Harada, Kuno, and 
Wang 1985, Huckstepp et al. 2010a, Meigh et al. 2013). As such we chose to further 
investigate the role of Cx26 in chemoreception, by using a novel genetic tool. 
As it stands KO of any protein from birth, as in the aforementioned studies of 
putative chemosensory transducers, introduces many unknow and unnatural variables 
into the development of an animal and its physiology (regardless of the cell specificity). 
In order to truly ascertain the physiological relevance that a protein plays in the HCVR of 
an intact, wild-type, animal it is important that we strive to develop and refine 
techniques that alter the animal system as little as possible. In order to achieve this goal, 
we require progressive experimental design such as the Cx26DN tool that has been 
characterised in the previous chapter (see 3 Characterisation of co-assembly and CO2-
Insensitivity of a Connexin26 dominant negative mutant). Such an innovative technique 
brings with it benefits of temporal and spatial gene control similar to those provided by 
the Cre/lox recombination technique (Feil, Valtcheva, and Feil 2009), and thereby allow 
the natural development of mice before ablation of a protein’s function. In this way, CO2 
chemoreception can be tested at any age and in a more realistic/physiological scenario 
than previous KO studies. Furthermore, by introducing Cx26DN via LV the system provides 
additional benefits of being able to target any part of the body without affecting other 
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tissues, and of specifically removing the Cx26 property of interest (i.e. CO2-sensitivity) 
whilst maintaining expression of the protein within cells. Therefore, the LV-Cx26DN 
system is applicable to rats (not just mice) and might be seen to allow for the 
investigation of CO2-sensitivity in a scenario that is even more realistic/physiological than 
that produced by the cre/lox system. 
As stimulation of the RTN (rostral chemosentive site) elicits a HCVR that consists 
of a large change in tidal volume (Li, Randall, and Nattie 1999) and there is unpublished 
evidence that Cx26 modulates tidal volume (but not frequency) in the caudal 
chemosensitive site of mice aged 3-7 months (personal communication from Nicholas 
Dale and Georgy Koentges – and discussed later in this chapter), we hypothesised that 
the same Cx26-mediated control of tidal volume is also important within the rostral 
chemosensitive site (Figure 4.1). If correct, removal of Cx26 CO2 sensitivity in rostral glia, 
after adulthood, will result in a measurable reduction in adaptive changes in tidal 
volume. In this chapter this hypothesis is tested by utilising the Cx26DN mutant that has 
previously been shown to remove CO2 sensitivity from cells stably expressing Cx26WT (see 
3 Characterisation of co-assembly and CO2-Insensitivity of a Connexin26 dominant 
negative mutant).  
By using a LV harbouring the Cx26DN gene, experiments in this chapter aimed to 
transduce glia at the rostral chemosensitive site (RTN) of the VMS, after mice reached 
adulthood. Cx26DN expression will act to remove CO2 sensitivity thereby preventing any 
Cx26-mediated ATP release that usually occurs within the RTN. Subsequently, the effect 
that Cx26 CO2 gating has on the HCVR can be determined. Removing CO2 sensitivity in 
this manner is much more elegant than the global KO studies of GPR4, TASK2, Kir4.1, and 
Cx26, and should provide a much more representative picture of chemoreception 
mechanics.  
 
4.2 Materials and Methods 
4.2.1 Lentivirus design and handling 
Two lentivirus (LV) constructs were designed to introduce either the Cx26DN or Cx26WT 
gene into the host cell genome (Figure 4.2a,b). Constructs are ~4900bp in length. The 
sequence of interest consisted off the Cx26 gene variant (Cx26WT or Cx26DN) immediately 
followed by an internal ribosome entry site and Clover sequence (Cx26:IRES:Clover). In 
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this way, LV expression of Cx26 protein would be marked by the expression of the 
fluorescent protein Clover. As protein production via IRES translation results in an 
uncapped peptide, expression of Clover is likely to occur at approximately 1:10 
translation rate compared to that of Cx26 (Mizuguchi et al. 2000, Martineau et al. 2004, 
HERNÁNDEZ et al. 2004, Hennecke et al. 2001, Dirks et al. 1994). To enhance translation 
of the Cx26:IRES:Clover transcripts, a woodchuck hepatitis virus posttranscriptional  
 
 
Figure 4.1   Hypothetical contribution of Connexin26 to the hypercapnic respiratory response 
initiated in the rostral ventral medullary surface. Schematic diagram showing how Connexin26 
(Cx26)-mediated ATP release could augment the activation of chemosensitive neurons in the 
rostral part of the ventral medullary surface. Under hypercapnic conditions glia within the 
Retrotrapezoid nucleus (RTN) might be responsible for Cx26-mediated ATP release. ATP release 
would act on P2Y receptors of RTN neurons responsible for mediating a hypercapnic ventilatory 
response (HCVR). More medial to the RTN, similar ATP release could be responsible for acting on 
an unknown receptor of raphe magnus neurons responsible for mediating a HCVR. CO2 produced 
by surrounding brain tissue would also feed into this pathway. CAN, channel responsible for a 
Calcium-activated non-selective cation current; TASK-2, two-pore-domain potassium channel 
type 2; GPR4, G protein-coupled receptor 4; P2YR, a GPCR purinergic receptor  
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Figure 4.2  Lentivirus design and in vivo expression. a,b)  Lentivirus construct sequences for the 
introduction of wild type Connexin 26 (Cx26
WT
) (a) or Dominant Negative Cx26 (Cx26DN) (b) into 
cells of the ventral medullary surface (VMS). Expression of Connexin 26 is under the control of a 
GFAP promoter, resulting in cell-specific expression only in those cells that express GFAP. An 
IRES:Clover sequence immediately after the Cx26 gene of interest provides a marker for which 
cells express the gene.  Cx26 Constructs are ~4900bp in length.  c) Maximum-intensity projection 
of cells at the VMS. GFP-amplification of Clover (green, left) shows expression of lentivirus 
constructs at the VMS expression. Glial cells are identified based on their morphology and 
positive immunostaining for the intermediate filament glial fibrillary acidic protein (GFAP) 
(magenta, middle). Co-localisation shows that construct expression occurs only within glial cells 
(grey, right). Scale; 40μm. Cx26, connexin; WT, wild type; DN, dominant negative; GFAP, glial 
fibrillary acidic protein; mCMV, mini cytomegalovirus; IRES, internal ribosome entry site; WPRE, 
woodchuck hepatitis virus posttranscriptional regulatory element; BGHpA, bovine growth 
hormone polyadenylation signal. 
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regulatory element (WPRE) was added after the Clover sequence. Expression of the 
Cx26:IRES:Clover constructs was under the control of a GFAP promoter, resulting in cell-
specific expression only in cells that express GFAP (i.e. a subset of glia consisting 
predominantly of astrocytes). To increase expression of the virally-encoded 
Cx26:IRES:Clover sequence, the construct contained a mini-cytomegalovirus (mCMV) 
promoter to control for the expression of GAL4, which acts as an enhancer to the GFAP 
promoter, and subsequently Cx26:IRES:Clover transcription. The LV construct also 
contained a bovine growth hormone polyadenylation signal (BGHpA) for packaging 
purposes. 
Lentivirus constructs were produced and packaged by Cyagen Biosciences (USA) 
using the third-generation packing system. This involves transfecting the lentiviral 
vectors (along with helper plasmids) into optimised packaging cells, which then package 
complete LV virons that are released into media. Released virons are then purified by 
PEG centrifugation. The third-generation system produces LV that is replication 
incompetent and thus very safe. Constructs had a titre > 108 TU/mL; as confirmed by 
qPCR on genomic DNA extracted from infected cells.  
LV was aliquoted in a Category 2 Microbiological Safety Cabinet lab and stored at 
-800C. For injections, LV was removed and held at 40C until loaded into pipettes. All 
excess LV and contaminated surfaces were disinfected with 10% Chemgene. 
 
4.2.2 Animals and brain surgery 
All animal procedures were evaluated by the Animal Welfare and Ethical Review Board of 
the University of Warwick and carried out in strict accordance with the Animals (1986) 
Scientific Procedures Act of the UK under the authority of PIL JVW1, PPL 80/2555 and 
PC07DE9A3. 
Male and female floxed Cx26 mice (Cohen-Salmon et al. 2002) (acquired from 
European Mouse Mutant Archive) between the ages of 12-18 weeks were used. As these 
mice were not cross bred, this genotype had no effect on Cx26 expression and should be 
considered wild type. This strain was chosen to remain consistent with Cx26-KO studies 
that were performed in the department (Nicholas Dale and Georgy Koentges, 
unpublished). 
For LV injections, anaesthesia was induced in a gas chamber by isoflurane (4%), 
before being placed on a heating pad and fastened into a stereotaxic frame, with 
	 118	
facemask, where body temperature was maintained at 370C (feedback via a rectal probe) 
and anaesthesia was maintained by isoflurane (intranasal, 0.5-2.5%). Analgesia was 
provided in the form of Metacam (Meloxicam; sub-cutaneous, 2 mg/kg) at the point of 
securing the animal in the stereotaxic frame in order to minimise the time between the 
animal regaining consciousness and the therapeutic dose of Metacam being reached in 
the blood (~6 hours). At the same time atropine was administered (sub-cutaneous, 0.05 
mg/kg) in order to counteract the effects of plural effusion caused by isoflurane. Eye 
ointment lubrication (Lacri-Lube) was applied directly after this pre-surgical medication 
to ease irritation that would arise due to the drying out of eyes and exposure to bright 
surgical lights during the procedure. To provide immediate analgesia, Subutex 
(Buprenorphine) was administered post-operatively (intraperitoneal, 0.05 mg/kg). When 
appropriate, additional analgesia was administered on days following surgery. 
Attempts to approach the medulla, through the Dura and Arachnoid matter just 
beneath the Occipital bone resulted in severe brain herniation. Instead, the head was 
levelled and a craniotomy of the interparietal plate was performed to make two holes for 
bilateral injections. In this way, the pipette track for virus injections went down through 
the cerebellum and into the medulla (Figure 4.3a). To achieve as ventral expression as 
possible, the pipette was lowered until head or pipette movement indicated touching of 
the pipette at the ventral surface of the skull. At this point the pipette was retracted 
0.100 mm and pressure was applied to inject the virus. If a small amount of pressure 
could not expel virus, the pipette was retracted in 0.050 increments (up to 0.200), testing 
virus injection each time. Virus injections were performed manually, using a 1 mL syringe, 
at a rate ~200 nL/min, and a total of 350-400 nL of undiluted virus was injected per side 
of the brain. Co-ordinates used in batch 1 were: 5.900 mm rostrocaudal, 1.100 mm 
mediolateral, and 5.300-5.900 mm dorsoventral. Co-ordinates used in batch 2 were: 
5.750 and 6.050 mm rostrocaudal (two injections per side of the brain), 1.050 mm 
mediolateral, and 5.300-5.900 mm dorsoventral. Injections were made at a 90 angle. Co-
ordinates were initially confirmed with fluorosphere injections. 
 
4.2.3 Immunohistochemistry 
Mice were culled by overdose of Isoflurane or intraperitoneal injection of Sodium 
Pentobarbital (>100 mg/kg), and transcardially perfused with paraformaldehyde (PFA; 
4%). The brain was harvested and post-fixed in 4% PFA for 24hrs at 40C (to increase   
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Figure 4.3  Virus injection target location. a) Sagittal section of the mouse brain, showing pipette 
tract based on the coordinates 5.900 rostrocaudal, 1.100 mediolateral, with a 9
0
 angle (blue 
dashed line). (image modified from Allen Brain Atlas Data Portal – http://atlas.brain-map.org/ - 
accessed on 12.08.2018). b) Mouse sagittal medullary section showing choline acetyltransferase 
immunostaining (magenta), with overlays showing key histological landmarks, and positioning of 
the ventrolateral respiratory column. In the diagrams up is dorsal, down in ventral, left is rostral, 
and right is caudal. R, rostral chemosensitive site; I, Intermediate chemosensitive site; C, caudal 
chemosensitive site; NA, nucleus ambiguous; VII, facial nucleus; preBot, pre-Bötzinger Complex; 
Bot, Bötzinger Complex; rVRG, rostral ventral respiratory group; RTN, retrotrapezoid nucleus; 
cVLM, caudal ventrolateral medulla; SO, superior olive; VMS, ventral medullary surface. Scale 
bars: 1 mm. 
 
tissue fixing), before being transferred to 30% sucrose (for cryoprotection) until the brain 
sunk to the bottom of the sucrose – usually ~2-3 days. PFA and sucrose were made in 
PBS. 
For sectioning, brainstems isolated, mounted with Tissue-Tek optimum cutting 
temperature compound (Sakura Finetek), and cut sagittally at 40 μm on a cryostat (Bright 
Instruments). Sections were arranged in order, in 24-well plates, and stored in PBS. For 
immunostaining, free-floating sections were incubated overnight in PBS containing 0.1% 
Triton X-100 (Sigma-Aldrich, UK) (0.1% PBS-T) and the appropriate primary antibodies 
from: goat anti-Choline Acetyltransferase (ChAT) (1:100) (Merck UK, ab144), chicken anti-
GFP (1:500) (abcam, ab4674), rabbit anti-glial fibrillary acidic protein (GFAP) (1:500) 
(abcam, ab68428). Sections were then washed in PBS for 6 X 5 mins before incubation for 
2.5-4 hrs in 0.1% PBS-T containing the appropriate secondary antibodies from: Donkey 
anti-goat Alexa Fluor 594 (1:250) (abcam, ab150132), goat anti-rabbit Alexa Fluor 594 
(1:250) (abcam, ab150080), goat anti-chicken Alexa Fluor 488 (1:250) (abcam, 
ab150169). Immunohistochemistry experiments and set up were such that there was 
never a mix of antibodies that would result in undesired cross-reactivity. After secondary 
antibody incubation, sections were washed again in PBS for 6 X 5 mins before mounting 
onto polylysine-coated slides (Polysine, VWR). Mounted slices were left to dehydrate 
overnight before applying coverslips using either Aqua-Poly/Mount (Polysciences Inc., 
Germany) or Fluoroshield with DAPI (Sigma-Aldrich, UK). All steps were performed at 
210C and during any period of incubation or washing sections were gently agitated on a 
shaker. 
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4.2.4 Immunohistochemistry imaging and virus expression scoring 
Virus expression and immunostaining were imaged using a Zeiss-710 confocal laser 
microscope, and FIJI software was used for further analysis.  
To gauge the expression level and location of LV constructs, the coverage of cell 
transduction (defined by un-amplified Clover expression) at either the rostral or caudal 
chemosensitive sites was inspected via confocal microscopy. A semi-quantitative score 
between 0-2 was given for each side of the brain, and scores were then pooled to give a 
mouse a score between 0-4. Scoring was as follows: 0, no expression; 1, visible 
expression (~1-50 cells); 2, high expression (>50 cells). The rostral chemosensitive region 
was considered to be the RTN, which was defined as the region ventral to the 7th nucleus 
(7N), plus regions that extend a little further rostral and caudal than the 7N. The caudal 
chemosensitive region is less well defined but was considered to be within 300 μm of the 
ventral surface, and span from the last quarter of the nucleus ambiguous, to the 
beginning of the caudal ventral respiratory group (cVRG). These definitions can be seen 
visually in Figure 4.3b. The mediolateral catchment area chosen for inclusion for 
expression scoring was any expression under the 7N (as defined by ChAT staining), plus 
an extra ~200 μm medial of the 7N. 
 
4.2.5 Whole-body plethysmography  
Hypercapnia-induced breathing responses in conscious mice were measured using 
whole-body plethysmography, as in previous studies (Trapp et al. 2008, Onodera et al. 
1997). This involved placing animals in a plethysmograph (pressurised chamber) with an 
attached pressure transducer to measure the breathing of the mouse, and gas inlets and 
outlets to permit gas flow into and out of the chamber. Animal respiratory movements 
are detectable in this way as inhalation and exhalation consist of a minor delay between 
body cavity expansion/deflation and the flow of air into/out of the lungs (respectively). 
This delay occurs because airflow through the respiratory tract must overcome airway 
resistance, thus providing periods during which the chamber exhibits greater internal 
pressure (i.e. during inhalation when body cavity expansion reduces chamber volume) or 
reduced internal pressure (i.e. during exhalation when body cavity deflation increases 
chamber volume). The respiratory response to inspired CO2 has been shown to match 
the response to intravenous CO2 loads (Lamb 1966). Therefore, by altering the CO2 
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composition of the gas passed into the chamber, this set up is capable of measuring the 
HCVR exhibited by subject animals. 
A mixture of N2 (80%), O2 (~20%), and CO2 (0-9%) was passed through the 
chamber at a rate of 1 L/min; which was determined by a 1 L/min flow meter attached to 
the outlet and adjusted via a bleed valve situated before gas entered the chamber. Prior 
to its entry into the chamber, the gas was heated via a water bath, and its O2/CO2 
composition was measured by a gas analyser (Hitech Instruments, GIR250 Dual Sensor 
Gas analyser). Every recording was calibrated, using a 1 mL syringe to injected 0.1, 0.2, 
and 0.5 mL volumes of air via a port for calibration. The pressure transducer output was 
amplified and recorded to a hard disk via a CED micro1401 interface and the Spike2 
software (Cambridge Electronic Design, UK).  
There were a couple of differences between the apparatus set up used to record 
breathing from animals in batch 1, and that used to record breathing from animals in 
batch 2. These are highlighted below. 
 
Batch 1 apparatus set up: 
The plethysmograph was constructed from an 850 mL plastic food storage container with 
a tight-fitting lid (Lock and Lock), which was filled to result in a chamber of volume ~500 
mL (to providing better signal-to-noise) and covered in red plastic (to help the animal feel 
less exposed). The plethysmograph was placed on a heating mat, and gas was heated via 
a water bath before passing through the chamber. Because the chamber was filled from 
the bottom up (to reduce the volume) it was found that there was poor conductance of 
heat from the mat to the area of the chamber the animal was situated. As such, the 
chamber could not be heated much above 240C and animals remained very active in 0% 
CO2 conditions. This made it difficult to acquire good traces of eupneic breathing. For the 
batch 1 setup the gas analyser was positioned immediately after N2/O2/CO2 mixing and 
was responsible for pumping air into the chamber. Also, the pressure transducer output 
was hardware filtered, after amplification, in order to remove high and low frequency 
bands that marred the breathing waveform. Calibrations were performed after the 
animal was removed from the plethysmograph. 
 
Batch 2 apparatus set up: 
A new plethysmograph was made from an 850 mL plastic food storage container with a 
tight-fitting lid (Lock and Lock) but was cut down to a final volume ~400 ml and designed 
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to have very little distance between the surface that the animal sits on and heating mat. 
The chamber was covered in red plastic (to help the animal feel less exposed). With this 
new chamber, the temperature could be kept ~290C – the thermoneutral zone for mice 
(Speakman and Keijer 2013) – and animal activity notably decreased. Furthermore, for 
this batch of animals the gas analyser was set up to sample the gas before it entered the 
chamber, which prevented the need for any hardware filtering (i.e. the signal input to 
Spike2 was only amplified, but not filtered). Calibrations were performed whilst the 
animal was within the plethysmograph. The plethysmography chamber and set up (from 
batch 2) can be seen in Figure 4.4. 
 
4.2.6 Plethysmography data capture and analysis 
For plethysmography experiments, a mouse was placed in the plethysmograph at 0% CO2 
and allowed at least 20 minutes to acclimatise and settle. After adequate periods of 
eupneic breathing were acquired, animals were exposed to 3%, 6%, and 9% CO2 
successively for 5 minutes. A typical plethysmography trace can be seen in Figure 4.5. 
Using the Spike2 software, plethysmography recordings were analysed by 
producing a cycle-by-cycle average for each breathing cycle from the recorded 
plethysmography trace/waveform (waveform averaging). For each condition (0%, 3%, 
6%, and 9% CO2), this required the selection of periods from the plethysmography trace 
during which the mouse was assessed to be quiescent and exhibiting eupneic breathing 
(as opposed to exploratory sniffing). To minimise any confounding effects from the fear 
response (that occurs with increasing CO2), such periods were only selected from time 
points within 3-5 mins after onset of the condition (Figure 4.5). This selection window 
has been used in similar plethysmography studies (Davis et al. 2006). Waveform 
averaging yielded a measure for tidal volume and respiratory rate (mean time between 
waveform peaks). Tidal volume was calibrated and normalised to body weight. 
All statistical analysis was performed in SPSS. For tidal volume and frequency, 
three-way mixed ANOVAs (which included repeated measures) were carried out, 
separately, with within-subject variables; week post-transduction and CO2 level, and the 
between-subject variable; virus (as animals were either injected with the Cx26WT or the 
Cx26DN LV). For tidal volume at 6% (weeks 0-4) and week 3 (0%, 3%, 6%, and 9% CO2) 
two-way mixed ANOVAs (which included repeated measures) were carried out, 
separately, with within-subject variables; week post-transduction or CO2 level, and the 
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between-subject variable; virus. For tidal volume at week 3; 6%, a one-way ANOVA was 
carried out to compare the mean tidal volume across groups expressing the Cx26WT LV, 
Cx26DN LV, or no expression, at a particular chemosensitive site.  
 
 
 
Figure 4.4  Plethysmography apparatus and setup. Plethysmographs were constructed from 
food storage containers, covered in red plastic (with one side transparent), and consisted of 4 
ports for; i) gas inlet, ii) gas outlet, iii) pressure transduce, and iv) calibration syringe. The 
chamber shown in this figure is that used for batch 2 animals. Chambers were placed on a 
heating mat and gas was heated by passing tubing through a water bath before entering the 
chamber. The composition of CO2 and O2 was sampled and measured before entry to the 
chamber. By adjusting a bleed valve pre-entry, the flow rate of gas through the chamber was 1 
L/min (measured by a fully open flow meter attached to the outlet port). 
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Figure 4.5  Representative whole-body plethysmography trace from conscious wild-type mice 
showing typical breathing changes in response to hypercapnia. Breathing frequency (Fr), CO2 
concentration (CO2), and tidal volume (VT) are plotted against a shared time axis. a) Experimental 
trace, taken before virus transduction, showing the end of the acclimatisation period at 0% CO2, 
and the subsequent response to 3%, 6%, and then 9% CO2. The plethysmograph was heated on a 
heating mat, keeping the chamber ~29
0
C. Animals often experience a mild shock response from 
the change in environmental pCO2, sometimes taking a couple of minutes of exposure in order to 
produce a steady trace when quiescent. Furthermore, as recordings were performed on 
unrestrained, unanaesthetised, animals much of a trace contains noise from movement, as well 
as exploratory-related breathing characteristics – such as sniffing. For these reasons, analysis was 
only preformed within the last two minutes of a given condition (grey bars), and only on sections, 
within the two minutes, during which the animal was quiescent, thus providing a steady and 
reproducible trace. b) Magnified traces from grey bars in (a), demonstrating quiescent breathing 
(and accompanying frequency) at 0%, 3%, 6% and 9% CO2. VT and Fr can be seen to increase 
(increased amplitude and frequency, respectively) as CO2 concentration increases – with the 
most drastic changes seen between 0-3% and 3-6%. Some parts of the traces corresponding to 
very high noise due to animal movement were clipped in order to provide a better visual 
representation of the parts of the trace that were analysed. 
 
4.2.7 Power calculation 
To determine the number of animals (measurements) required to statistically discern if 
there is a difference in tidal volume between groups at 6% CO2, a power calculation was 
performed in G*Power 3.1 (Faul et al. 2007, Faul et al. 2009). The calculation was based 
on the F-test “ANOVA: Repeated measures, within-between interaction”, selecting 
“effect size specification as in SPSS” from the option window. Greenhouse-Geisser 
nonsphericity correction (ε) and partial eta squared values, calculated from the pilot 
study in the statistical package SPSS, were used for the power calculation. Other input 
parameters were set at 0.05 α-error probability, 0.8 power, and 3 groups (Cx26WT, 
Cx26DN, and sham injection). 
 
4.3 Results 
  
The data presented in this chapter chronologically documents the process and 
progression of viral injections, data analysis, and immunohistochemistry for two batches 
of animals.  Data from the first batch is examined and discussed in its entirety before 
being re-evaluated in light of the immunohistochemistry; including an in-depth 
examination of the results at the most logical time point. The second batch is then 
	 127	
analysed in analogous manner (however there was no need for re-evaluation).  Because 
such analysis does not fully conform to the structure and layout of previous chapters, this 
section (4.3 Results) comprises of results alongside less conventional discussion and is 
then succeeded by a more typical discussion section (4.4 Discussion). 
Although KO of Cx26 in GFAP-expressing cells produces a reduction in tidal 
volume (personal communication from Nicholas Dale and Georgy Koentges), this KO 
occurred from birth and completely removed Cx26 expression in either all GFAP 
expressing cells, or almost all NCCs. Therefore, although informative, the Cx26-KO data 
was not appropriate for determining the study design of the Cx26DN Lentivirus (LV) 
experiments that are presented in this chapter. Instead, data in this chapter can be 
considered a pilot study for investigating the importance of Cx26 CO2 sensitivity using 
this Cx26DN LV method. 
 
4.3.1 Design and expression of lentivirus constructs 
LV allows construct inserts of 2.5-5.0 kb and integrates into genomic DNA, allowing for 
prolonged construct expression that remains stable over at least two months in vivo 
(Osten, Dittgen, and Licznerski 2006, Feeley et al. 2006, Sugiyama et al. 2005). This 
contrasts Adenovirus, which can see a complete loss of expression by 4 weeks post 
transduction (Feeley et al. 2006), and Adeno-associated virus (AAV), which only has an 
insert capacity of 2.5 kb. Due to our construct lengths and planned time course 
experiments, LV was chosen over Adenovirus or AAV vectors. 
In order to investigate the role of Cx26 CO2 sensitivity in vivo LV constructs were 
designed to contain the Cx26DN gene, immediately followed by a downstream IRES:Clover 
sequence, all under control of the GFAP promoter (see 4.2.1 Lentivirus design and 
handling), Figure 4.2a. In this way, targeted injections restrict the population of cells that 
are transduced, and the GFAP promoter ensures that the construct is only expressed in 
GFAP+ cells. Owing to the downstream IRES:Clover sequence, visualisation of viral Cx26 
expression was confirmed by soluble Clover fluorescence, and expression in GFAP+ cells 
was confirmed by colocalisation with GFAP immunostaining. GFAP colocalisation and 
morphological examination showed Clover expression to be restricted to glia, with all 
cells expressing Clover also expressing GFAP (Figure 4.2c). The expression of the GFAP 
(an intermediate filament) is not necessarily ubiquitous in cells; therefore, it can be 
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expected that some regions of cells expressing soluble Clover will show no co-localisation 
with GFAP. 
To control for the overexpression of Cx26, a second LV construct was designed to 
insert and express the Cx26WT gene in place of Cx26DN gene. As experiments involving 
Cx26DN and Cx26WT constructs were blinded, with identical experimental parameters, any 
breathing phenotype observed will be a result of the difference between Cx26DN and 
Cx26WT proteins. As the only difference between these two variants is the K125R and 
R104 mutations, any such phenotype can be concluded to be a consequence of altered 
CO2 sensitivity. 
 
4.3.2 Initial analysis of batch 1 animals showed no breathing phenotype 
Mice aged 12-18 weeks were bilaterally injected with one of two LV constructs to 
introduce either the Cx26DN (n = 9) or Cx26WT (n = 9) gene into glia at the VMS. Injection 
co-ordinates aiming for the retrotrapezoid nucleus (RTN) were chosen and confirmed to 
match those areas studied in comparable respiratory studies and shown to be important 
in various respiratory responses (Guyenet et al. 2016, Huckstepp et al. 2015, Abbott et al. 
2009). This area roughly corresponds to the medial half of the RTN, however the extent 
of virus spread seen in these experiments would cover the lateral part of the RTN as well. 
Whole-body plethysmography was used to measure breathing frequency, tidal 
volume (VT), and minute ventilation (VE) at weeks 0-4 post-transduction (Figure 4.6). A 
visual examination of frequency (Figure 4.6, middle panels) shows high variation in the 
measurements, but no visible difference between mice injected with the Cx26WT or 
Cx26DN construct at any time point or CO2 level. A Three-way mixed ANOVA (3WXA) 
calculated no statistical difference in frequency between virus groups at any CO2 level, at 
any week. 
A visual examination of tidal volume (VT) data (Figure 4.6, left panels) shows 
higher variation at higher CO2 levels, and a very subtle difference between WT and DN 
groups at week 3, 6% CO2. Given that LV takes around a week to reach substantial levels 
of expression (Osten, Dittgen, and Licznerski 2006, Feeley et al. 2006) and that Cx26DN 
takes 6 days to take effect in vitro (Figure 3.9), we anticipated that an in vivo effect 
would take somewhere between 2-3 weeks, which would be consistent with this visual 
interpretation. However, 3WXA calculated no statistical difference, implying that any 
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Figure 4.6  Batch 1: Connexin26-mediated hypercapnic breathing response in conscious mice. 
Mice aged 12-18 weeks were bi-laterally injected at the ventral medullary surface (VMS) to 
introduce either the Dominant Negative Connexin26 (Cx26
DN
) or wild type Connexin26 (Cx26
WT
) 
gene into genomic DNA. Whole-body plethysmography measurements of tidal volume (left), 
frequency (middle), and minute ventilation (right) were recorded for each mouse before 
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acetyltransferase immunostaining (magenta), with overlays showing key histological landmarks, 
and positioning of the ventrolateral respiratory column. b-d) Representative slices showing the 
locations of virus expression (Clover, green) within batch 1 animals. Due to decalibration of 
equipment, within batch 1 there were only some animals that had expression in the RTN (b), with 
the majority showing expression much more caudally - more caudal than the nucleus ambiguous 
(c, d). Bottom panels show magnification of the dashed rectangular overlays in the top panels. In 
the diagrams up is dorsal, down in ventral, left is rostral, and right is caudal. R, rostral 
chemosensitive site; I, Intermediate chemosensitive site; C, caudal chemosensitive site; NA, 
nucleus ambiguous; VII, facial nucleus; preBot, pre-Bötzinger Complex; Bot, Bötzinger Complex; 
rVRG, rostral ventral respiratory group; RTN, retrotrapezoid nucleus; VMS, ventral medullary 
surface. Scale bars: (a); 1mm, (b-d top panels); 1mm, (b-d bottom panels); 200μm (b), 100μm (c), 
200μm (d).  
 
In light of this expression-based subdivision in batch 1, animal data was 
reanalysed only including animals showing expression within the caudal chemosensitive 
area. Reanalysis of animals with expression in the RTN was not carried out due to 
insufficient numbers. 
 
4.3.4 Batch 1 animals with expression at the caudal chemosensitive region show a 
blunted tidal volume response to 6% hypercapnia  
Upon reanalysis of batch 1 frequency and tidal volume, including only those animals with 
expression in the caudal chemosensitive area, there was again no visual or statistical 
(3WXA) difference in frequency between WT and DN groups (Figure 4.8, middle panels). 
This suggests that expression of Cx26DN had no effect on adaptive changes in breathing 
frequency. 
Interestingly, when comparing tidal volume (Figure 4.8, left panels) the subtle 
difference that was seen between WT and DN groups at week 3, 6% CO2 (Figure 4.6, 
week 3 left panel), becomes more apparent when only animals with caudal expression 
are compared (Figure 4.8, week 3 left panel). Nevertheless, 3WXA still found no 
statistical difference in tidal volume between WT and DN groups.  
Given that any effect resulting from LV-introduction of Cx26DN was anticipated to 
take between 2-3 weeks to manifest, and the recent data suggesting Cx26 expression in 
caudal GFAP+ cells control adaptive changes in tidal volume, it seems too coincidental 
that this difference at week 3, 6% CO2, gets more pronounced upon selecting for caudal 
expression. As such, despite the lack of statistical support from the 3WXA, this difference 
at week 3, 6% CO2, was investigated further (Figure 4.9). 
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Figure 4.8  Batch 1 caudal virus expression only: Connexin26-mediated hypercapnic breathing 
response in conscious mice. This data ONLY INCLUDES mice from Batch 1 that were found to 
have expression at the caudal chemosensitive site of the ventral medullary surface, as opposed 
to those that only had expression more rostrally. Mice aged 12-18 weeks were bi-laterally 
injected at the ventral medullary surface (VMS) to introduce either the Dominant Negative 
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Connexin26 (Cx26
DN
) or wild type Connexin26 (Cx26
WT
) gene into genomic DNA. Whole-body 
plethysmography measurements of tidal volume (left), frequency (middle), and minute 
ventilation (right) were recorded for each mouse before transduction (week 0) and each week, 
for four weeks, post-transduction (weeks 1-4). At each time point, recordings were taken at 0%, 
3%, 6%, and 9% CO2. Data is plotted by week, grouping animals based on whether they are 
expressing Cx26
DN
 (black circles, n = 8) or Cx26
WT
 (empty circle, n = 6). At week 3 a difference in 
adaptive changes in tidal volume, between mice expressing Cx26
WT
 and Cx26
DN
, could be inferred 
- especially at 6% CO2. A three-way mixed ANOVA was carried out separately for tidal volume, 
frequency, and minute ventilation in the statistical package SPSS, testing across the variables: 
week, CO2 level, and the type of virus transduced with (Cx26
WT
 or Cx26
DN
), as well as the 
interactions between them. In all three tests, a significant difference was calculated only for CO2 
level – i.e statistical comparisons across the entire dataset did not support the visual indication of 
a tidal volume phenotype. Recordings were taken in the CED software Spike2, with tidal volume 
calculated as the difference between peak and trough values after waveform averaging (with 
respect to each breath), frequency calculated as the number of breaths per minute, and minute 
ventilation calculated as the product of the two. All recordings were calibrated using values 
obtained by puffing 0.1mL, 0.2mL, and 0.5mL volumes of air into the chamber (using a 1mL 
syringe). Boxes show the interquartile range. The median is indicated as a horizontal line within 
the box, and the mean is represented by a cross within the box. Range bars show minimum and 
maximum values. 
 
When considering week 3 recordings as an isolated experiment (i.e. omitting 
repeated measurements from other weeks) a two-way mixed ANOVA (2WXA) does 
reveal a statistical difference (p = 0.019), with post-hoc testing calculating significant 
differences between WT and DN groups at both 6% (0.005, one-tailed) and 9% (0.049, 
one-tailed) CO2. It is probable that no statistical significance is found when testing across 
all weeks in the 3WXA due to the high variation across weeks (Figure 4.9b) – WT, 2.9±0.5 
μL/g; DN, 2.7±0.5 μL/g. High VT variation has been observed in other plethysmography 
studies (Stunden et al. 2001, Davis et al. 2006). 
In an attempt to deduce what caused the difference seen at week 3, 6% CO2, the 
few animals with no expression in the caudal area (2.9±0.2 μL/g, n = 4) were compared 
to animals in the WT (3.3±0.5 μL/g, n = 6) and DN (2.6±0.5 μL/g, n = 8) groups that did 
show expression caudally (Figure 4.9c). There was no significant difference between 
animals with no caudal expression and either group, which raises the question of 
whether animals expressing Cx26DN caudally exhibited a reduced HCVR or whether 
animals expressing Cx26WT caudally exhibited a heightened HCVR.  
By semi-quantitatively scoring expression at the caudal chemosensitive site, we 
may glean insight into the effect of each variant. Plotting relative virus expression scores  
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Figure 4.9  Batch 1: possible tidal volume phenotype in response to 6% CO2 at 3 weeks post-
transduction. This data compares tidal volume (VT), from mice in batch 1, based on the scored 
virus expression at the caudal chemosensitive site of the ventral medullary surface (VMS). a) 
Whole-body plethysmography measurements of VT in response to hypercapnic conditions, 
recorded at 3 weeks post-transduction. Taken as an isolated experiment (i.e. not including 
repeated measurements from weeks 0, 1, 2, or 4), a two-way mixed ANOVA reveals that a 
significant difference in VT is evident for the interaction between virus expressed and CO2 level (p 
= 0.019). Post hoc testing revealed a significant difference in VT at 6% between animals 
expressing the Cx26
DN
 virus construct in the caudal area (black circles, n = 8) and those animals 
expressing the Cx26
WT
 virus construct in the caudal area (empty circle, n = 6). b) Change in VT, at 
6% CO2, across weeks 0-4. Despite a difference at weeks 3, no significant interaction is calculated 
between virus expressed and week, presumably due to the high variation in VT measurements 
that can be seen across the time course. c) VT recorded at week 3, 6% CO2. One-way ANOVA 
shows a significant difference in VT depending on group, with post hoc tests revealing a 
difference between animals expressing Cx26
WT
 and Cx26
DN
 at the caudal chemosensitive region (p 
= 0.005, one-tailed). Mice with no expression in the caudal region are shown (empty triangles) as 
a comparison. d) VT with respect to the level of expression in the caudal chemosensitive area of 
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the VMS. Using the Clover fluorescence as an indicator of viral-Cx26 expression, a semi-
quantitative score was assigned to each animal based on the Clover expression (apparent under 
confocal microscopy) that was seen at the caudal chemosensitive site of the VMS. The difference 
between Cx26
WT
 and Cx26
DN
 groups increases with the level of virus expression. All statistical 
tests were carried out in the statistical package SPSS. Boxes show the interquartile range. The 
median is indicated as a horizontal line within the box, and the mean is represented by a cross 
within the box. Range bars show minimum and maximum values. 
 
against VT (Figure 4.9d) indicated that there is no correlation between VT and the level of 
Cx26WT expression at the caudal site. However, there does appear to be a negative 
correlation between VT and the level of Cx26DN expression at the caudal site. This 
indicates that increasing the number of glia expressing Cx26DN in the caudal area has a 
negative effect on adaptive changes in tidal volume. 
Examination of these results suggests that expression of Cx26DN in glia within the 
caudal chemosensitive area might reduce adaptive changes in tidal volume at 3 weeks 
post-transduction. However, proper statistical analysis including all repeated measures 
across weeks 0-4 does not support any such difference. Furthermore, if a phenotype is 
observed 3 weeks post transduction, there is question as to why this phenotype cannot 
be perceived 4 weeks post transduction.  
When comparing VE of caudal-expressing batch 1 animals (Figure 4.8, right 
panels), the visual difference in VT at week3, 6%, appears to be replicated in 5 of the 8 
animals from the DN group, with the remaining three showing values similar to those 
from the WT group – perhaps as these 3 were able to compensate for lower VT by 
increasing their breathing frequency. Other than at weeks 3, there is no visual or 
statistical difference between WT and DN at any timepoint or CO2 level.  
 
4.3.5 Batch 2 animals showed no breathing phenotype and accurate injection sites 
LV injections into animals from batch 1 were inaccurate, due to faulty apparatus, and 
shed no light on the chemoreceptive role of Cx26 in RTN glia. Therefore, after fixing the 
apparatus and reconfirming injection coordinates (with fluorosphere beads), a second 
blinded study was carried out in the same manner as batch 1 (WT, n = 9; DN, n = 8). For 
the second batch some refinements were made to the plethysmography apparatus and 
recording (see 4.2.5 Whole-body plethysmography). Also, two smaller LV injections were 
given per side of the brain (0.250 μm apart in the rostrocaudal axis) in an attempt for 
better virus coverage along the rostrocaudal axis of the RTN. 
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A visual examination of frequency data (Figure 4.10, middle panels) shows 
significantly lower variation than that seen in batch 1, and no visible difference between 
mice injected with the Cx26WT or Cx26DN construct at any time point or CO2 level. A 3WXA 
calculated no statistical difference in frequency between virus groups at any CO2 level, at 
any week. A visual examination of tidal volume (VT) data (Figure 4.10, left panels) shows 
higher variation at higher CO2 levels, but no visible difference between WT and DN 
groups. A 3WXA calculated no statistical significance for tidal volume between virus 
groups was found. Appropriately, VE (Figure 4.10, right panels) also shows no visual or 
statistical difference between WT and DN at any timepoint or CO2 level. 
Unlike batch 1, the immunohistochemistry on batch 2 animals showed consistent 
virus expression in the RTN (Figure 4.11), thus there was no need for group sub-division 
or reanalysis. In light of this, data from batch 2 animals suggests that expression of 
Cx26DN in glia within the RTN has no affect on the HCVR exhibit by these animals, as there 
was no difference in either breathing frequency or tidal volume measurements between 
DN and control (WT) groups. 
For comparison with data from batch 1 animals, a more detailed analysis of batch 
2 tidal volume data was carried out at the conditions most expected to show a 
phenotype, i.e. week 3, 6% (Figure 4.12). No statistical difference was found when 
treating week 3 measurements as an isolated experiment (Figure 4.12a), despite removal 
of the high variation that was again seen across weeks 0-4 (Figure 4.12b). There was no 
difference between WT and DN groups even when considering only data from 6% CO2 at 
week 3 (Figure 4.12c), and no correlation, for either virus group, between LV construct 
expression in the RTN and tidal volume. 
 
4.3.6 Different GFAP+ cell morphologies at the ventral medullary surface 
For LV experiments in this chapter transcription was driven by a GFAP promoter and 
therefore a range of glial cells were transduced along the VMS. Although different glia 
morphologies have been reported throughout the brain (Matyash and Kettenmann 2010, 
Kettenmann and Verkhratsky 2016) there has been little characterisation specifically in 
the VMS – with the exception of some more dorsal astrocytes within the preBötzinger 
complex (Sheikhbahaei et al. 2018). In our LV-GFAP:Cx26DN we observed many different 
morphologies in the rostral and caudal chemosensitive areas, which suggests a range of 
GFAP+ cell subtypes (Figure 4.13 and Figure 4.14). 
	 144	
Figure 4.14  Glia morphologies in the caudal chemosensitive region of the ventral medullary 
surface. a) Histological landmarks shown by choline acetyltransferase immunostaining 
(magenta), identifying the rostrocaudal region (thick dashed rectangle) of cells shown in b-f. b-f) 
Maximum-intensity projections of glia at the ventral medullary surface (VMS) expressing Cx26-
IRES:Clover. Some glia at the ventral surface (glia limitans) have their cell bodies pushed flat 
along the surface, again with processes extending dorsally (white arrows). This cell morphology 
closely matches that of a sub-population of neural-crest cells that have been shown to play a role 
in Connexin26-mediated CO2 chemoreception. The yellow arrow in d points to a possible artery 
or vein bifurcation, as seen by the Y-shaped glial cell arrangement. In the diagrams up is dorsal, 
down in ventral, left is rostral, and right is caudal. Blue; DAPI, magenta; choline acetyltransferase 
immunostaining. Scale bars: (a), 1mm; (b-f), 50μm. In the sections shown in this figure, the 
leptomeninges have mostly fallen away leaving the glia limitans as the outermost layer. 
 
4.4 Discussion 
 
In this section the role that Cx26 plays in adaptive changes in breathing frequency and 
adaptive changes in tidal volume is considered in turn, at both the RTN and the caudal 
chemosensitive areas.  
Also, in this section selected data from Cx26-KO studies performed by Xintao 
Zhang (which have been alluded to previously as “personal communication from Nicholas 
Dale and Georgy Koentges”) is included (Supplement figure 4.1 and Supplement figure 
4.2) due to its importance in interpreting the results of this chapter. 
 
4.4.1 The role that Connexin26 CO2 sensitivity plays in adaptive changes in breathing 
frequency at the rostral chemosensitive site 
Cx26 is not expressed in neurons along the VMS, however it is within the leptomeninges 
and in GFAP+ cells of the glial limitans, including tracts of cells alongside penetrating 
blood vessels (Huckstepp et al. 2010a, Nagy et al. 2001, Solomon et al. 2001, Mercier and 
Hatton 2001), Supplement figure 4.1b. Recent analysis has calculated Cx26 expression to  
extend 87±10 μm into the rostral chemosensitive area (Supplement figure 4.1b, top 
right panel) and has shown that, despite its ubiquitous expression, specific removal of 
Cx26 from in the leptomeninges has no effect on breathing (personal communication 
from Nicholas Dale and Georgy Koentges). As brains from our experiments showed clear 
transduction in cells of the glial limitans (Figure 4.7 and Figure 4.11) we have assumed 
that Cx26DN expression successfully removed CO2-mediated Cx26 hemichannel opening, 
and the subsequent Cx26-mediated ATP release, from glia in these transduced areas. This 
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expectation is based on our in vitro dye loading results, which showed Cx26DN removes 
Cx26 opening under hypercapnic conditions in vitro (see 3 Characterisation of co-
assembly and CO2-Insensitivity of a Connexin 26 dominant negative mutant). It must be 
noted however that ATP release from transduced glia was not recorded, and therefore 
our interpretations should only be considered putative until more data is provided.  
When LV-GFAP:Cx26 variants were expressed at the rostral chemosensitive site 
(RTN), there was no difference in breathing frequency between WT and DN groups 
during hypercapnia (at any CO2 level, at any week) (Figure 4.10). This suggests that Cx26 
CO2 sensitivity plays no role in modulating breathing frequency at the rostral 
chemosensitive site – as its removal has no effect on adaptive changes in frequency. 
Indeed, given that peripheral chemoreceptors are responsible for a very large amount of 
frequency control (Berkenbosch et al. 1979), and that GPR4 appears to have filled the 
role for frequency control via central chemoreceptors (Kumar et al. 2015), such a result is 
perhaps unsurprising.  
This result is consistent with our hypothesis that Cx26-mediated ATP release 
influences adaptive changes in tidal volume, working in parallel with mechanisms that 
influence the frequency side of the HCVR (such as those associated with GPR4). This 
result is also consistent with data from GFAP:Cx26-KO mice, which showed no difference 
in adaptive changes in breathing frequency between wild-type mice and mice with 
conditional deletion of Cx26 from GFAP+ cells (Supplement figure 4.1c). 
An alternative explanation as to why there was no change in breathing frequency, 
when Cx26DN is expressed, is that under hypercapnic conditions Cx26 hemichannels are 
opened by more than just CO2 and therefore we see no phenotype as ATP is still 
released. However this is unlikely as other logical candidates for a hypercapnia-evoked 
Cx26 response (pH, HCO3-, [Ca2+]i) have been shown to have no effect on Cx26 
hemichannel gating (Huckstepp et al. 2010b) (see 2 Gating determinants of Connexin26 
hemichannels: intracellular calcium and CO2 sensitivity of a pathological mutation).  
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Supplement figure 4.1  Connexin26 expression in GFAP+ cells contributes to respiratory 
chemoreception. a) Biosensor recordings of CO2-evoked ATP release from horizontal slices of the 
ventral medullary surface (VMS), recorded from GFAP:Cx26-WT and GFAP:Cx26-KO mice. 
Deletion of Cx26 from GFAP
+
 cells drastically reduces CO2-evoked ATP release from the rostral 
(top) and caudal (bottom) chemosensory areas. Each trace is an average of 5 experiments, 
dashed line indicates the standard error. b) Top panels: VMS parasagittal section of the rostral 
chemosensitive area from a WT mouse showing immunostaining for GFAP (red), laminin 
(magenta), and Cx26 (green), with Hoechst staining (blue). Cx26 expressing extends 87 ± 10 μm 
into the rostral WT chemosensitive area (dotted line). Bottom pannels: Equivalent  section from a 
GFAP:Cx26-KO mouse. Cx26 staining remains in the leptomeninges, but is completely absent 
from parenchyma (asterisk), thus demonstrating that it is normally expressed in GFAP
+
 cells. 
Right panels show Hoechst and Cx26 staining only. GL, glia limitans; LM, leptomeninges; SAS, 
subarachnoid space. Scale bars, 20 μm.  c) Cumulative probability plots of respiratory rate (left) 
and tidal power (right) for mice at 0% (black circles), 3% (red circles), and 6% (blue circles) 
inspired CO2. The lighter filled circles represent data from GFAP:Cx26-KO mice whilst the fully 
filled circles represent data from GFAP:Cx26-WT. Tidal power is obtained from a power spectrum 
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created by FFT analysis (Spike2 software) and is intrinsically related to tidal volume – it 
corresponds to the integral of the breathing trace. There is no difference in respiratory rate 
between wild type and knockout mice at any CO2 level. The tidal power of breathing for 
GFAP:Cx26-KO mice is significantly less than WT mice at 6% inspired CO2, but no different at any 
other CO2 level. Data and  figures were produced by Xintao Zhang. 
 
4.4.2 The role that Connexin26 CO2 sensitivity plays in adaptive changes in tidal 
volume at the rostral chemosensitive site 
When LV-GFAP:Cx26 variants were expressed at the rostral chemosensitive site (RTN), 
there was no difference in tidal volume between WT and DN groups during hypercapnia 
(at any CO2 level, at any week) (Figure 4.10). Expression of Cx26DN was in the correct 
location, and the transduction coverage with the RTN was good. Based on our 
assumption that Cx26DN successfully removes glial Cx26 CO2 sensitivity, and subsequent 
ATP release, this result suggest that Cx26 CO2 sensitivity plays no role in modulating tidal 
volume at the rostral chemosensitive site – as its removal has no effect on adaptive 
changes in tidal volume. This does not support our hypothesis that Cx26-mediated ATP 
release influences adaptive changes in tidal volume, and therefore the hypothesis is 
rejected. 
These results are consistent with the conclusion made from Cx26-KO studies. In 
these investigations floxed Cx26 mice (the same used for experiments in this thesis) were 
crossed with GFAP-Cre mice or Wnt1-Cre mice, resulting in tissue-wide KO of the Cx26 
gene in either all GFAP+ cells or (almost all) neural crest cells (NCCs), respectively. The 
Wnt1-Cre transgene is not expressed in astrocytes (or their progenitors), and so 
astrocytes in Wnt1:Cx26-KO mice still expressed Cx26. On the other hand, all NCCs cells 
expressing Cx26 also expressed GFAP.  Furthermore, NCCs were only found in the caudal 
(not rostral) chemosensitive area. Whole-body plethysmography showed a reduction in 
adaptive changes in tidal volume (but not frequency) in both GFAP:Cx26-KO (Supplement 
figure 4.1c) and Wnt1:Cx26-KO mice (Supplement figure 4.2c). This phenotype was 
observed in mice aged 3-7 months. The phenotype for both sets of mice were similar (if 
anything larger in Wnt1:Cx26-KO mice), which suggests that only Cx26 expression in the 
caudally-located NCCs contributes to adaptive changes in tidal volume – and that Cx26 in 
all other GFAP+ cells provides no additional respiratory drive (compare Supplement 
figure 4.1c and Supplement figure 4.2c). This suggests that Cx26 expression in the RTN is 
not necessary for chemoreception.  
	 148	
 
 
Supplement figure 4.2  Connexin26 expression in neural crest cells of the caudal medulla 
contributes to respiratory chemoreception. a) Biosensor recordings of CO2-evoked ATP release 
from horizontal slices of the ventral medullary surface (VMS), recorded from Wnt1:Cx26-WT and 
Wnt1:Cx26-KO mice. Deletion of Cx26 from Wnt1
+
 cells has no effect on CO2-evoked ATP release 
from the rostral chemosensory area (top), but drastically reduces it in the caudal chemosensitive 
area (bottom). Each trace is an average of 5 experiments, dashed line indicates the standard 
error. b) Anatomical characterization of the GFAP+ neural crest cells in caudal medulla. 
Genetically marked neural crest cells (vGFP, green) can be seen to express Cx26 (red) and GFAP 
(magenta) and reach deep into the brain parenchyma. Image from a confocal z-stack, maximum 
intensity. Scale bar, 20 μm. c) Cumulative probability plots of respiratory rate (left) and tidal 
power (right) for mice at 0% (black circles), 3% (red circles), and 6% (blue circles) inspired CO2. 
The lighter filled circles represent data from Wnt1:Cx26-KO mice whilst the fully filled circles 
represent data from Wnt1:Cx26-WT. Tidal power is obtained from a power spectrum created by 
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FFT analysis (Spike2 software) and is intrinsically related to tidal volume – it corresponds to the 
integral of the breathing trace. There is no difference in respiratory rate between wild type and 
knockout mice at any CO2 level. The tidal power of breathing for Wnt1:Cx26-KO mice is 
significantly less than WT mice at 6% inspired CO2, but no different at any other CO2 level. Data 
and  figures were produced by Xintao Zhang. 
 
It is unknown what effect ablating Cx26 from all GFAP+ or Wnt1+ cells from birth 
has on the development of the respiratory networks. For example, connexin dependent 
signalling is important in neural progenitor cell proliferation and the maturation of 
neuronal networks (Malmersjö et al. 2013, Jäderstad et al. 2010), and, of particular 
importance for these studies, the e-pF (which later becomes the pFL that adjoins the RTN)  
requires connexins for embryonic synchronisation of its oscillator (Fortin and Thoby-
Brisson 2009). How much of this development is reliant on Cx26 is unknown, however it 
is feasible for some form of compensation to occur in response to the absence of Cx26 in 
supporting glial cells. Such compensation could mask the contribution that Cx26 normally 
plays in GFAP+ cells of wild-type mice. However, data in this chapter would also suggest  
that Cx26 in GFAP+ cells of the RTN are not necessary for chemoreception. 
Recently it has been suggested that during hypercapnia astrocytic release of PGE2 
occurs in a connexin-mediated manner and acts alongside ATP to increase respiratory 
drive (see 1.2.7 Glia and ATP release). It was suggested that hypercapnic release of PGE2 
might occur through Cx26 hemichannels (Forsberg et al. 2016, Forsberg, Ringstedt, and 
Herlenius 2017). In this chapter we assume that CO2-evoked Cx26 hemichannel opening 
was removed from RTN glia, however there was no effect (decrease or increase) on the 
HCVR. This suggests that, under physiological conditions in conscious mice, either PGE2 
release does not occur through Cx26 hemichannels or (as PGE2 data was obtained from 
neonatal mice) that the release of PGE2 from the RTN ceases to be important in central 
chemoreception some time before 3 months.  
 
4.4.3 Connexin26-mediated ATP release in the RTN  
Non-Cx26 mediated mechanisms of ATP release, which are pH-dependent, have been 
reported in astrocytes within the RTN (Gourine et al. 2010, Wenker et al. 2010). 
However, at the VMS only very small changes in pH occur in response to physiological 
changes in pCO2 (Shams 1985), with pH maintained between 7.4 and 7.25 (Fencl 1971, 
1986) and a pCO2 >100mmHg required for pH to drop below pH 7.1 (Katsura et al. 1992b, 
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Katsura, Ekholm, and Siesjö 1992a). Therefore, it is unknown to what extent these pH-
dependent mechanisms will exert their effect under mild-moderate hypercapnia 
conditions. Nevertheless, these mechanisms should be taken into consideration when 
evaluating ATP-mediated hypercapnic responses as certain sources of data do show that 
they occur within realistic physiological conditions (see 1.2.7 Glia and ATP). 
Regardless of the roles of pH-mediated ATP release, biosensor recordings show 
clear CO2-mediated ATP release in the RTN, which is completely abolished when Cx26 is 
ablated from GFAP+ cells (Supplement figure 4.1a, top panel). Given this, if Cx26-
mediated ATP release in the RTN was necessary for chemoreception, experiments in this 
chapter would have been expected to yield at least a hint of a phenotype (Figure 4.10 
and Figure 4.12). Therefore, although we do not confirm the status of ATP release in 
these experiments it is inferred that, in the RTN of mice aged 3-5 months, CO2-evoked 
ATP release via Cx26 hemichannels is not necessary for central CO2 chemoreception. 
Whether Cx26-mediated ATP release in the RTN has a more pivotal role during other 
stages of rodent life is yet to be answered. 
Results from this chapter suggest that such Cx26-mediated ATP release does not 
contribute to the HCVR (frequency or tidal volume) in the RTN. This raises the question 
as to whether there is a role for Cx26-mediated ATP release in the RTN of adult mice, 
other than a redundant chemoreception system. Perhaps the most likely alternative role 
is to cause vasoconstriction on local blood vessels. Usually blood vessels dilate during 
hypercapnia in order to increase O2 supply to, and CO2 removal from, tissue. However, it 
has recently been discovered that vascular tone in the RTN is maintained during 
hypercapnia via puringergic signalling (Hawkins et al. 2017). This would help ensure that 
CRC receive accurate and consistent chemosensory information during hypercapnia. 
Given that ATP induces vasoconstriction in other areas of the brain (Kur and Newman 
2014, Peppiatt et al. 2006), astrocytic ATP release in the RTN is a likely candidate to 
mediate this effect. Alternative roles for Cx26-mediated ATP release in the RTN are put 
forward in the next chapter (see 5.2 Connexin26 mediated ATP release in RTN - what 
does it do if it does not regulate breathing?).  
It should be noted that, despite the spread of the virus, there was very little 
transduction of cells in the area medial to the RTN, where serotonergic raphé neurons 
reside. These raphé neurons do not fall within the traditionally defined rostral 
chemosensitive area however have been found to be chemosensitive (Richerson 2004, 
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Teran, Massey, and Richerson 2014, Li, Zhou, and Nattie 2006, Messier, Li, and Nattie 
2004), and might benefit from glial ATP release in their role of generating a 
chemoreceptive signal. As has been mentioned, GFAP:Cx26-KO mice might have 
undergone compensation that masked the contribution of rostral GFAP+ cells and 
therefore we cannot rule out the possibility that Cx26-mediated ATP release is important 
in regulating the HCVR at these more medial sites.  
 
4.4.4 The role that Connexin26 CO2 sensitivity plays in adaptive changes in breathing 
frequency at the caudal chemosensitive site  
When LV-GFAP:Cx26 variants were expressed at the caudal chemosensitive site, there 
was no difference in breathing frequency between WT and DN groups during 
hypercapnia (at any CO2 level, at any week) (Figure 4.8). Based on our assumption that 
Cx26DN successfully removes glial Cx26 CO2 sensitivity, and subsequent ATP release, this 
result suggest that Cx26 CO2 sensitivity plays no role in modulating breathing frequency 
at the caudal chemosensitive site – as its removal has no effect on adaptive changes in 
frequency. 
This result supports the unpublished Cx26-KO data showing that the removal of 
Cx26 from a sup-population of GFAP+ cells in the caudal chemosensitive area reduces 
adaptive changes in tidal volume but has no effect on adaptive changes in breathing 
frequency (Supplement figure 4.2c). As with the RTN, this is perhaps unsurprising given 
the major contribution to frequency control that has already been attributed to 
peripheral chemoreceptors and GPR4. 
 
4.4.5 The role that Connexin26 CO2 sensitivity plays in adaptive changes in tidal 
volume at the caudal chemosensitive site 
When LV-GFAP:Cx26 variants were accidently expressed at the caudal chemosensitive 
site (RTN), a 3WXA revealed no statistical difference in tidal volume between WT and DN 
groups during hypercapnia (at any CO2 level, at any week) (Figure 4.8). However, at week 
3 a lower tidal volume can visually be seen at 6% in mice expressing Cx26DN, with a 21% 
reduction in mean tidal volume compared to animals expressing Cx26WT. This difference 
is supported by statistical analysis when week 3 is taken as an isolated dataset (Figure 
4.9a,c) and suggests that removal of Cx26 CO2 sensitivity from glia in the caudal 
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chemosensitive area reduces adaptive changes in tidal volume. This possibility is further 
supported as tidal volume decreased with increasing Cx26DN virus expression (Figure 
4.9d).  
Isolated analysis of week 3 data also reveals a decrease in the DN group at 9% CO2 
(p = 0.049, one tailed). This is barely significant however supports the difference seen at 
6% CO2. In contrast, at 3% CO2 (week 3) no difference is seen, presumably as this level of 
hypercapnia was insufficient to see an effect of Cx26DN expression. Exposure of animals 
to 9% CO2 is really pushing physiological conditions, and so this data might not accurately 
reflect systems that are usually responsible for coordinating a HCVR. At this level of CO2 
pH is likely driven down to levels at which pH-mediated ATP release readily occurs 
(Gourine et al. 2010, Wenker et al. 2010), which would result in compensation for the 
ATP not being released via Cx26, and subsequently increase respiratory drive. 
Nevertheless, if there is Cx26-mediated control of tidal volume at 6% CO2 it stands to 
reason that the response occurring at 9% is also, at least in part, mediated by Cx26.  
The tidal volume phenotype at 6% is consistent with GFAP:Cx26-KO studies, 
which identified a small population of GFAP+ neural crest cells that were responsible for 
Cx26-mediated control of tidal volume, at 6% but not 3% CO2, in this same caudal area 
(Supplement figure 4.2c). Although not definitive, this consistency further supports the 
tidal volume phenotype seen at week 3, 6% CO2, in mice expressing Cx26DN in the caudal 
medulla. 
One inconsistency of this conclusion is that the phenotype observed 3 weeks post 
transduction is not discernible in recordings taken a week later. We anticipated Cx26DN 
would require 2-3 weeks, from LV-GFAP:Cx26DN transduction, to take effect; needing 
time to be expressed in sufficient quantities, and then for heteromeric connexons to 
replace potential connexon turnover stores, and finally for the expression of heteromeric 
hemichannels in the plasma membrane to overcome the function of any remaining 
Cx26WT homomeric hemichannels. This explains why a phenotype was not observed until 
week 3. It is possible that the phenotype disappears at week 4 due to compensation from 
other chemoreception mechanisms. Although this may seem fast for compensation to 
occur, owing to the importance of breathing the respiratory system is known to be 
capable of such adjustments. For example, in goats carotid sinus nerve denervation led 
to a 60% loss of the HCVR and an inability to regulate blood gases during room air 
breathing; however this was rectified after just 2 weeks (Pan et al. 1998). 
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The data from mice with LV expression in the caudal chemosensitive data, 
alongside that from Cx26-KO studies, indicates that Cx26 CO2 sensitivity in the caudal 
chemosensitive area is highly likely to be important in modulating tidal volume. If this 
result proves to be valid it would demonstrate the role of Cx26 in the respiratory 
response of conscious animals. Furthermore, it would evidence the progression from 
identification and mutation of the CO2-binding motif in Cx26, through to confirmation of 
the very breathing phenotype that was predicted to result from such a mutant. 
We expect that the tidal volume phenotype was only subtle as a consequence of 
accidentally targeting the caudal chemosensitive area. Therefore, expression in the 
caudal area has not been optimised to transduce these caudal cells reliably. Sub-optimal 
expression of Cx26DN is likely to have reduced the effect size in these studies. As such, 
even an indication that Cx26DN expression in the caudal medulla affected tidal volume 
warrants the need to purposely target this area to confirm whether or not Cx26DN 
expression reduces adaptive changes in tidal volume. To this end, the data that has been 
collected from mice with expression in the caudal chemosensitive area should be 
considered a (unintentional) pilot study for a full study, which will use the LV-GFAP:Cx26 
constructs to comprehensively investigate the role of Cx26 CO2 sensitivity in glia within 
this caudal chemosensitive area. (see 4.4.8 Future work: design of a full study to 
investigate the role of Connexin26 CO2 sensitivity in glia within the caudal chemosensitive 
site). 
As with transduction in the rostral medulla, caudal transduction did not appear to 
spread too far medially into the vicinity of the chemosensitive raphé nuclei, and so we 
cannot comment on the role of Cx26-mediated ATP in this caudomedial region of the 
VMS. This being said, immunohistochemistry was less clear in the caudal area and so it is 
possible that, given their long processes, some of the transduced cells made connections 
as far as these raphé neurons.  
 
4.4.6 Summary of the role Connexin26 CO2 sensitivity plays in chemoreception at the 
ventral medullary surface 
Based on our assumption that Cx26DN successfully removes glial Cx26 CO2 sensitivity, and 
subsequent ATP release, from our data we deduce that Cx26 CO2 sensitivity plays no role 
in modulating breathing frequency or tidal volume in the RTN. We also conclude that 
Cx26 CO2 sensitivity plays no role in modulating breathing frequency in the caudal 
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chemosensitive area. However, our data suggests that Cx26 CO2 sensitivity could play an 
important role in modulating tidal volume in the caudal chemosensitive areas (Table 4.1). 
A given chemosensory signalling pathway might be reasoned to influence only 
one of breathing tidal volume or frequency due to the pathway affecting either the 
amplitude or the number of the signals it produces. For example, Cx26-mediated ATP 
release at the caudal site might affect only tidal volume because glial efferents send 
signals to the cVLM which then send larger signals to the preBotC (resulting in deeper 
breaths). On the other hand, chemoreceptive pathways responsible for modulating 
breathing frequency can be imagined to act by increasing the number of signals that are 
received by the integrating nuclei (thereby increasing the number of breaths produced). 
 
Table 4.1  Summary of the role that Cx26 hemichannels play in chemoreception at 
different chemosensitive sites at the ventral medullary surface 
 Breathing Frequency (Fr) Tidal Volume (VT) 
Retrotrapezoid nucleus No role No role 
Caudal chemosensitive 
area 
No role Prospective rolea 
a experiments are to be repeated to confirm/reject observations made in this study 
 
4.4.7 Glia morphologies could prove important for function  
Differences between glial populations are proving to be as varied and important as 
different neuronal populations (Jäkel and Dimou 2017). Recently, chemosensitive glia in 
the VMS have started to be characterised (Sheikhbahaei et al. 2018, Forsberg, Ringstedt, 
and Herlenius 2017), which will help begin to build up a picture as to how we should 
categorise these glial populations and what their functions are. It has been noted that 
central chemosensitive cells in the VMS, including astrocytic glial cells, are often close to 
the surface of the glial limitans and/or have cell bodies or processes in juxtaposition to 
penetrating blood vessels (Richerson 2004, Gourine et al. 2010, Wenker et al. 2010, 
Huckstepp et al. 2010a). This stands to reason as the VMS is affluently supplied with 
blood vessels and so these locations would allow for a more accurate measurement of 
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blood pCO2, thereby making these cells highly suitable for directing a HCVR or other 
hypercapnic responses. 
Expression of GFAP-driven Clover (from LV-GFAP:Cx26:IRES:Clover constructs) 
within the rostral and caudal chemosensitive areas of the VMS highlighted a range of glia 
morphologies (Figure 4.13 and Figure 4.14). Many of these cells have processes that are 
much thicker and less branched than traditional star-shaped astrocytes and reach deep 
into the parenchyma to make connections with cells. Although Cx26 expression is found 
throughout the glia limitans in these areas, it might be that such expression is only a 
property of a sub-population of GFAP+ cells, which would be specifically responsible for 
Cx26-mediated ATP release. Such a sub-population might be identifiable by its 
morphology, with their processes expected to make connections with nearby respiratory 
nuclei. Alternatively, Cx26 expression could be fairly homogenous throughout all GFAP+ 
cells in the chemosensitive areas, and perhaps the morphology of a glial population 
tailors the function of this chemosensory transducer.  
Other groups have reported that astrocytes in the RTN are involved in 
chemoreception via non-Cx26 mediated, pH sensitive, mechanisms (Gourine et al. 2010, 
Wenker et al. 2010). Based on morphology alone we cannot confidently confirm the 
presence of these pH sensitive astrocytes in our sections, although it likely that many 
were transduced. The flat-bodied glia (with few processes and limited branching) that 
were transduced in the caudal chemosensory area (Figure 4.14, white arrows) seem to 
conform to a unique morphology and may be differentiated from the round-bodied glia 
seen in our studies. In fact, the morphology of these flat-bodied cells closely matches 
those of the GFAP+ NCC population that is responsible for Cx26-mediated adaptive 
changes in tidal volume (Supplement figure 4.2b). If these flat-bodied cells are indeed 
from the same NCC population then the reduced tidal volume seen in batch 1 DN mice 
(at week 3, 6% CO2) becomes even more convincing as it links this phenotype to the 
same protein (Cx26) and cells (NCCs) that have been shown to be responsible for 
adaptive changes in tidal volume (Wnt1:Cx26-KO studies, Supplement figure 4.2). 
The morphology of different glial cell types could reflect the niche role for the 
chemosensory transducer/s expressed within them. The long, dorsal-reaching, processes 
seen in many of the transduced cells are highly likely to convey signals from the ventral 
surface to dorsal neurons (e.g. respiratory nuclei of the VLRC). If both CO2- and pH-
mediated chemoreception in glia are important, then perhaps chemoreceptors 
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responsible for each mechanism are expressed in distinct glial populations that have 
morphologies appropriate for sampling from, and signalling to, different locations. If glia 
are receiving different CO2 input signals (e.g. CO2 or pH), or receiving them from different 
locations, glial networks might be set up, connected by gap junction and hemichannel 
signalling. This would act to amplify and summate chemosensory signals in order to 
ensure an effective and efficient HCVR.  	
4.4.8 Future work: design of a full study to investigate the role of Connexin26 CO2 
sensitivity in glia within the caudal chemosensitive site  
Data presented in this chapter suggest that Cx26-mediated ATP release in the RTN is not 
necessary for central chemoreception in mice aged 3-5months. In contrast, when animals 
expressed Cx26DN in the caudal chemosensitive region there was a decrease in tidal 
volume 3 weeks post-transduction at higher CO2 levels (Figure 4.9), and at no other time 
point (Figure 4.8). However, this difference was only statistically supported when testing 
across CO2 level at week 3 (Figure 4.9a), and not when testing across the entire dataset 
(3WXA), or across week at 6% CO2 (Figure 4.9b). Taken together these statistics suggest 
that the differences observed in week 3 are a coincidence. However, considering this 
result was from accidental targeting of the caudal chemosensitive area and so closely 
matches the phenotype from Cx26:KO studies, such a coincidence should not be 
overlooked. 
A positive result in the caudal area would provide proof-of-principle for the use of 
Cx26DN as a genetic tool to investigate CO2-dependent signalling via Cx26 in vivo, thereby 
validating the conclusions made previously in this chapter. As the data looks so 
promising, the tidal volume analysis from batch 1 animals has been considered as a pilot 
study, and the results have been used for a power analysis in order to plan a full study 
into the effect of expressing Cx26DN in glia at the caudal chemosensitive area. 
During these experiments it is likely that some glial cells that do not natively 
express Cx26 are transduced, resulting in the expression of Cx26 (WT or DN) in glia that 
do not usually expresses Cx26. As such, it might be suggested that this could result in 
hyper-chemosensitivity in areas injected with LV-GFAP:Cx26WT. Although analysis 
suggests that Cx26DN is reducing adaptive changes in tidal volume rather than Cx26WT 
increasing adaptive changes (Figure 4.9d), this data is from accidental targeting, has a 
low number of repeats, and has no statistical support. Therefore, this must be 
	 157	
considered preliminary and does not rule out the possibility that the difference between 
WT and DN groups at week 3, 6% CO2, might be (at least in part) due to increased 
chemosensitivity brought about through Cx26WT expression in glia not normally express 
Cx26 – thus increasing the amount of ATP released during hypercapnic conditions. An 
argument could also be made for increased ATP release in response to overexpression of 
Cx26WT in transduced cells that are natively expressing Cx26. For these reasons the full 
study has been designed to include a third group of animals that are not transduced with 
a Cx26 gene, but instead receive a sham injection. This will provide a comparison for 
animals expressing Cx26WT, to control for any abnormal expression of Cx26WT.  
A suitable power calculator could not be found for determining sample size based 
around a 3WXA (i.e. analysing data across all weeks and all CO2 levels). It is assumed that 
the difference in tidal volume at week 3, 6% CO2, is not validated by a 3WXA because of 
the variation across weeks 0-4 (Figure 4.9b). Therefore the power calculation was instead 
carried out in G*power 3.1 (see 4.2.7 Power calculation), based around a 2WXA looking 
at tidal volume at 6% CO2, across all weeks. As a statistical significance has already been 
shown by a 2WXA looking at week 3, across all CO2 levels (Figure 4.9a), this power 
calculation should convey a sample size that will also provide acceptable power from a 
3WXA to analyse the entire dataset (as was performed in this chapter). For the power 
calculation, nonsphericity correction and partial eta squared values (0.674 and 0.148, 
respectively) were calculated from batch 1 animals (pilot study); treating the 4 animals 
with no caudal virus expression as the third group (representing the sham injections).  
The total sample size for a full study, with power 0.8, was calculated to be 36 (i.e. 
12 in each group). This contrasts the sample size of 18 (with groups of n = 8, 6, and 4) 
that was used for the pilot study. With intentional targeting in the caudal chemosensitive 
area and improved plethysmography techniques it is likely that this sample size will result 
in greater power than 0.8, and will also help increase the power of analysis by 3WXA. 
In addition to this study, similar targeting of glial cells underneath the raphé 
neurons might be carried out. These serotonergic nuclei have been shown to be 
chemosensitive but reside more medial than the traditional rostral and caudal 
chemosensitive areas. Therefore, it is possible Cx26 may play a chemoreceptive role at 
these sites by augmenting raphé stimulation (Figure 4.1). 
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5 DISCUSSION 
 
In this chapter we discuss experiments and interpretations from Chapter 4 (see 4 
Progress towards testing the role of CO2-sensitivity via Connexin26 in glial cells as a 
chemosensory regulator of breathing) in a broader context; discussing the limitations of 
the LV-GFAP:Cx26 experiments used, speculating on the importance of Cx26-mediated 
ATP release in the RTN, and commenting on our current understanding of respiratory 
chemoreception. 
 
5.1 Caveats of the LV-GFAP:Cx26 experiments 
	
This thesis has reported on the use of lentivirus to introduce the Dominant Negative 
Cx26 mutant (Cx26DN) in GFAP+ cells as a means of investigating the effect of Cx26 CO2-
sensitivity in specific regions of the VMS, in mice aged 3-4 months. Unlike non-inducible 
KO studies, the LV-GFAP:Cx26 technique prevents any compensation that may drastically 
change the respiratory system during early development, thereby ensuring that Cx26DN is 
introduced to a wild-type system. As Cx26DN expression is dependent on LV transduction, 
it also allows for manipulation of specific populations of GFAP+ cells (rather than global 
KO in all GFAP+ cells).  
Despite its advantages there are still a couple of unknown variables associated 
with this technique. Virus injections involve lowering a capillary through the brain in 
order to access the region of interest. It is possible that the trauma caused by this might 
damage tissue that is important to the behaviour under investigation, thereby 
confounding the data. Such trauma might also cause inflammation. This would be of 
particular relevance to our studies given the recent data implicating PGE2 to central 
chemoreception (Forsberg et al. 2016, Forsberg, Ringstedt, and Herlenius 2017). 
Although this might influence plethysmography measurements up to a week after 
surgery, it is unlikely to affect measurements taken after two weeks post-transduction. 
 
In this thesis the data obtained from our LV-GFAP:Cx26 experiments does not 
fully exclude some alternative interpretations of the results – thereby identifying aspects 
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that could be amended in order to better optimise the study design for future 
experimentation. These are discussed below. 
 
5.1.1 Experimental controls 
In this thesis two groups of animals were studied, those transduced with LV-GFAP:Cx26DN 
and those transduced with LV-GFAP:Cx26WT. These groups were chosen to control for the 
overexpression of Cx26 and therefore be able to attribute any difference between the 
two groups specifically to the mutations in the Dominant Negative, i.e. lack of CO2-
sensitivity. Some may suggest that expression of either Cx26WT or Cx26DN could affect the 
system in some way that alters the HCVR other than influencing CO2 sensitivity. Our data 
would argue against this possibility as no visual or statistical difference in VT or frequency 
was found (grouping DN and WT measurements) between week 0 (pre-transduction) and 
the following 4 weeks (Figure 4.6, Figure 4.8, and Figure 4.10). 
It is plausible however that overexpression of Cx26WT, especially in glia that do 
not normally express Cx26, might create a system that is hypersensitive to CO2 as a result 
of extra Cx26 causing extra CO2-evoked ATP release. It would be expected that this would 
produce animals that are hypersensitive to hypercapnia, resulting in an increased HCVR. 
Although our virus expression data would argue against these possibilities (Figure 4.9d), 
we are aware that repeats were low and there is no statistical support for this 
interpretation. 
In the full study, that has been planned to target the caudal chemosensitive site, a 
second control has been included in the form of a group of animals that will be subjected 
to sham injections (see 4.4.8 Future work: design of a full study to investigate the role of 
Connexin26 CO2 sensitivity in glia within the caudal chemosensitive site). This should 
provide evidence to concretely support any similar interpretations that are made from 
this study. 
Another criticism of the results reported in this thesis may be that there is no true 
positive control – the reduced tidal volume seen with caudal Cx26DN expression at week 
3, 6%, was not supported by a 3-way mixed ANOVA including all data across all weeks. 
Without a clear positive control the study is open to certain criticism regarding the 
functionality of the LV-GFAP:Cx26DN technique. To address this concern, the follow up 
study should include biosensor recordings to confirm that Cx26-mediates ATP release is 
indeed removed from chemosentive regions expressing Cx26DN; thereby validating  our 
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results in the context of our current understanding of glia-mediated chemoreception (see 
1.2.7 Glia and ATP release).  
 
5.1.2 Undetermined roles of Cx26 
Connexins have been shown to play an important role within the central respiratory 
networks (Wenker et al. 2012, Moreira et al. 2015, Forsberg et al. 2016, Huckstepp et al. 
2010a). Although this includes Cx26 hemichannels (Huckstepp et al. 2010a), a role for 
Cx26 gap junctions has not been ruled out. Unpublished data suggests that Cx26 gap 
junctions are also gated by CO2 via the same mechanism that is dependent on K125 and 
R104 residues, but that Cx26 gap junctions close under hypercapnic conditions (personal 
communication from Nicholas Dale). Therefore, the same K125R R104A mutations are 
likely to disrupt Cx26DN gap junction closure during hypercapnia (in the same way they 
disrupt Cx26 hemichannel opening). If this is the case, and Cx26 gap junctions play a role 
in the respiratory network, then the expression of Cx26DN could affect chemoreception in 
ways other than preventing hemichannel mediated ATP release. This introduces an 
unknow variable when interpreting our results. 
It is known that Cx26 is capable of forming heteromeric connexons and 
heterotypic gap junctions with a variety of other members from the connexin family 
(Koval, Molina, and Burt 2014). Included amongst these Cx26 is compatible with Cx32, 
which is also CO2-sensitive (although much less sensitive than Cx26) and is known to be 
expressed in certain glia in the brain, and in the VMS (although precisely which cells in 
the VMS is unknown) (Huckstepp et al. 2010a, Nagy et al. 2003). The function of 
heteromeric Cx26/Cx32 connexon hemichannels or heterotypic Cx26/Cx32 gap junctions 
is unknown. It is also unconfirmed whether Cx26DN coassembles with Cx32 in the same 
way as Cx26WT – although coassembly is likely considering the K125R and R104A 
mutations do not affect the compatibility motifs that have been identified for 
heteromeric (or heterotypic) oligomerisation (Koval, Molina, and Burt 2014) – however if 
Cx26DN and Cx32 were to coassembly the resultant heteromeric connexon would be 
expected to be CO2 insensitive given the dominant negative nature of Cx26DN. Again, 
these unknown variables bring additional complexity when interpreting our results, and 
would do the same were this tool used to investigate Cx26 functions in other tissues 
(that express connexins able to coassemble with Cx26). 
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5.2 Connexin26 mediated ATP release in RTN - what does it do if it does not 
regulate breathing?  
 
Cx26-mediated ATP release in both the RTN and caudal chemosensitive region has been 
shown to occur in vitro, in adult mice brain slices, at a pCO2 that is within the bodies 
physiological range (Supplement figure 4.1a and Supplement figure 4.2b). However, it 
has also been shown in vitro, in neonatal mice, that adenosine in the preBötC is capable 
of inhibiting inspiratory drive (Zwicker et al. 2011). If this were the case in the RTN in our 
mice then this would explain why introduction of the Cx26DN mutant had no effect (i.e. 
the action of Cx26-mediated ATP release is usually inhibited by adenosine). 
Alternatively, it could be argued that Cx26 hemichannels do not open in the RTN 
in vivo, in intact animals. This could be due to some yet unknown mechanism that is 
capable of controlling the microenvironment of the RTN such that, in intact animals, the 
pCO2 never rises high enough for Cx26 carbamylation – and therefore ATP release does 
not actually occur under true physiological conditions. Another reason Cx26 might not 
open in the RTN is due to Cx26 modulators that are acting to close the hemichannels. In 
vivo, negative modulators may be present in higher concentrations in the RTN compared 
to other regions expressing Cx26 (e.g. the caudal area), thus preventing CO2-mediated 
opening. If this is the case, one candidate for such modulation would be taurine. Taurine 
(as well as other aminosulfonates) close Cx26 hemichannels upon acidification (Locke et 
al. 2011, Yu et al. 2007) and is present in higher levels in the rostral ventrolateral medulla 
compared to the caudal ventrolateral medulla (Kubo, Kihara, and Misu 1989). Such 
modulators of Cx26 opening could contribute to a complex concoction within the 
cerebrospinal fluid, which is tightly regulated in order to mediate appropriate 
hypercapnic responses at different chemosensitive sites.  
It should be noted that, although possible, the mechanisms suggested above are 
unlikely to be completely absent in brain slices. Therefore, assuming that Cx26-mediated 
ATP release does occurs in the RTN of adult mice in vivo, our results raise the question as 
to the purpose of this ATP release. We have already discussed a role that it might play in 
maintaining vascular tone in the RTN – thereby ensuring accurate and consistent 
chemosensory signals are received during hypercapnia (see 4.4.3 Connexin26-mediated 
ATP release in the RTN). However, it is possible that in the RTN such ATP release has 
alternative, or additional, functional roles. 
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Given the number of projections, from RTN glia, that terminate on the facial 
nucleus (VII) (Figure 4.13), below we speculate on some alternative pathways, linked to 
VII functions, that Cx26-mediated ATP release might be involved in. 
 
5.2.1 Control of airway resistance 
If glial projections to the VII were able to influence facial muscle movements during a 
hypercapnic response, they could potentially aid efficient ventilation through control of 
airway resistance. 
Central facial palsy arises through defects in the VII, and damage to the mid face 
complex results in the loss of flattening of the nasolabial fold, and subsequent collapse of 
the nostril – this results in difficulty breathing (Gausas 2006). It could be that ATP release 
via Cx26 hemichannels act on the VII neurons of the mid face complex in order to help 
open nasal passages during hypercapnia, thereby reducing resistance and allowing easier 
airflow. Alternatively, the ATP release could act to stimulate the stylohyoid and/or 
digastric laryngeal muscles, which are innervated by the VII (Facialis 1918). During 
inspiration the larynx is stimulated (Green and Neil 1955) and is required to be moved in 
order to not obstruct the trachea (e.g. the vocal cords need to be pulled apart). In this 
way, the larynx also affects airway resistance. 
Under these theories, expression of Cx26DN in the RTN, as in our studies, would 
have resulted in increased resistance in the airways. This would have resulted in difficulty 
breathing but not necessarily a difference in either tidal volume or frequency, as animals 
could exert extra effort to maintain a normal VT and frequency. Testing for a change in 
airway resistance would require a mouse measurement similar to the FEV1 (forced 
expiratory volume in the first second of exhalation), which is measured during human 
spirometry, or better still a measure of specific airway resistance (sRaw, cmH20.s). To 
obtain this recording dual-chamber plethysmography should be implemented. In dual-
chamber plethysmography animals are restrained by means of a rubber neck collar that 
separates a thoracic and a nasal chamber. A plethysmograph is capable of producing a 
trace due to the changes in pressure that only arise due to air flow needing to overcome 
airway resistance (see 4.2.5 Whole-body plethysmography). By recording air flow in the 
two chambers resistance is able to be recorded by means of the time delay between a 
change in pressure in the thoracic chamber and a change in pressure in the nasal 
chamber. 
	 163	
 
5.2.2 Species-specific role 
Given that our studies were performed in mice, species-specific roles should be 
considered when interpreting the results. Species-specific glia have been reported, e.g. 
interlaminar glia present in the cerebral cortex of primate brains is not present in the 
cerebral cortex of rodent brain (Colombo et al. 1995, Colombo 1996, Colombo and Reisin 
2004). Therefore, it could be speculated that many of the surface glia seen at the VMS in 
our study project to the VII to play a role specific to rodents. As rodents are obligate 
nasal breathers this role might be a specialised mechanisms for controlling airway 
resistance, as discussed above (see 5.2.1 Control of airway resistance).  
Alternatively, given that the VMS is the key site for many respiratory-related 
behaviors, such species-specific glia could be involved in a behavior such as sniffing - 
which is drastically more important for rodents and used during exploration. If these cells 
release ATP in response to hypercapnia, then the connections they make with the VII 
might be proposed to control muscles that are involved in increasing/decreasing sniffing 
under hypercapnic conditions. 
Even between rodents there might be differences in the respiratory network. Of 
note to the work presented here, there is in vitro data (from neonatal brain slices) 
suggesting that in the preBötC of mice, but not rats, there is high ectonucleotidase 
activity that degrades ATP to adenosine, which subsequently acts antagonistically to ATP 
in order to inhibit respiratory drive. If such activity exists elsewhere in the brainstem of 
mice, e.g. the RTN, then the drive to breathe that is caused by ATP in mice might not be 
as clear-cut. 
 
5.2.3 Hypercapnia-induced auditory hypervigilance 
The VII innervates the stapedius, which attaches to, and controls dampening/amplifying 
vibrations of, the staples in the ear. This is turn dampens/amplifies the sound waves that 
are perceived by the brain (Drake, Vogl, and Mitchell 2009). Cx26-mediated ATP release 
could be responsible for either causing contraction or relaxation of the stapedius, 
thereby dampening or amplifying sounds (respectively). If Cx26-mediated ATP release 
were to relax the stapedius this would amplify sounds during periods of high CO2. Also, 
the Superior Olive (SO) sits just rostral and dorsal of the RTN (Figure 1.1). The medial SO 
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(MSO) and lateral SO (LSO) are initial relay stations for incoming auditory information 
from the cochlear nucleus. ATP release from the glia in question might diffuse towards 
these networks and act on them to improve their performance. 
It could be rationalised that sound enhancement during periods of high CO2 could 
be beneficial. When animals become very active during the 'fight or flight' response (e.g 
escaping or fighting predators) they will produce excess CO2. Under these circumstances 
it might be advantageous to amplify sounds in order to become more aware of 
threatening stimuli. Also, when rodents sleep in burrows the CO2 levels rise due to there 
being many bodies in a confined space. At night it might be advantageous for pray 
animals to heighten their sense of hearing in order to be more aware of roaming 
predators. This would be consistent with Cx26 evolutionary studies which have shown 
alligator Cx26 is not sensitive to CO2. This predator does not sleep in burrows or have 
any need to increase its hearing at night.  
It is well established that defects in Cx26 are a major contributor to hearing loss 
(Petersen and Willems 2006), however much of this pathology has been attributed to 
properties of Cx26 other than CO2 sensitivity. Given the infancy of Cx26 CO2 sensitivity 
research, it is feasible that additional and/or alternative mechanisms underlying Cx26-
related hearing loss are yet to be linked to this property. If such a connection existed 
between Cx26 CO2 sensitivity in the RTN and innervation of the stapedius, it would 
identify a novel Cx26-related mechanism that might be defective in certain patients and 
contribute to their hearing-loss pathology. Such a connection would also provide a link 
between the loss of CO2 sensitivity seen in KID syndrome mutants and the deafness 
symptoms that present in KID syndrome patents. This link would be in addition to that 
made between Cx26 CO2 sensitivity and reduced respiratory drive (Meigh et al. 2014). 
 
5.3 Better understanding central respiratory chemoreception: experimental 
considerations 
 
The in vitro and in vivo research that has been undertaken into understanding respiration 
has granted us some invaluable insight and understanding that has been, and will 
continue to be, of benefit for biomedical research and healthcare implications. However, 
when studying respiration there are a couple of considerations that cannot be 
	 165	
overlooked, for fear of producing conflicting interpretations and conclusions that are not 
fully relevant. 
 
5.3.1 Age dependent hypercapnic respiratory response  
Whilst there is debate over the changes in rodent HCVR from P0-P12 there is a general 
consensus that it increases from ~P12-P30 (Darnall 2010). At least one further change in 
chemoreception occurs over the lifetime of the animal, as older mice (32-44 weeks) show 
a lower HCVR than those in early adulthood (10-16 weeks) (Onodera et al. 1997). The 
precise reasons (mechanical and evolutionary) for these changes are unknown. 
Nonetheless, because the system witnesses these changes, age is an important factor for 
both experimental design and data interpretation. Many studies acquire data from 
neonates or report mixed data from neonatal in vitro slice recordings and in vivo 
plethysmography from animals at a much older age (sometimes adulthood). Conclusions 
made from these experiments should be accepted with caution (in the same way as data 
from anaesthetised animal should be).  
 In this thesis it has been suggested that Cx26 CO2-sensitivity is not important for 
chemoreception in the RTN in mice aged 3-4 months (which falls within the “adult 
period), however we cannot comment on the importance of Cx26 during other phases of 
development. We also provide evidence suggesting that Cx26 CO2-sensitivity is important 
in chemoreception in the caudal area of mice at this same age. This may seem 
contradictory to GPR4/TASK-2 double-KO mice that show complete abolishment of a 
HCVR, however this conclusion was made from a sample size of only 4 and so is not 
reliable (Kumar et al. 2015). Nevertheless, if this double-KO data were to be accepted 
then one explanation of our data is that glial chemosensitivity (including Cx26-mediated 
ATP release in the caudal region) only becomes important at later stages of 
development, when it takes over part of the role that GPR4/TASK-2 plays earlier in 
development. 
 If glia were to only take on a chemoreceptive role later in development it might 
be speculated that respiratory nuclei start off as vital components for chemoreception 
early in the lifespan of an animal, as the brain is smaller and chemosensory signals can 
easily penetrate to these neurons. However, as the brain grows throughout the animal’s 
life these nuclei end up residing further from the ventral surface than they once did; 
thereby relying on the emergence of new chemosensitive cell types that are more 
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suitably positioned (closer to blood vessels and the aCSF) and can take over some of the 
chemoreceptive responsibilities, sending signals via long processes. In the medulla, 
proliferation of glia ventral to respiratory nuclei might also provide extra protection and 
support for these nuclei – especially given that they are located in a part of the brain that 
is significantly more mobile and exposed than other parts. If glia were to mature into 
chemoreceptive roles throughout development there might be potential for future 
therapies to accelerate their development in young patients with central respiratory 
problems, thereby compensating for defects in CRCs responsible for neonatal 
chemoreception. 
 
5.3.2 Relevant experimental techniques 
The LV-GFAP:Cx26DN technique presented in this thesis aims to maintain the animal 
system in a state that is as physiological as possible. As has been discussed throughout 
this thesis, this method is more precise than KO genetic studies – both temporally and 
spatially refining the targeting of a specific component. It is also more physiological than 
optogenetic stimulation, which overstimulates the system and might stimulate a 
pathway that would not usually be activated in the animal - thus providing a false 
positive. In this way the LV-GFAP:Cx26DN method allows for accurate interpretations as to 
the relevance that Cx26 CO2-sensitivity, in distinct areas, has on modulating breathing. 
However even this technique can be criticised for disturbances it might cause within a 
system (see 5.1 Caveats of the LV-GFAP:Cx26 experiments). 
Perhaps the only truly physiological experiments would be those capable of 
imaging cellular activity live in conscious animals. Recording neuronal and glial firing in 
chemosensitive areas would provide us with definitive answers as to which cell 
populations are active under relevant hypercapnia conditions. From there, relevant CRCs 
(and their chemosensory transducers) can become the focus of research, with the aim of 
further understanding respiratory pathways and providing targets for therapeutic 
purposes.  
Other members of the Dale group have been able to record such activity from 
RTN neurons and glia using the latest in vivo Ca2+ imaging techniques. However, the 
results are highly unexpected. Using the head-mounted nVista microscope (Inscopix, 
USA) live Ca2+ imaging from neurons and glia in the VMS have been recorded. Very 
recent, unpublished, data shows that in the RTN of conscious adult mice there is no 
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neuronal or glial activation in response to hypercapnia (personal communication from 
Nicholas Dale). Interestingly the data also show that cells in the raphé magnus do 
respond to hypercapnia. This shows the importance for in vivo experiments to be 
performed under true physiological conditions and also reveals a revelationary discovery 
– that the RTN is not involved in responding to chemoreception in conscious adult 
animals but the raphé magnus is. Such a result supports the findings in this thesis – that 
removal of Cx26-mediated ATP release in the RTN has no effect on adaptive changes in 
breathing and must presumably have some other physiological role. Since the raphé 
magnus and RTN are close together, future experimenters need to be careful in targeting 
their manipulations precisely to these areas. 
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6 CONCLUSION 	
This thesis has detailed the progress made towards using a mutant version of the 
Connexin26 (Cx26) – dubbed ‘Dominant Negative’ Cx26 (Cx26DN) – to remove CO2-
sensitivty from cells natively expressing wild-type Cx26 protein (Cx26WT). This thesis has 
demonstrated that Cx26DN subunits remove CO2-induced hemichannel opening in a 
dominant negative manner by coassembling with Cx26WT to form heteromeric connexon 
hemichannels. In vivo expression of Cx26DN, to remove Cx26-mediated ATP release from 
glia at the ventral medullary surface (VMS), suggests that Cx26 plays no role in central 
respiratory chemoreception within the RTN but is likely to play a role in mediating tidal 
volume at the caudal chemosensitive site. Expression of Cx26DN in the caudal 
chemosensitive site was accidental and these experiments must be repeated in order 
confirm whether or not Cx26 expression is indeed important in this area. 
If Cx26DN expression is confirmed to reduce adaptive changes in tidal volume, 
these findings will not only shed light on our understanding of central respiratory 
chemoreception but will also validate the use of Cx26DN as a novel genetic tool that can 
elegantly remove Cx26 CO2 sensitivity from specific cells. By allowing us to selectively 
probe discrete populations of cells, at any stage of development, such a tool could 
spearhead research into the virtually unexplored role that Cx26 CO2 gating has in the 
body.   
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